University of Louisville

ThinkIR: The University of Louisville's Institutional Repository
Electronic Theses and Dissertations
8-2022

Translating particulate hexavalent chromium-induced
chromosome instability from human lung cells to experimental
animals, human lung tumors and whale cells.
Haiyan Lu
University of Louisville

Follow this and additional works at: https://ir.library.louisville.edu/etd
Part of the Medicine and Health Sciences Commons

Recommended Citation
Lu, Haiyan, "Translating particulate hexavalent chromium-induced chromosome instability from human
lung cells to experimental animals, human lung tumors and whale cells." (2022). Electronic Theses and
Dissertations. Paper 3963.
https://doi.org/10.18297/etd/3963

This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's
Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized
administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of
the author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu.

TRANSLATING PARTICULATE HEXAVALENT CHROMIUM-INDUCED
CHROMOSOME INSTABILITY FROM HUMAN LUNG CELLS TO
EXPERIMENTAL ANIMALS, HUMAN LUNG TUMORS AND WHALE CELLS
By
Haiyan Lu
M.D., Wenzhou Medical University, 2003
M.S., Wenzhou Medical University, 2008

A Dissertation
Submitted to the Faculty of the
School of Medicine of the University of Louisville
In Partial Fulfillment of the Requirements
for the Degree of
Doctor of Philosophy in Pharmacology and Toxicology
Department of Pharmacology and Toxicology
University of Louisville
Louisville, KY
August 2022

Copyright 2022 by Haiyan Lu
All Rights Reserved

TRANSLATING PARTICULATE HEXAVALENT CHROMIUM-INDUCED
CHROMOSOME INSTABILITY FROM HUMAN LUNG CELLS TO
EXPERIMENTAL ANIMALS, HUMAN LUNG TUMORS AND WHALE CELLS
By
Haiyan Lu
M.D., Wenzhou Medical University, 2003
M.S., Wenzhou Medical University, 2008
A Dissertation Approved on
July 27, 2022
By the following Dissertation Committee:

John Pierce Wise, Sr., Ph.D.
Lu Cai, M.D., Ph.D.
J. Calvin Kouokam, Ph.D.
Ke Jian Liu, Ph.D.
Sandra S. Wise, Ph.D.
Qunwei Zhang, Ph.D.

ii

DEDICATION
This dissertation is dedicated to my husband, Chunlei Qian. Thank you for
your unwavering love and unconditional support. Thank you for cheering me on as
I take on a new challenge. Thank you for taking care of the children over the years
and allowing me to conduct my scientific research without any worries. Your
support makes me successful!

iii

ACKNOWLEDGEMENTS
First, I would like to thank Dr. Wise, my mentor, for all his support, guidance,
and encouragement. He not only gave me the opportunity, but also gave me a lot
of patient support. His support made my research a success and made it possible
for me to become a scientist. His kindness, erudition, and passion for science have
guided me through the years. I would also like to thank him for his great
encouragement for me to believe in myself. I could not have imagined all the
incredible opportunities I have had because of his support and confidence in my
ability to succeed. I also thank him for holding pumpkin carvings, thanksgiving
dinners, Christmas parties, and Chinese New Year dumpling parties and for
fostering a wonderful work environment that always feels like a big, warm family.
I would also like to thank my doctoral committee: Dr. Lu Cai, Dr. Calvin
Kouokam, Dr. Ke Jian Liu, Dr. Sandra Wise, and Dr. Qunwei Zhang for all their
knowledge, guidance, and suggestions during all these years. Thank you to Dr.
Hein for all the guidance and support over the past 6 years as a leader of the
Department of Pharmacology and Toxicology, and to everyone in the Department
for the opportunity to learn so much more through the research and inspiration
over the years.
I also want to thank everyone in the Wise Lab (current and past members).
Special thanks to Dr. Sandy Wise, Dr. Rachel Speer and Dr. Cynthia Browning for

iv

their guidance, support, and great training when I first started in the lab. Special
thanks to Dr. Tayler Croom-Pérez and Dr. Adam Pérez for their guidance and great
training in lab techniques. Thanks to Jennifer Toyoda, Idoia Meaza, and Aggie
Williams for their support and friendship. Thanks to Dr. Gary Hoyle and Dr. Jamie
Young for their training in animal experiments. Thanks to Dr. John Wise Jr., for
training in the confocal technique. Thanks to Dr. Jun Yan for teaching me flow
cytometry techniques. Thanks to Dr. Alicia Bolt for assistance in flow cytometry
experiments.
Finally, I must thank my family and friends who have always supported me.
Thank you for always having confidence in my ability to succeed and for providing
so much support. I want to thank my parents and mother-in-law, their love greatly
encouraged me, and financial support help me through these years. I also want to
thank my husband, Chunlei, for all the support and made me grow so much with
his help. Thanks to my son, Leon, for his smile giving me hope while the difficult
days. Thanks to my daughter, Daisy, for her company and love. I am so grateful
for everything you have ever done for me.
This dissertation would not have been possible without all the financial
support provided by many different sources. I received numerous travel awards
and research awards from the University of Louisville and the Society of Toxicology
which allowed me to present my research at many conferences. This work was
supported by the National Institute of Environmental Health Sciences
[R01ES016893 and R35ES032876 to JPWSr.] and the University of Louisville
School of Medicine Basic Grants Program (SSW).

v

ABSTRACT
TRANSLATING PARTICULATE HEXAVALENT CHROMIUM-INDUCED
CHROMOSOME INSTABILITY FROM HUMAN LUNG CELLS TO
EXPERIMENTAL ANIMALS, HUMAN LUNG TUMORS AND WHALE CELLS
Haiyan Lu
July 27, 2022
Lung cancer is a major human health problem. While smoking is the most
well-known cause of lung cancer, people who never smoked develop the disease.
Understanding how non-tobacco environmental carcinogens cause lung cancer is
key to combating this disease. Hexavalent chromium [Cr(VI)] is a well-established
human lung carcinogen, but its carcinogenic mechanism is uncertain.
Chromosome instability (CIN) is a hallmark of lung cancer and a major
factor in Cr(VI)-induced lung cancer. Studies in human lung cells show Cr(VI)
induces DNA double strand breaks and suppresses homologous recombination
(HR) repair by targeting RAD51, resulting in CIN.
We translated these outcomes to rats, as this species develops Cr(VI)induced lung tumors. We exposed 12-week-old Wistar rats to a single dose of zinc
chromate for 24 hours or a weekly dose for 90 days via oropharyngeal aspiration.
DNA double strand breaks and HR repair increased in a concentration-dependent
manner in rat lungs after 24-hour Cr(VI) exposure. After 90-day exposure, DNA
double strand breaks increased, but HR repair decreased. These effects were
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distinct in bronchioles but muted in alveoli, consistent with Cr(VI)-induced human
lung tumors originating in bronchial epithelium.
We translated these outcomes to Cr(VI)-associated human lung tumors.
DNA double strand breaks significantly increased but RAD51 expression
decreased in lung tumors; demonstrating Cr(VI)-induced DNA double strand
breaks and HR inhibition persist in tumors.
Long-lived whales can experience long-term exposure to environmental
contaminants but have low cancer rates. We measured the ability of Cr(VI) to
induce DNA double strand breaks, HR repair, and chromosome damage in
bowhead whale lung cells. Cr(VI) induced DNA strand breaks in whale cells, but
the HR repair response remained intact. Thus, whale cells are resistant to Cr(VI)induced loss of HR repair with no apparent CIN. These results indicate significant
differences in the response of human and bowhead whale lung cells to Cr(VI)
exposure.
Overall, our studies translate Cr(VI)-induced DNA double strand breaks and
HR repair impacts to rat lung tissue, human lung tumors and whale lung cells.
Cr(VI) induces DNA double strand breaks and inhibits HR repair in vivo, but does
not cause HR repair failure and CIN in whale lung cells.
.
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CHAPTER I
INTRODUCTION

Chromium
Discovery and use history
Chromium (Cr), atomic number 24, is a relatively abundant element present
in the Earth’s crust. It was discovered in 1797 by the French chemist LouisNicholas Vauquelin while examining a material known as crocoite (PbCrO4), a
mineral (Kyle and Shampo, 1989). The following year he isolated metallic
chromium from the chromium ore, crocoite (IARC, 1990). Its brilliant color inspired
Vauquelin to give the metal its current name (from the Greek word “chroma”,
meaning color). Chromium is a hard, steel-gray metal widely dispersed in natural
deposits. It is always combined with other elements, especially oxygen. Chromite
(FeCr2O4) is the major ore, and the ores are refined to metal after mining. Ironcontaining chromium was first produced in the mid-19th century, and the first use
of chromium as an alloying agent in the steel manufacture took place in France in
the 1860s.
With the discovery of global chromite deposits, the chromium industry has
developed rapidly (Barnhart, 1997). In 2013, the largest producers of chromium
ore were South Africa (48%), Kazakhstan (13%), Turkey (11%), and India (10%),
and chromium ore production in several other countries accounted for about 18%
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of the world production (Papp, 2015). In 2019, the global production of chrome ore
increased to 44,000 kilotons. The largest producers were South Africa (38.6%),
India (22.7%), and Kazakhstan (15.2%) (Schulte, 2020).
Although only small amounts of chromium are mined in the United States,
the latter is a major producer of chromium end products, including chromium
chemicals, metals, and stainless steel (ATSDR, 2012). Chromium is a hard metal
that requires a high polish and has a high melting point. Due to its hardness and
resistance to corrosion, chromium is used in alloys and stainless steel to increase
the hardening ability and corrosion resistance (ATSDR, 2012; Barnhart, 1997).
Globally, approximately 80% of chromium is used in metallurgical applications,
from chrome plating to stainless steel production. Chromium salts show a variety
of bright colors, which justify their use in many other applications, including
pigment production, leather tanning, and the production of wood preservatives
(ATSDR, 2012; Barnhart, 1997).

Physical and chemical properties
Cr exists in many chemical and physical forms that are different in their
environmental behaviors and biological activities. While the valence states of Cr
range from -2 to +6, Cr(0), Cr(III), and Cr(VI) are the three main oxidative states of
Cr that are most commonly present in the workplace and general environment
(Pechova et al., 2007). Cr compounds with oxidation states of +1, +2, +4, and +5
are very unstable and rarely occur in the environment. Cr(0) is usually encountered
in the form of metal in alloys with other metals such as nickel, iron, and cobalt.
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Stainless steel is the product with the largest amount of metal chromium. Although
Cr(0) is stable to atmospheric oxygen oxidation under ambient conditions, hightemperature processes (such as welding or exposure to corrosive chemicals)
result in the formation of higher oxidation states: Cr(III) and Cr(VI). Cr-based
prostheses may also undergo slow oxidation, thereby releasing higher oxidation
forms of Cr (Case et al., 1994; Merritt et al., 1995). Cr(III) is easily found in nature,
but Cr(VI) rarely occurs and is mainly produced through industrial activities (Kotas
et al., 2000).
Chromium compounds are usually classified as soluble or insoluble in
water. Common water-soluble compounds include chromium chloride, chromium
acetate, sodium chromate, and potassium chromate; water-insoluble chromium
compounds include chromium oxide, chromium sulfate, lead chromate, and zinc
chromate (IARC, 1990). The mutual transformation between Cr (VI) and Cr (III) can
occur naturally in the environment. These chemical reactions depend on many
factors such as the availability of oxygen, the capacity of oxidizing or reducing
agents, temperature, and pH. Generally, under acidic conditions, Cr (VI) can be
reduced to Cr (III), while under alkaline conditions, Cr (III) can be oxidized to Cr
(VI) (Kotaś et al., 2000; Richard et al., 1991; Zhitkovich, 2005). Due to the organic
matter in biological systems, Cr (VI) is also quickly reduced to Cr (III). However,
oxidation from Cr (III) to Cr (VI) does not occur in biological systems (Barceloux et
al.,1999; Dayne et al., 2001).
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Chromium exposure
Environmental exposure
Cr is naturally present in the environment through the presence of
continental dust, which is released due to soil and rock erosion or volcanic
eruptions (Kotaś et al., 2000). However, most Cr(VI) is released into the
environment through anthropogenic activities (ATSDR, 2012). Due to Cr’s
widespread use, the anthropogenic sources include fixed points in the metal, textile
and cement industries, as well as leather tanneries. According to the Toxics
Release Inventory, about 36 million lbs of Cr compounds were released into US
waters, soils, and air in 2009 (ATSDR, 2012).
Anthropogenic activities account for 60-70% of all Cr in the atmosphere
(Bielicka et al., 2005). Cr is released into the atmosphere by burning of fossil fuels,
incineration of electronic waste, production of refractory bricks, cement
processing, and production of chromium-containing pigments (Catrambone et al.,
2013; Singh et al., 2015). In a survey between 1977 and 1984, typical airborne
total chromium concentrations in the US were between 0.01 and 0.03 ug/m3
(ATSDR, 2000). Industrial disposal of Cr-containing dust can significantly increase
non-occupational exposure. Estimates of atmospheric chromium emissions in Los
Angeles, California, and Houston, Texas in 1976 and 1980 showed that emissions
from combustion of fixed fuels accounted for about 46-47% of the total Cr, and
emissions from the metal industry range from 26 to 45% of the total Cr. (ATSDR,
2000). The combustion of coal and oil is estimated to emit 1,723 tons of chromium
in the atmosphere each year. However, only 0.2% of this chromium is Cr(VI).
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Meanwhile, it is estimated that the chrome-plating source contributes 700 metric
tons of chromium annually to air pollution, of which 100% is considered to be Cr(VI)
(ATSDR, 2000).
Many Cr(VI) compounds have high water solubility, and at neutral pH,
monochromate may be found as a pollutant in groundwater. However, in the
presence of low pH and/or organic materials, Cr(VI) tends to be reduced to Cr (III).
Although Cr(VI) released into the soil is expected to be reduced to the trivalent
state, in case of high concentration in water or low reducing power of the soil (for
example in sandy soil), Cr(VI) may not be reduced before it gets to groundwater
(Paustenbach et al., 2003). Electroplating, leather tanning and textile industries
release relatively large amounts of chromium into surface water. Leaching from
topsoil and rocks is the most important natural source of chromium into water
bodies. If the solid waste generated by chromate treatment facilities is not properly
processed in a landfill, it may become a source of groundwater pollution, and the
residence time of chromium may be several years (ATSDR, 2011). According to
the Toxics Release Inventory, in 1997, it was estimated that the chromium
released into water from 3,391 large-scale processing facilities was 111,384
pounds, accounting for about 0.3% of the total environmental emissions (ATSDR,
2000).
Cr(VI) enters the soil mainly through waste disposal activities. Between
1991 and 1994, about 39 tons and 162 tons of total Cr(VI) as sewage sludge were
disposed to landfills and farmland annually, respectively (DoE, 1996). Industrial
solid Cr(VI) waste is mostly dumped in restricted landfills nowadays. However, past
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industrial activities have caused severe land pollution. The world's largest chrome
producer in the 19th century (headquartered in Shawfield, Scotland, operating until
1967) widely used chromite ore processing residues as landfill materials in
southeastern Glasgow. According to reports, between 1960 and 1966, 60 to 70
tons of Cr(VI) waste were dumped every day (EHD, 1991a). According to the
Toxics Release Inventory, the estimated chromium released into the soil from
3,391 large-scale processing facilities in the United States in 1997 was 30,862,235
pounds, accounting for approximately 94.1% of total environmental emissions
(ATSDR, 2000).

Occupational exposure
As Cr is commonly used in metallurgical and chemical industries, workers
experience exposure through inhalation of dust, mists, or fumes, and direct dermal
contact with chromium-containing materials. More than 80 occupations that may
expose chromium have been identified (IARC, 1990). In 1994, Meridian Research,
Inc. estimated that there are 808,177 production workers may be exposed to Cr
(VI) in U.S. industries (Meridian, 1994). The industries involved in the survey
include electroplating, welding, painting, paint and coating manufacturers;
chromate producers, chromate pigment manufacturers, CCA manufacturers,
printing ink manufacturers, chromium catalyst manufacturers, plastic colorant
manufacturers, plating mixture manufacturers, producers of wood preserving
materials, ferrochromium producers, iron and steel foundries. More than 98% of
the potentially exposed workers were found in six industries: electroplating,
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painting, welding, paint and coating production, iron and steel foundries, and iron
and steel production. Although occupational exposure in the U.S. has decreased
significantly since the 1980s due to improved emissions control, in 2006, the
Occupational Safety and Health Administration (OSHA) estimated that 558,000
American workers were exposed to Cr (VI) compounds. Of these, 352,000 were
exposed to more than 0.25 micrograms per cubic meter, and 68,000 were above
the permissible exposure limit (PEL) of 5 micrograms per cubic meter (OSHA,
2006). Table 1.1 shows the estimated number of workers exposed by the
application group (Shaw Environmental, 2006).
Specifically, workers engaged in industrial or chromite production are
exposed to higher levels of Cr(VI) compared to the general public (ATSDR, 2012).
In particular, the occupations with the highest potential risks are metallurgy,
tanning, pigment production, and chromate manufacturing (ATSDR, 2012). In the
occupational environment, the content of hexavalent chromium in the air may vary
depending on the occupation, with concentrations of 5-600 ug/m3 (Stern, 1982).
Table 1.2 shows the inhalation exposure levels in chromium industries. In 1971,
OSHA introduced the PEL of 52 ug/m3 for Cr(VI). Even when the PEL of Cr (VI)
came into effect, stricter regulations came into effect when the PEL was reduced
to 5 ug/m3 in 2006 (OSHA, 2006). However, the occupational exposure limits for
insoluble hexavalent chromium compounds in other countries are still high (Table
1.3).
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Table 1.1 Estimated number of workers exposed to Cr(VI) by application group

Total Number of Exposed

Application Group

Workers

Welding (stainless steel)

127,746

Welding (carbon steel)

141,633

Painting

82,253

Electroplating

66,859

Steel Mills

39,720

Iron and Steel Foundries

30,222

Textile Dyeing

25,341

Wood Working

14,780

Printing

6,600

Paint and Coating Producers

2,569

Producers of Chromates

150

Chromium Dye Producers

104

Adapted from Federal Register 10099, Table VIII-3 (2006)
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Table 1.2 Airborne Cr(VI) levels in various industries.

Total Airborne Cr(VI)
Industry

Levels (ug/m³)

Chrome plating

5-25

Ferrochrome alloy production

10-140

Stainless-steel industry welding

50-400

Chrome pigment production

60-600

Cr(VI) production

100-500

Adapted from Stern et al. (1982)

Table 1.3 Occupational exposure limits for insoluble Cr(VI) in different countries

Country

Insoluble Cr(VI) TWA (ug/m³)

Australia

50

Ireland

50

Japan

10

Mexico

10

Netherlands

10

Poland

100

Sweden

20

United Kingdom

50

Adapted from ACGIH (2011). *TWA= time weighted average
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Health effects of chromium exposure on the respiratory system
Chromium in different valences differs in toxicity and chemical properties.
While Cr (III) compounds serve as a nutritional supplement and appear to have
pharmacological effects in certain diabetic populations, Cr (VI) compounds
generally exert carcinogenic effects in exposed individuals, as well as injuries in
cells, including DNA damage, chromosomal aberrations, and microsatellite
instability (Zhitkovich, 2005; O’Brien, 2003; Nickens et al., 2010; Wise et al., 2012).
Cr(VI) enters the body through inhalation, ingestion, or absorption through the skin.
For occupational exposure, the respiratory tract and skin are the main routes of
absorption. Various physical, physiological, and anatomical factors determine the
fraction and regional deposition of inhaled particles (OSHA, 2006). Due to the
airflow pattern in the airway, more particles tend to deposit in certain prone areas
in the lung. Therefore, this may cause chromium to accumulate in certain locations
of the bronchial tree, resulting in high chromium concentrations in these areas
(OSHA, 2006). Large inhaled particles (> 5 um) are effectively removed from the
airflow in the extrathoracic area. Particles larger than 2.5 um are usually deposited
in the tracheobronchial area, while particles smaller than 2.5 um are usually
deposited in the lung area (OSHA, 2006). Yu et al. found the particle size
distribution of Cr(VI) ranged from 0.18 to 18 um in the New Jersey Meadowlands
District. In the particle size range of 1.0 to 5.6 um, the Cr(VI) concentration was
higher than other particle size fractions and Cr(VI) was enriched in particles with
diameter less than 2.5 um (Yu et al., 2014). The particles deposited in the
extrathoracic and tracheobronchial regions of the lung are predominantly cleared
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by the mucociliary escalator. Individuals exposed to high concentrations of Cr(VI)
may also have altered respiratory mucosal cilia clearance (OSHA, 2006). The
particles that reach the alveoli can be absorbed by the blood or cleared by
phagocytosis.
The absorption of inhaled chromium compounds depends on various
factors, including the physical and chemical properties of the particles (size,
solubility, oxidation state) and the activity of alveolar macrophages. Hexavalent
chromate anions enter cells by facilitated diffusion, through non-specific anion
channels (similar to phosphate and sulfate anions) (Wiegand et al., 1985), while
Cr(III) compounds cannot pass through the cell membrane using this means (Gray
and Sterling, 1950). Chromium has been found in the tissues of chromium workers,
indicating that chromium can be absorbed from the lungs (Cavalleri and Minoia,
1985; Gylseth et al., 1977; Minoia and Cavalleri, 1988; Randall and Gibson, 1987).
Animal studies have also shown blood amounts of chromium increase after
inhalation or intratracheal instillation (Bragt and van Dura, 1983; Langård et al.,
1978; Wiegand et al., 1987). Unabsorbed chromium in the lungs can be removed
by mucociliary clearance and enter the gastrointestinal tract.
The respiratory tract is the main target for the inhalation of chromium
compounds. In 2012, an ATSDR review showed many reports and studies
published from 1939 to 1991 found workers exposed to Cr(VI) compounds for
different durations from 15 to 364 days had the following respiratory effects:
nosebleeds, chronic rhinorrhea, itchy and sore nose, nasal mucosa atrophy,
perforations, nasal septal ulcers, bronchitis, pneumoconiosis, decreased lung

11

function and pneumonia (ATSDR, 2012).
Numerous studies have reported nasal septal perforation and other
respiratory effects on workers chronically exposed to Cr(VI) compounds. NIOSH
reported that 4 of 11 male employees exposed to “hard-chrome” in an Ohio
electroplating facility had nasal septum perforation (NIOSH, 1975c). Totally 11
cases of nasal septal perforation were reported in 2,869 shipyard welders in South
Korea. The affected workers had welded for 12-25 years. The concentration of
Cr(VI) in welding fumes ranged from 0.044 mg/m3 to 0.34 mg/m3 in their workshop
(Lee et al., 2002).
Two cross-sectional epidemiological studies of chrome plating workers and
stainless-steel production workers showed no nasal septal perforation at an
average chromic acid concentration < 2 ug/m3. The workers exposed to Cr(VI)
experienced nasal ulcers and/or nasal septal perforation at concentrations from 2
ug/m3 to 20 ug/m3. Nasal mucosal ulcers and/or nasal septal perforation appeared
in exposed workers at the peak concentrations of 20-46 ug/m3 (Lindberg and
Hedenstierna, 1983; Huvinen et al., 1996; 2002a,b). Cr(VI) is considered a
respiratory sensitizer that can trigger immune-mediated narrowing of airways and
inflammation of bronchial tubes, causing asthma. Not all exposed workers are
sensitive to Cr(VI); Cr(VI)-triggered asthma only occurs in sensitized individuals.
The level of occupational exposure to Cr(VI) causing airway sensitization or
occupational development of asthma is unclear (OSHA, 2006). Many case studies
and reports have shown an association between occupational chromate exposure
and asthma (Bright et al., 1997; Budanova, 1980; Burges et al., 1994; Fernandez-

12

Nieto et al., 2006; Hannu et al., 2005; Leroyer et al., 1998; Moller et al., 1986; Park
et al., 1994).

Chromium carcinogenicity
A large number of epidemiological studies of chromate workers have
provided conclusive evidence that Cr is a carcinogen. This was supported by the
results of subsequent numerous animal and cell culture studies. In 1990, the IARC
classified Cr as a Group 1 carcinogen, considered “carcinogenic to humans”
(IARC, 1990). Epidemiological studies have shown the main target organ of Cr is
the lung. Therefore, the following discussion focuses on the carcinogenicity of Cr
to the lung.

Epidemiology studies of Cr(VI) exposed workers
Many studies have examined the ability of Cr(VI) to induce carcinogenic
effects, specifically lung cancers. In 1948, Machle and Gregorious reported the
first study on Cr(VI)-induced lung cancer in the US. This first comprehensive
epidemiological study found that 21.8% of all deaths in the chromate industry were
due to cancers of the respiratory system. More importantly, the latter study
concluded that it appears the problem in the chromium industry is limited to
cancers of the respiratory system, suggesting that chromium targets the lung
(Machle and Gregorious, 1948). Since then, a large number of studies have
successively reported the incidence of lung cancer among chromium workers
(Alderson et al., 1981; Satoh et al., 1981; Korallus et al., 1982; Langard, 1990;
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Gibb et al., 2000; Luippold et al., 2003; Luippold et al., 2005; Birk et al., 2006).
Epidemiological studies have shown that insoluble, particulate Cr(VI) compounds
are more carcinogenic than soluble Cr(VI) compounds (Baetjer, 1950; Hayes et al.,
1979; Alderson et al., 1981; NIOSH, 2006). Epidemiological studies targeting
specific chromate compounds are difficult due to the confounding nature of
occupational exposures. However, an increased incidence of bronchial cancer was
found in workers exposed to sodium chromate (raw material for the production of
zinc chromate) and zinc chromate in a zinc chromate production factory (Langard
and Norseth, 1975). In addition, a factory that exclusively used zinc chromate
pigments had high chromate tumor incidence among workers (Langard and
Vigander, 1983). Pathological examination showed Cr particles are deposited at
the bifurcation of the bronchus, which are the main formation sites of chromiuminduced tumors (Ishikawa et al., 1994a). Kondo et al. reported Cr accumulates in
the bronchial stroma instead of epithelial cells, and Cr levels are higher in the
bronchioles and subpleural areas of the lung (Kondo et al., 2003). There is a strong
correlation between cumulative exposure to Cr and lung cancer, with lung cancer
mortality increasing with exposure time (Davies et al., 1984; Gibb et al., 2000;
Luippold et al., 2003). The main pathological type of Cr-induced lung tumors is
squamous cell carcinoma, with a small percentage of small cell carcinoma and
adenocarcinoma (Ewis et al., 2001; Ewis et al., 2006; Hirose et al., 2002; Katabami
et al., 2000; Kondo et al., 1997).

Evidence from animal studies
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Chronic inhalation studies provide evidence that Cr(VI) is carcinogenic in
animals. Multiple studies have shown Cr induces tumor formation in the lungs of
experimental animals. For example, lung tumors were observed in Wistar rats
exposed to sodium dichromate aerosol (0.1 mg Cr/m3) for 18 months (Glaser et al.
1986). Tumor formation was found in the lungs of Sprague Dawley rats
continuously administered 1.25 mg/kg sodium dichromate solution by intratracheal
instillation once weekly for 30 months (Steinhoff et al. 1986). Takahashi et al. found
1 squamous cell carcinoma, 7 carcinomas in situ or dysplasia, 8 squamous
metaplasia, and 5 goblet cell hyperplasia in 15 rats after inserting a pellet of
strontium chromate into the bronchus for 9 months. Chromium accumulation
increases significantly with the progression of bronchial epithelial malignancy
(Takahashi et al. 2005b). Among 20 different Cr compounds tested, strontium
chromate induced the highest number of bronchial carcinomas, followed by zinc
chromate and lead chromate (Levy et al., 1986). Levy and Venitt reported
squamous metaplasia is increased in rats exposed to Cr(VI)-materials but not
increased in rats exposed to Cr(III) materials. Of the rats exposed to Cr(VI), only
those receiving insoluble materials developed bronchial squamous carcinoma
(Levy and Venitt 1986).

Evidence from cell culture studies
The carcinogenicity of chromium has also been demonstrated in many cell
culture studies. Cr(VI) compounds have the ability to induce cellular transformation
in various cell lines (Patierno et al., 1988; Elias et al., 1989; Xie et al., 2007;

15

Rodrigues et al., 2009). Recently, multiple studies have shown lung epithelial
BEAS-2B cells or BEP2D cells can be transformed by Cr(VI) compounds (Azad et
al., 2010; Park et al., 2016; Sun et al., 2011; Xie et al., 2007). Moreover, tumor
formation was found when Cr(VI)-transformed cells were injected into nude mice
(Rodrigues et al., 2009; Sun et al. 2011, Wang et al. 2011). Cell culture studies
further confirmed that particulate Cr(VI) is more carcinogenic than soluble Cr(VI).
Elias et al. found chromate pigments containing Zn or Pb with moderate to very
low water solubility can induce neoplastic transformation in SHE cells (Elias et al.,
1989). Other studies found particulate lead chromate is more cytotoxic and
genotoxic to human lung cells than soluble sodium chromate (Wise et al., 2002;
Wise et al., 2006a). These studies have shown Cr(VI) has carcinogenic potential
and particulate chromium is more carcinogenic, but further mechanistic information
is still under investigation.

Characteristics of Cr-induced lung tumors
Pathological examination showed Cr-induced lung tumors were mainly
squamous cell carcinoma, and a small part was small cell carcinoma and
adenocarcinoma (Ewis et al., 2001; Ewis et al., 2006; Ishikawa Y et al., 1994a;
Ishikawa Y et al., 1994b; Kondo et al., 1997). Kondo et al. found precancerous
manifestations of atypical hyperplasia and squamous metaplasia in bronchial
biopsy specimens of follow-up chromium workers, and with the progression of
bronchial epithelial malignancy, the accumulation of chromium in corresponding
parts increased significantly (Kondo et al., 2003). Cumulative Cr exposure is
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strongly associated with lung cancer, and lung cancer mortality increases with the
duration of Cr exposure (Davies et al., 1984; Gibb et al., 2000; Luippold et al.,
2003). Pathological examination revealed Cr particles deposited at the bronchial
bifurcations, which are the main sites of Cr-induced tumor formation (Ishikawa et
al., 1994a). Kondo et al. found the deposition site of inhaled Cr in the lung was the
bronchial stroma, not the epithelium, and accumulated at higher levels in the
bronchioles and subpleural areas of the lung (Kondo et al., 2003).
Little evidence of mutations in key oncogenes or tumor suppressor genes
has been found in molecular studies in Cr-induced tumors. Ewis et al. found no
point mutations at key positions in the Ha-ras and Ki-ras oncogenes in chromateassociated lung cancer samples (Ewis et al., 2001). This study suggests point
mutation-activated Ras oncogene does not play a major role in the oncogenic
mechanism of chromate-induced lung cancer. Kondo et al. found a lower rate of
missense mutations in p53 in chromate lung cancer samples than in lung cancer
patients who had not been exposed to chromate, and did not find base changes in
p53 that are common in lung cancer (Kondo et al., 1997). Studies have found
microsatellite instability and epigenetic changes in chromate lung cancer
(Takahashi et al., 2005a; Kondo et al., 2006). Takahashi et al. found the majority
of chromate-associated lung cancers exhibited two or more loci of microsatellite
instability (MSI) compared with chromate-naïve lung cancer patients. In addition,
the length of chromate exposure was associated with the incidence of MSI. This
study suggests the carcinogenic mechanism of chromate lung cancer may be
different from that of non-chromate lung cancer (Takahashi et al., 2005a).
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Takahashi et al. found the frequency of replication errors in chromate lung cancer
was very high, and the inhibition rate of DNA mismatch repair genes hMLH1 and
hMSH2 proteins in chromate lung cancer was significantly higher than that in nonchromate lung cancer. This study demonstrates a strong correlation between
inactivation of hMLH1 expression and microsatellite hyperinstability in chromate
lung cancer and speculates that inhibition of hMLH1 protein causes genetic
instability in chromate lung cancer (Takahashi et al., 2005a). Ali et al. found the
methylation rates of CpG islands in APC, MGMT, and hMLH1 genes in chromate
lung cancer were significantly higher than those in non-chromate lung cancer (Ali
et al., 2011). Kondo et al found decreased expression and aberrant methylation of
p16 in chromate lung cancer (Kondo et al., 2006). These studies suggest
methylation of certain tumor suppressor genes may be associated with genomic
instability in chromate lung cancer. In addition, one study found the expression of
the anti-apoptotic protein surviving was decreased in small cell lung cancer type
chromate lung cancer, but not P53 (Halasova et al., 2010). Pulmonary surfactant
protein is important for normal lung function and clearance of dust from the upper
respiratory tract (Griese, 1999). Ewis et al. found the chromate lung cancer group
had significantly higher surfactant protein B variants (deletions/insertions) than the
non-chromate lung cancer group, healthy individuals, and chromate workers
without lung cancer (Ewis et al., 2006). The mutation of pulmonary surfactant
protein B leads to damage of the pulmonary surfactant system and affects the
clearance of chromium particles in the respiratory tract, which is considered to be
related to the occurrence of lung cancer caused by chromate (Ewis et al., 2006).
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Proposed mechanism of chromium-induced carcinogenesis
Research into the carcinogenic mechanism of Cr(VI) has been ongoing for
decades since the IARC identified chromium and chromium compounds as
carcinogens. The exact mechanism of Cr(VI) carcinogenesis and its details have
not yet emerged. In the following sections, we discuss the key features that have
been studied in these oncogenic drivers and the events that led to their
development.

The role of physicochemical properties of Cr in Cr-induced carcinogenesis
The physicochemical properties of Cr play a crucial role in the mechanism
of Cr(VI)-induced carcinogenesis. Uptake and metabolism are important aspects
of Cr(VI) carcinogenicity. Studies have shown Cr(VI) compounds partially dissolve
extracellularly to form metal cations and chromate oxyanions (Wise et al., 1993;
Xie et al., 2004). Chromate is structurally similar to sulfate and phosphate, which
makes it easy to enter cells through anion transport channels (Wiegand et al.,
1985; Sehlmeyer et al., 1990; Alexander and Aaseth, 1995). Inside the cell, Cr(VI)
is rapidly reduced to Cr(III), forming a stable complex with proteins and DNA, which
causes high accumulation of metals in cells (Sehlmeyer et al., 1990). This
metabolic process is performed by naturally occurring intracellular antioxidants
such as cysteine, ascorbate and glutathione (Suzuki and Fukuda, 1990;
Standeven and Wetterhahn, 1991; Standeven and Wetterhahn, 1992; Quievryn et
al., 2001). Other potential intracellular Cr(VI) reducing agents include cytochrome
P450 reductase, mitochondrial electron transport complexes, aldehyde oxidase,
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and glutathione reductase (Mikalsen et al., 1989; Ryberg and Alexander, 1984;
Banks and Cooke, 1986; Shi and Dalal, 1989). Reactive oxygen species released
during the reduction process can cause oxidative damage to key molecules in cells,
including DNA, RNA, proteins, and lipids (Leonard et al., 2004; Wang et al., 2011).
Cr(V) and Cr(IV) are produced during the reduction process. The reactive
intermediates directly interact with DNA to form Cr-DNA adducts (Snow and Xu,
1991; Bridgewater et al., 1994; Zhitkovich et al., 1995; Quievryn et al., 2002). It is
generally accepted that the reduction process is a critical part of Cr(VI)
carcinogenesis. However, if chromate particles are phagocytosed into cells, there
appears to be no toxic effect as well as no apparent effect of the cation (Xie et al.,
2004; Wise et al.,1993).
The solubility of Cr compounds is an important factor affecting the
carcinogenicity of Cr. Epidemiological studies have shown insoluble chromate is
more carcinogenic than soluble chromate, as evidenced by reduced lung cancer
incidence among chromate workers after the removal of lime from the production
process, thereby eliminating the production of insoluble calcium chromate (Davies
et al., 1991). Experimental studies also support that the solubility of chromium
affects its carcinogenic potential. Several studies have shown particulate Cr(VI)
induces tumor formation in rat lungs when administered as intrabronchial
particulates (Balansky et al., 2000; Levy and Venitt, 1986; Levy et al. 1986), but
soluble Cr(VI) did not induce an increase in tumor formation (Levy et al., 1986). A
cell experiment found particulate Cr(VI) induces tumor transformation in
C3H/10T1/2 cells, while soluble Cr(VI) does not (Patierno et al., 1988).
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Cr(VI)-induced DNA damage and chromosome instability
Cr(VI) has complex genotoxicity, which is characterized by damage to DNA
bases and sugar-phosphate backbone (Tsapakos and Wetterhahn 1983,
Gulanowski et al., 1992; Voitkun et al., 1998). The mechanism of Cr-induced
formation of DNA damage can involve Cr-DNA interactions (direct), reactive
oxygen species (ROS) (indirect) or carbon radicals (indirect) (Sugden and Stearns,
2000). Reduction of Cr(VI) can lead to the generation of various lesions, including
oxidized bases, Cr-DNA base/phosphate adducts, protein-Cr-DNA cross-links (CrDPC), Asc-Cr-DNA plus complexes, DNA–DNA interstrand crosslinks and DNA
strand breaks (Stearns and Wetterhahn, 1994; Stearns et al., 1994; Zhitkovich et
al., 1996; Arakawa et al., 2000; Bridgewater et al., 1994; Casadevall and
Kortenkamp, 1995; Casadevall et al., 1999; Stearns et al., 1995). DNA double
strand breaks after Cr(VI) exposure are well documented (Qin et al., 2014; Xie et
al., 2005; Wise et al., 2010).
If left unresolved or repair fails, DNA double strand breaks can result in
chromosomal instability (Masuda and Takahashi, 2002). Chromosome instability
is a hallmark of human tumors. Chromosomal instability is present in most lung
cancers and has been detected in chromate-induced tumors (Maeng et al., 2004).
Chromosomal instability can be a numerical change or a change in chromosome
structure. This dissertation focuses on structural chromosomal instability.

Structural chromosomal instability
Structural chromosomal instability involves changes in the physical
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structure of the genome, usually manifested as nucleotide deletions, chromosomal
breaks, unequal exchanges of genetic material or translocations between two
chromosomes (Albertson et al., 2003). Structural chromosomal instability has been
studied in chromate workers. Conventional Giemsa staining and fluorescence in
situ hybridization (FISH) have been used for chromosomal aberration analysis.
Maeng et al. found blood Cr concentrations were statistically correlated with the
frequency

of

chromatid

exchange

and

the

total

frequency

of

chromosome/chromatid breaks and exchanges, as measured by Giemsa staining.
Meanwhile, the frequency of translocations, insertions and acentric fragments
detected by the FISH technique was significantly higher in Cr-exposed workers
than in controls, also correlating with blood Cr concentrations (Maeng et al., 2004).
Halasova et al. found total chromosomal aberrations were higher in exposed
individuals than in controls among welders exposed to hexavalent chromium for a
long time, and that the number of chromosomal types of breakage was almost
twice as high in exposed individuals (Halasova et al., 2008). Moreover, Chromatidtype aberrations are positively correlated with blood chromium levels (Halasova et
al., 2012).
Cell culture studies have provided substantial data supporting Cr(VI)induced structural chromosomal instability. Chromosomal aberrations increase in
a concentration-dependent manner in cultured cells after exposure to Cr (Wise et
al., 2002; Wise et al., 2003; Wise et al., 2006a; Xie et al., 2005; Xie et al., 2009;
Qin et al., 2014). Both particulate and soluble Cr(VI) cause chromosomal
aberrations in cultured cells, as demonstrated by numerous studies. Chromosome
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damage profiles in human lung cells were similar after exposure to lead chromate
and sodium chromate, with chromatid lesions being the most common type.
Aberrations become more complex with increasing concentrations, with damage
to entire chromosomes such as isochromatid lesions, chromatid exchanges and
dicentric chromosomes (Wise et al., 2002; Wise et al., 2006). Studies have found
that chromosomal instability caused by soluble and particulate Cr(VI) is different.
Chromosomal aberrations increased in human lung cells after 24 h exposure to
sodium chromate but decreased over time after 48 h or 72 h exposure (Wise et al.,
2006; Holmes et al., 2006). By contrast, in human lung cells exposed to particulate
Cr(VI), such as lead chromate or zinc chromate, chromosomal aberrations
increased with prolonged exposure (Wise et al., 2006; Holmes et al., 2006).
However, another study found sodium chromate induced more chromosomal
aberrations in human urothelial cells after 120 h exposure than 24 h exposure
(Wise et al., 2016). Xie et al. demonstrated Cr(VI) can induce different levels of
chromosome damage in different cell lines. This study found differences in
chromosomal aberrations induced by particulate Cr(VI) exposure, but not after
soluble Cr(VI) exposure (Xie et al., 2015). Although chromosomal aberrations
caused by soluble or particulate chromium are not entirely consistent across cell
lines and exposure times, these studies demonstrate chromium causes structural
chromosomal instability. There are also differences in the chromosomal aberration
potentials of different insoluble Cr(VI) compounds. The highest levels of
chromosomal aberrations were found with zinc chromate, the lowest with lead
chromate, while the effects of barium chromate were intermediate (Wise et al.,
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2004; Wise et al., 2010).
Substantial evidence suggests Cr(VI)-induced carcinogenesis is driven by
genomic instability. However, the exact mechanism is unclear. Chromosome
instability appears to play a role in this complex molecular mechanism. This project
focuses on the mechanisms of Cr(VI)-induced structural chromosomal instability,
in particular the effect of Cr(VI) on high-fidelity DNA repair.

Mechanism of Cr-induced structural chromosome instability
Cr-induced DNA double strand breaks
DNA double strand breaks are the most dangerous DNA lesions that arise
when two complementary strands of the DNA duplex are simultaneously damaged
in proximity (within 10 base pairs) and physically dissociated from each another.
Many exogenous DNA damaging agents, including anticancer chemotherapeutic
drugs (Chen and Stubbe, 2005; Nowosielska and Marinus, 2005; Singh and
Krishna, 2005) and ionizing radiation (IR) (Milligan et al., 1995), can cause DNA
double strand breaks. Endogenous DNA double strand breaks generally result
from DNA replication through single stranded lesions and mechanical stress (Aylon
and Kupiec, 2004). These breaks can be indirectly produced through stalled or
collapsed replication forks when replication forks encounter single strand breaks
or DNA crosslinks (Friedberg et al., 2006). For a defined biological purpose, DNA
double strand breaks also spontaneously occur in meiosis and V(D)J
recombination to initiate recombination (Lieber et al., 2003).
Cr(VI) induces a spectrum of DNA damage that includes DNA single strand
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breaks, Cr-DNA adducts and DNA-protein crosslinks (O'Brien et al., 2003).
Although Cr(VI)-induced double strand breaks have not been investigated in vivo
so far, a large number of cell culture studies have shown Cr(VI) induces the
formation of double strand breaks (table 1.4). γ-H2AX foci formation and neutral
comet assays are two methods that were used in these studies to measure DNA
double strand breaks. H2AX, a histone protein, gets phosphorylated at Ser 139 in
response to DNA double strand breaks (Fernandez-Capetillo et al., 2004).
Phosphorylated H2AX forms foci at the sites of DSBs and the number of γ-H2AX
foci closely correlates with the amount of expected DNA double strand breaks
induced by IR (Rogakou et al., 1999). Another study observed a direct correlation
between the number of γ-H2AX foci and DNA double strand breaks suggested
each γ-H2AX focus may represent an individual break (Sedelnikova et al., 2002).
Therefore, the formation of γ-H2AX foci is considered a quantitative marker of DNA
double strand breaks. Walkman et al. reported potassium chromate induces a
significant increase of γ-H2AX foci in HeLa cells (Wakeman et al., 2004). Ha et al.
found γ-H2AX foci formation in sodium chromate treated human dermal fibroblasts
(Ha et al., 2004). Xie et al. discovered lead chromate induces DNA double strand
breaks in human lung cells (Xie et al., 2005). Particulate and soluble Cr(VI)
compounds induced similar levels of DNA double strand breaks in human
bronchial fibroblasts (Xie et al., 2005; Wise et al., 2010).
The mechanism by which Cr(VI) induces DNA double strand breaks is still
unclear. Studies suggest Cr(VI)-induced DNA double strand breaks are produced
through an indirect mechanism because DNA double strand breaks produced by
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Cr(VI) are cell cycle stage-specific. These breaks appear in the late S phase or G2
phase, but not G1 phase indicating they occur as a consequence of DNA
replication or repair in some way (Wakeman et al., 2004; Ha et al., 2004; Xie et al.,
2009; Peterson-Roth et al., 2005; Reynolds et al., 2007). Wakeman et al. found
short time (4 h) exposure to high concentrations of potassium chromate (up to 80
uM) induced γ-H2AX to appear in the S phase (Wakeman et al., 2004). Ha et al.
found γ-H2AX appeared in S phase after 3 hours of 200uM sodium chromate
exposure (Ha et al., 2004). However, Xie et al. found γ-H2AX to appear in the G2
phase after 24-hour exposure to low concentrations (0.2-0.5ug/cm2) of zinc
chromate (Xie et al., 2009). Cr-DNA adducts are the most commonly implicated
form of Cr(VI)-induced DNA damage to precede the breaks thought to occur
through a stalled replication fork (Holmes et al., 2008). It has been argued the
breaks occur from the mishandling of Cr-DNA damage through mismatch repair
(MMR) (Peterson-Roth et al., 2005; Reynolds et al., 2007; Reynolds et al., 2009).
It is also possible that they manifest through the mishandling of single strand
breaks that are frequently produced after Cr(VI) exposure. Such causes are
consistent with the breaks being indirectly produced and with their cell cycle
specificity.
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Table 1.4 Cr(VI) Induces DNA Double Strand Breaks in human cell cultures.

Chemical

Sodium
chromate

Potassium
chromate

Lead
chromate

Potassium
chromate

Lead
chromate

Conce
ntration

3-6 uM

5-80
uM

0.1-5
ug/cm²

0.2-5
uM

0.1-1
ug/cm²

Treat

Model

Time

System

Assays

Summary of Effects

Ref

Neutral
comet assay,

DNA double strand
breaks are
generated during
Cr(VI) treatment.
Cr(VI)-induced γH2AX production is
S phase specific and
is absent after
serum starvation.

Ha et al.,
2004

HeLa cells

Neutral
comet assay,
Immunostaining for γH2AX foci

Cr(VI) treated cells
are typical “comet
tails” characteristic
of DNA strand
breaks and Cr[VI]
induced a significant
increase of cells with
γ-H2AX foci.

Wakeman
et al.,
2004

24 h

WTHBF-6
human
lung
fibroblasts

Neutral
comet assay,
Western blot
analysis for
pATM,
Immunostaining for γH2AX foci

Cr(VI) induced DNA
double strand
breaks
concentrationdependent increase,
and actived ATM
and γ-H2AX
proteins.

Xie et al.,
2005

3h

IMR90
human
lung
fibroblasts
, human
lung
epithelial
cells

Immunostaining for γH2AX, and
53BP1 foci in
cyclin B1
expressing
cells

Cr(VI)-induced DNA
double strand
breaks occurred in
the G2 phase.
Preloading
ascorbate induced
increases in γ-H2AX
foci formation and
micronucleus
formation.

Reynolds
et al.,
2007

24 h

WTHBF-6
human
lung
fibroblasts

Neutral
comet assay

Cr(VI) induced DNA
double strand
breaks
concentrationdependent increase.

Xie et al.,
2008

1-3 h

30
min –
24 h

Normal
human
dermal
fibroblasts
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Zinc
chromate

0.1-0.5
ug/cm²

Barium
chromate

0.01-1
ug/cm²

Lead
chromate

0.01-1
ug/cm²

Zinc
chromate

0.1-0.5
ug/cm²

Sodium
chromate

0.05-5
uM

Zinc
chromate

Potassium
chromate

Sodium
chromate

0.1-0.3
ug/cm²

5-20
uM

1-5 uM

24 h

WTHBF-6
human
lung
fibroblasts

24 h

WTHBF-6
human
lung
fibroblasts

24120 h

WTHBF-6
human
lung
fibroblasts

3-6 h

H460
human
lung
epithelial
cells;
IMR90
normal
human
lung
fibroblasts
MEFs

24
and
120 h

HUC;
hTERTimmortaliz
ed human
urothelial
cells

Immunostaining for γH2AX, Flow
cytometry for
cell cycle
analysis and
γ-H2AX

Cr(VI) induced a G2
arrest. Cr(VI)induced DNA double
strand breaks
occurred in the
G2/M phase.

Xie et al.,
2009

Immunostaining for γH2AX

All chromium
compounds caused
concentrationdependent
increases in DNA
double-strand
breaks. There were
no significant
differences in the
ability of the
chromium
compounds to cause
DNA double-strand
breaks.

Wise et
al., 2010

Neutral
Comet assay

Cr(VI) induces DNA
double strand
breaks in human
lung cells in a
concentrationdependent manner.

Qin et al.,
2014

WB for γH2AX,
Immunostaining for γH2AX,
53BP1 and
H3K9me3

Cr(VI) induced DNA
double strand
breaks increase in a
concentrationdependent manner.
Cr(VI)-induced DNA
double strand
breaks produced in
the G2 phase and
were located
in euchromatic DNA.

DeLoughe
ry et al.,
2015

Immunostaining for γH2AX

Cr(VI) induced DNA
double strand
breaks increase in
concentrationand
time dependent
manner.hTERTstatus did not affect
the extent of Crinduced DNA
damage.

Wise et
al., 2016
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DNA double strand break repair
Unrepaired or misrepaired DSBs can lead to the accumulation of total
chromosomal rearrangements and mutations, leading to loss of genetic
information. There are two main repair pathways for repairing DSBs: classical nonhomologous end joining (c-NHEJ) and homologous recombination (HR). The
choice of pathway depends mainly on the cell cycle stage and the presence of
homologous sequences that can be used as templates for repair (Hustedt and
Durocher, 2017). Classical non-homologous end joining (c-NHEJ) typically
involves several iterative steps of DNA end-processing at a double strand break
and ligates the broken ends back together, eliminating the requirement of a
homologous template (Pannunzio et al., 2018). It is active throughout the cell cycle
but is especially important during the G0 and G1 phases (Hustedt and Durocher,
2017). DSB ends joined by c-NHEJ may cause additions or losses of nucleotides,
thus allowing a degree of genetic variability that is critical for physiological
processes such as V(D)J and class-switching recombination (Bétermier et al.,
2014; Pannunzio et al., 2018). In contrast, HR is generally a high-fidelity repair
pathway because it utilizes homologous sequences as repair templates (Lisby and
Rothstein, 2015). It functions only in the late S and G2 phases of the cell cycle
when sister chromatids are available as repair templates (Hustedt and Durocher,
2017). In addition, there are two DNA repair pathways that can be used to repair
double strand breaks that result in lower genomic fidelity, including single strand
annealing (SSA) and alternative end joining (Alt-EJ). While both pathways are
considered error-prone, they lead to different outcomes and thus their contributions
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to genomic instability are unequal.

Homologous recombination repair
An early determinant of DSB repair pathway choice is DNA end resection—
processing of DNA ends to generate 3' single strands, which are required for HR
but inhibit c-NHEJ. At the initiation of HR repair, the ends of the double strand
break are recognized and excised to form 3' single-stranded DNA (ssDNA)
overhangs (Mladenov et al., 2016). Single-stranded DNA generated by excision of
DSB ends provides substrates for the RAD51 filaments required for assembling
strand invasion; in addition, the invaded 3' ends provide primers for repair
synthesis of intact duplex templates. Initial processing of the ends involves the
MRN complex, which includes MRE11, RAD50 and NBS1, and the CtIP protein.
The MRN complex binds to the ends of the double strand break and resects the
ends through the nuclease activity of MRE11 (Williams et al., 2007; Williams et al.,
2008). CtIP stimulates the endonuclease activity of MRE11 in the MRN complex
(Cannavo et al., 2014). After endonuclease cleavage, the resection proceeds in
both directions. The exonuclease activity of MRN proceeds in the 3'-5' direction,
while EXO1 and BLM/DNA2 nucleases catalyze long-range 5'-3' excision (Garcia
et al., 2011; Shibata et al.,2013; Nimonkar et al., 2011).
ATM is activated by the MRN complex at the site of DNA damage and
autophosphorylates at S1981 (Bakkenist and Kastan, 2003; Myler et al., 2017).
ATM plays a key role in DNA repair by phosphorylating the C-terminal tail of
histone variant H2AX on serine 139 (Burma et al., 2001). It also activates the
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endonuclease activity of MRE11 by phosphorylating CtIP, which triggers DSB end
resection (You et al., 2009). Single-stranded DNA generated by excision is
subsequently coated with replication protein A (RPA), which is recruited to DSBs
by CtIP (Sartori et al., 2007).
The invasion of 3' single-stranded DNA into the homologous duplex is the
decisive step in HR. This process is guided by the strand-exchange recombinase
RAD51. RAD51 is a DNA-dependent ATPase that forms nucleoprotein filaments
with DNA, which is a homolog of the bacterial RecA protein (Shinohara et al.,
1992). RPA-coated single-stranded DNA is a substrate for the recruitment of
RAD51. RAD51 is recruited and loaded onto ssDNA while replacing RPA, forming
a helical nucleoprotein filament responsible for recognizing homologous
sequences and invading template DNA strands (Baumann et al., 1996; Sung and
Robberson, 1995). This is a crucial step in HR repair. RAD51 filaments begin
searching for homology in the other strand after binding to single-stranded DNA.
The DNA strands invade at positions of homology, forming heteroduplex DNA
junctions called D-loops (Sung et al., 2003; Renkawitz et al., 2014).
After nuclear filaments invade the donor duplex and subsequent D-loop
formation, the repair uses the homologous sequence as a template for synthesis,
leading to the formation of the Holliday junction (Constantinou et al., 2001). After
Holliday junctions are resolved by resolvase proteins producing crossover or noncrossover products that are ligated, HR repair completes the accurate recovery of
DNA double strand breaks (Heyer et al., 2004; Wyatt and West, 2014).
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HR utilizes homologous sequences to repair DNA breaks, preventing
structural chromosomal instability and maintaining high genomic fidelity. It is an
error-free DNA double strand break repair mechanism.

Repair of Cr(VI)-induced DNA double strand breaks
c-NHEJ and HR repair are the main repair pathways to repair DNA double
strand breaks. However, the mechanism of Cr(VI)-induced DNA double strand
break repair remains incompletely defined. Bryant et al. found Cr(VI) causes DNA
double strand breaks and triggers RAD51 foci formation and HR repair in Chinese
hamster cells; in addition, HR repair protein XRCC3-deficient and BRCA2-deficient
HR-deficient cells both were hypersensitive to Cr(VI) (Bryant et al., 2006).
However, these authors did not detect c-NHEJ repair. In another study, Stackpole
et al. found both RAD51C-deficient and XRCC3-deficient Chinese hamster cells
had increased cytotoxicity and chromosomal aberrations after lead chromate
exposure, relative to wildtype and cDNA-complemented cells (Stackpole et al.,
2007). Camyre et al. found Ku80 deficiency does not affect chromate-induced
cytotoxicity and chromosome damage in Chinese hamster ovary cells, suggesting
c-NHEJ does not prevent Cr-induced chromosomal instability (Camyre et al.,
2007). Tamblyn et al. found Mus81-deficient cells are more sensitive to the
cytotoxic effects of Cr(VI) as well as Cr(VI)-induced growth arrest compared with
wild-type cells. Mus81-deficient cells exhibited marked γ-H2AX elevation and
displayed increased chromosome instability following Cr(VI) exposure compared
with wild-type cells. Mus81 is one of the resolvases of Double Holliday junction
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resolution of the HR repair pathway (Wyatt et al., 2013). Taken together, these
studies demonstrate the importance of HR repair in the repair of Cr-induced DNA
double strand breaks and in preventing Cr-induced structural chromosome
instability in mammalian cells, whereas c-NHEJ does not prevent Cr-induced
chromosome instability.

Cancer and whales
Peto's paradox
Cancer afflicts most vertebrates and appears to occur most frequently in
mammals (Galis and Metz, 2003). The similarity of basic carcinogenetic
mechanisms in mammals and the conservation of many tumor suppressor systems
have enabled scientific research to model human disease using rodents and other
mammals (Leroi et al., 2003). In the prediction of cancer risk, it is generally
believed that the incidence of cancer is positively correlated with body size and
age (Caulin and Maley, 2011). Cancer occurs when cells divide and mutate. Cell
division is normal in organisms, as is somatic mutation. Most of the time, somatic
mutations are either harmless or the body repairs them. If these mutations cannot
be repaired, cancer may develop. Because cancer develops through the
accumulation of somatic mutations, each proliferating cell is at risk of malignant
transformation assuming that all proliferating cells have similar odds of mutation.
Therefore, if an organism has more cells, i.e., more chances to initiate tumors, the
likelihood of developing cancer should increase. Likewise, if an organism lives
longer, its cells have more time to accumulate mutations. The likelihood of
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carcinogenesis is therefore an increasing function of age, so an organism's lifetime
cancer risk should also increase with its lifespan (Frank et al., 2007). If these
assumptions hold, cancer incidence can be predicted by its positive correlation
with body size and age (Caulin and Maley, 2011). However, it is well known that,
at the cross-species level, larger organisms generally have longer lifespans
(Speakman, 2005). In 1975, Peto et al. found at the species level, the incidence of
cancer appears to be independent of the number of cells in an organism (Peto et
al., 1975). For example, although whales have more cells than humans, cancer
rates in whales are far lower than in humans (Nagy et al., 2007). If the probability
of cancer throughout the cell is constant, then the incidence of cancer in whales
should be higher than in humans. There appears to be no correlation between
body size, longevity and cancer across species, with a lack of this relationship
known as Peyto's paradox. In fact, cancer rates vary to some extent across
mammalian species.

Whales and cancer
Whales are mammals that live in the ocean. The baleen whale suborder
contains the largest and longest-lived mammals on earth. The blue whale
(Balaenoptera musculus) included in this suborder is the largest mammal on earth.
Baleen whales have long lifespans, most with an estimated lifespan of 80-100
years, and bowhead whales over 200 years (George et al., 1999). Despite their
large size and longer lifespans compared with humans’, baleen whales appear to
have significantly lower rates of cancer than humans. Cancer rates in wild whales
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are generally low (0.7%-2%) (Geraci et al., 1987; Newman and Smith, 2006). So
far, reports of whale cancer are very limited, and the data available are from whale
autopsy reports. The low number of reported cancers in whales may also be
related to the longevity of whales. In 1987, Geraci et al. reported 14 tumors,
including 6 papillomas, 5 leiomyomas, 2 adrenal adenomas, and one bronchial
carcinoma, in more than 1800 free-range and captive cetaceans (Geraci et al.,
1987). In 2006, a literature review by Newman and Smith documenting neoplasia
in marine mammals revealed only 26 documented cases in baleen whales,
including 11 in fin whales and 3 in humpback whales, 10 in blue whales, 1 in sei
whales, and 1 in bowhead whales which reported lipoma in bowhead whale liver
(Newman and Smith, 2006). Therefore, the large size and long lifespan of baleen
whales, but a low incidence of cancer, reflects the Peto's paradox.

Potential mechanisms for evading cancer
The mechanisms by which baleen whales evade cancer are currently
unclear. Blue whales with 1,000 times more cells than humans do not show an
increased risk of cancer, suggesting that natural mechanisms can suppress cancer
1,000 times more effectively than found in human cells (Caulin and Maley, 2011).
Peto suggested that evolution may be responsible for the differences in the rate of
carcinogenesis in individual cells across species (Nunney, 2013). When
individuals in a population are under selective pressure for cancer risk, the
population has to evolve some cancer suppressors as an adaptation or suffer
possible extinction (Tollis et al., 2017). Genomic analysis revealed that the African
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elephant (Loxodonta Africana) genome contains 20 copies of the tumor suppressor
gene TP53 (40 alleles), whereas humans have 1 copy of TP53 (2 alleles)
(Abegglen et al., 2015). Blind mole rats, subterranean rodents with significant anticancer ability, have amino acid changes in p53 protein corresponding to mutations
commonly found in human tumors, which weaken the apoptotic function of p53 in
favor of a reversible cell cycle stasis (Ashur-Fabian et al., 2004; Avivi et al., 2005;
Kato et al., 2003). A unique splice variant of heparanase with antitumor properties
has also been identified in blind mole rats (Nasser et al., 2009). Recent studies
have found evidence of some cancer-suppressing mechanisms in baleen whales.
There is a large proportion of transposable elements (TEs) in the bowhead whale
genome (~32%), especially the long-inserting nuclear element LINE-1 (Keane et
al., 2015). Slow mutation rates are found in cetaceans, which may limit tumor cell
generation and cancer progression (Tollis et al., 2019; Jackson et al., 2009).
Sequencing of the bowhead whale genome identified specific mutations in ERCC1,
a gene associated with cancer and aging, and gene duplications in PCNA, a gene
associated with DNA repair, cell cycle, and aging (Keane et al., 2015). The
turnover rate of tumor suppressor genes is nearly 2.4-fold higher in cetaceans than
in most other mammals and highest in baleen whales, which may have favored the
evolution of their anticancer resistance traits (Tejada-Martinez et al., 2021).
Chromosomal instability is one of the hallmarks of cancer. In some
comparative studies of whale cells and human cells, it was found whale cells are
more resistant to chromium-induced chromosomal instability than human cells (Li
Chen et al., 2009a; Li Chen et al., 2009b; Li Chen et al., 2012; Wise et al., 2015).
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Acute particulate Cr(VI) exposure produces less chromosomal instability in North
Atlantic right whale (Eubalaena glacialis) lung fibroblasts compared with human
lung fibroblasts (Li Chen et al., 2009a). Reduced Cr(VI)-induced chromosome
instability was detected in sperm whale (Physeter macrocephalus) skin fibroblasts
and fin whale (Balaenoptera physalus) skin fibroblasts compared with human skin
fibroblasts (Li Chen et al., 2012; Wise et al., 2015). DNA repair is an important
mechanism for maintaining chromosomal stability to prevent carcinogenesis.
Genome analysis of bowhead whales identified gene duplications in the PCNA
gene, which is involved in HR repair (Keene et al., 2015; Sebesta et al., 2013).
High expression of HR repair genes was found in naked mole rats (Heterocephalus
glaber), another long-lived species with a low incidence of cancer (MacRae et al.,
2015). A recent study showed prolonged Cr(VI) exposure does not inhibit HR
repair in North Atlantic right whale lung cells (Browning et al., 2017). Therefore,
HR repair may be more efficient in whale cells and thus play an important role in
counteracting Cr(VI)-induced chromosomal instability.
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CHAPTER II
MATERIALS AND METHODS

Materials
Animals
12-week-old male and female Wistar rats (Envigo, Indianapolis, IN) were
maintained under standard laboratory conditions. All animals were housed under
a 12:12 hour light-dark cycle and provided food and water ad libitum. Animal
procedures were approved by the Institutional Animal Care and Use Committee
(IACUC) of University of Louisville, and followed the appropriate guidelines set
forth by the American Veterinary Medical Association.

Cell lines
WTHBF-6 is an hTERT immortalized clonal cell line derived from human
bronchial fibroblasts (Wise et al., 2004b). This cell line was developed by the Wise
laboratory from primary lung fibroblasts derived from healthy lung tissue of a 67year-old Caucasian man. Rat Lung Fibroblasts (RLF) (R506-05a) were purchased
from Cell Applications (San Diego, CA), which are primary cells derived from
normal rat lung. Bowhead whale primary lung fibroblasts (BHW200Lu) were
utilized in this study. BHW200Lu is a primary cell line isolated from the lung of a
subsistence-hunted bowhead whale in Barrow, Alaska.
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Cell Culture
Dulbecco’s Minimal Essential Medium and Ham’s F12 (DMEM/F-12) 50:50
mixture, Dulbecco’s phosphate buffered saline (PBS) 1X without calcium or
magnesium, penicillin/streptomycin solution, glutagro supplement (200 mM),
tissue culture dishes, flasks and plasticware were purchased from Corning
(Corning, NY). Trypsin/EDTA (0.25%) and cosmic calf serum were purchased from
Hyclone (Logan, Utah). Goat serum and sodium pyruvate (100 mM) were
purchased from Lonza (Allendale, NJ). Rat fibroblast growth medium (R116-500),
HBSS (062-100), Trypsin/EDTA (070-100), and Trypsin Neutralizing Solution
(080-100) were purchased from Cell Applications (San Diego, CA).

Metal Preparation
Zinc chromate (CAS no. 13530-65-9; 99.7% purity) was purchased from
Pfaltz and Bauer (Waterbury, Connecticut). Scintillation vials were purchased from
Wheaton (Millville, NJ). Acetone was purchased from J.T. Baker (Philipsburg, NJ).

Antibodies
Anti-RAD51 antibody (sc-8349) was purchased from Santa Cruz (Dallas,
TX). Anti-RAD51 antibody (PA5-27195) was purchased from Thermo Fisher
(Carlsbad, CA). Anti-γ-H2AX antibody for immunofluorescence was purchased
from Cell Signaling (Danvers, MA). Anti-cytokeratin antibody (C2931) was
purchased from Sigma-Aldrich (St. Louis, MO). Anti-PMCA ATPase antibody
(MA3-914) was purchased from Invitrogen (Grand Island, NY). Anti-γ-H2AX-
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AF647 antibody (pS140) (560447) was purchased from BD Biosciences (Franklin
Lakes, NJ). Fluorescent secondary antibodies were purchased from Life
Technologies (Grand Island, NY).

Tissue embedding
Tissue Cassettes (18000-130) were purchased from VWR (Radnor, PA).
Ethanol (2716) was purchased from Decon Labs (King of Prussia, PA). 10%
neutral buffered formalin (16004-128) was purchased from VWR (Radnor, PA).
Paraffin (39602004) was purchased from Leica (Deer Park, IL).

Hematoxylin and Eosin staining
Gill's Hematoxylin (3535-16) was purchased from Ricca Chemical
Company (Arlington, TX) and Eosin (HT110116) was purchased from SigmaAldrich (St. Louis, MO). Xylene was purchased from Millipore (Billerica, MA).
Permount mounting medium (17986-01) was purchased from Electron Microscopy
Sciences (Hatfield, PA).

Immunofluorescence
Immunofluorescent staining of formalin-fixed paraffin embedded tissue samples.
The TrueBlack blocking buffer and background suppressor (23012) were
purchased from Biotium (Fremont, CA). Sudan black B (0593) was purchased from
VWR (Radnor, PA). Prolong Diamond Antifade Mountant with DAPI was
purchased from Invitrogen (Grand Island, NY). Coverslips were purchased from
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VWR (Randor, PA).

Immunofluorescent staining of cells.
Nunc Lab Tek II glass chamber slides were purchased from Thermo Fisher
Scientific Inc. (Waltham, MA). FNC coating mix was purchased from AthenaFS
(Baltimore, MD). 4% paraformaldehyde in PBS was purchased from Alfa Aesar
(Ward Hill, MA) and Dulbecco’s phosphate-buffered saline (10x) with magnesium
and calcium was purchased from Corning (Corning, NY). Triton X-100 was
purchased from Sigma-Aldrich (St. Louis, MO). Bovine serum albumin was
purchased from EMD Millipore (Billerica, MA). Sodium azide was purchased from
Amresco LLC (Solon, OH). Goat serum was purchased from Lonza (Allendale, NJ),
and Prolong Gold Antifade Reagent with DAPI was purchased from Invitrogen
(Grand Island, NY). Coverslips were purchased from VWR (Randor, PA).

Neutral Comet Assay
The comet assay electrophoresis system, lysis solution, comet slides, LM
agarose and slide racks were purchased from Trevigen Inc. (Gaithersburg, MD).
The dry bath incubator and slide warmer were purchased from Boekel Scientific
(Feasterville, PA). Sodium chloride (NaCI), sodium acetate (NaOAc), glycine and
the Millipore water system were purchased from EMD Millipore (Billerica, MA).
Sodium hydroxide (NaOH), sodium dodecyl sulphate (SDS), hydrogen chloride
(HCl), ammonium acetate and Tris(hydroxymethyl)aminomethane (Tris base),
were purchased from J.T. Baker (Phillipsburg, NJ). Proteinase K was purchased
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from Ameresco (Solon, OH). Ethylenediaminetetraacetic acid (EDTA) was
purchased from Sigma-Aldrich (St. Louis, MO). Ethanol was purchased from
Pharmco-AAPER (Hartford, CT). SYBR green was purchased from Life Science
Tech (Grand Island, NY). The Comet IV software was purchased from Perceptive
Instruments Ltd. (Edmunds, UK). Fluorescent microscopes were purchased from
Olympus (Center Valley, PA).

Sister Chromatid Exchange
5-bromo-2’-deoxyuridine (BrdU) was purchased from Sigma-Aldrich (St.
Louis, MO). Dulbecco’s phosphate-buffered saline (10x) with magnesium and
calcium was purchased from Corning (Corning, NY). Sodium chloride was
purchased from EMD Millipore (Billerica, MA), and sodium citrate was purchased
from J.T. Baker (Philipsburg, NJ). Hoechst 33258 pentahydrate was purchased
from Invitrogen (Grand Island, NY).

Flow Cytometry
RNase A (BP2539100) was purchased from Fisher BioReagents (Hampton,
New Hampshire). Mouse IgG1 kappa-AF647 Isotype (557714) was purchased
from BD Biosciences (Franklin Lakes, NJ). Propidium Iodide (PI) (P3566) was
purchased from Invitrogen (Eugene, Oregon). Rat serum was purchased from
StemCell Technologies (Cambridge, Massachusetts).

Methods
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Animal Models of Zinc Chromate Exposure
70 male and 70 female Wistar rats were utilized in our study. Twelve-weekold male and female Wistar rats were exposed to zinc chromate particles in saline
solution or saline alone by oropharyngeal aspiration after brief 3% isoflurane
(Henry Schein, 029405) anaesthesia. The rats were exposed to zinc chromate for
24 hours (Aim 1) or 90 days (Aim 2). In Aim 1, dose groups included 0, 0.2, 0.4,
and 0.8 mg Cr/kg (body weight) with single administration for 24 hours. In Aim 2,
dose groups included 0, 0.4, and 0.8 mg Cr/kg (body weight) once weekly
administration repeated for 90 days. Animals were exposed for 24 hours or 90
days to evaluate the onset and persistence of the outcomes. At the end of each
exposure time, animals were euthanized, and the lungs were isolated (Figure 2.1).
The animal lungs in each group were used to measure chromium levels by ICPMS. For 7 animals in each group, the isolated rat lungs fixed by formalin inflation
were used for immunohistochemistry and H&E staining (Figure 2.2).
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Figure 2.1. Single and repeated dosing regimens. In Aim 1, 12-week-old Wistar
rats were treated with either 1 dose saline vehicle or zinc chromate and euthanized
on Day 1. In Aim 2, 12-week-old Wistar rats were treated with once weekly
administration for 90 days and then euthanized.

44

Figure 2.2. Rat grouping and outcomes examined. 12-week-old, male and female
Wistar rats were treated with 0, 0.2, 0.4, or 0.8 mg Cr/kg (body weight) for 24 hours
or 0, 0.4, or 0.8 mg Cr/kg (body weight) for 90 days. In every dose group, lung
tissues from 7 rats were used for H&E staining and immunohistochemistry analysis,
and lung tissues from 3 rats for zinc chromate accumulation measurements.
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Sample collection
Upon euthanasia after intraperitoneal injection of a mixture of 90 mg/ml
ketamine (University of Louisville Comparative Medicine Research Unit) and 10
mg/ml xylazine (Midwest Veterinary Supply), blood was collected and placed on
ice. After perfusion with cold PBS, lungs were removed and sliced, and tissue was
allocated for appropriate use. Samples for histology/immunohistochemistry were
fixed with 10% neutral buffered formalin.

Preparation of lung sections for histology and immunohistochemistry
After fixation with 10% neutral buffered formalin for 24 hours, lung samples
were stored in 75% ethanol for at least one hour and submitted to paraffin
embedding (Table 2.1). After embedding, lung sections were cut at 5 microns on
a microtome and affixed to slides.

Hematoxylin and eosin staining
Hematoxylin and eosin (H&E) staining provides a detailed representation of
tissues with high-resolution for histopathological studies, thus allowing the
identification of tissue abnormalities. H&E staining helps visualize otherwise
transparent tissues under a microscope and is critical for tissue-based research in
our Cr-exposed rat lung study. Lung sections were deparaffinized with xylene and
rehydrated with an ethanol gradient to distilled water. Lung sections were then
stained sequentially with Gill's Hematoxylin and eosin. After dehydration with an
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ethanol gradient, coverslips were mounted with the Permount mounting medium
(Table 2.2). The stained lung sections were analyzed by light microscopy.

Histological analysis
An Olympus light microscope with 10X, 20X and 40X objectives was used
to analyze the amounts of macrophages and immune cells in H&E-stained rat lung
tissue sections. We established a scoring system to analyze inflammation and
determined the degree of inflammation according to this scoring system (Table
2.3). Each slide was scored based on the number and size of abnormal
macrophages or inflammatory cells according to the scoring system.
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Table 2.1. Paraffin embedding procedure.

75% Ethanol

60 minutes, 1x

85% Ethanol

60 minutes, 2x

95% Ethanol

60 minutes, 1x

95% Ethanol

Overnight at 4°C

100% Ethanol

30 minutes, 4x

1:1 Xylene: Ethanol

30 minutes, 1x

Xylene

30 minutes, 4x

Paraffin

30 minutes, 3x
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Table 2.2. Hematoxylin and eosin staining steps.

Xylene

5 minutes, 2x

100% Ethanol

30 seconds, 2x

95% Ethanol

30 seconds, 2x

70% Ethanol

30 seconds, 1x

Distilled water

30 seconds, 1x

Gill's Hematoxylin

150 seconds, 1x

Distilled water

30 seconds, 1x

Acid Water Rinse

20 seconds, 1x

Distilled water

30 seconds, 1x

Bluing Reagent

40 seconds, 1x

Distilled water

30 seconds, 1x

80% Ethanol

40 seconds, 1x

Eosin

80 seconds, 1x

95% Ethanol

30 seconds, 1x

100% Ethanol

30 seconds, 4x

Xylene

5 minutes, 3x
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Table 2.3. Macrophages and inflammatory cells scoring system.

Score

Condition

0

None

1

1-4 small areas

2

≥5 and <15 small areas

3

≥ 15 small or 1 moderate area

4

≥ 15 small and 1 moderate area

5

≥ 2 moderates plus any number of small areas

6

Widespread in ≥2 different pieces

The recorded “small area” indicated where macrophages or inflammatory cells are
restricted to a limited, “small” area of the tissue. The “moderate” area is where
macrophages or inflammatory cells appear in larger, contiguous sections of the
tissue.
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Cell culture
Cr(VI) is a human lung carcinogen. Epidemiological studies of chromate
workers suggest that chromate-induced tumors are epithelial carcinomas, mainly
squamous cell carcinomas (Hirose et al., 2002; Ishikawa et al., 1994a). Although
squamous cell carcinoma originates in epithelial cells, Cr was found to accumulate
in fibroblasts of the bronchial stroma rather than in epithelial cells (Kondo et al.,
2003). These data suggest that fibroblasts accumulate Cr and may create a
microenvironment for nearby epithelial cells that facilitates their transformation into
cancer cells. Indeed, studies have shown fibroblasts play a key role in altering the
cancer microenvironment by releasing growth factors, chemokines, and other
carcinogenic components (Chen et al., 2014; Kalluri and Zeisberg, 2006).
Primary lung epithelial cells are difficult to use in culture because they
rapidly reach replicative senescence. Thus, they cannot be maintained long
enough for the exposure consistency required in this dissertation. The few
immortalized lung epithelial cell lines that exist have abnormal karyotypes, making
them unsuitable for chromosome instability studies. Our research considers the
effect of Cr(VI) on chromosomes as the primary target of Cr(VI) exposure;
therefore, currently available immortalized epithelial cells are not suitable for this
work. Furthermore, as fibroblasts have been shown to be key targets of Cr(VI)
exposure (Kondo et al., 2003), human bronchial fibroblasts (WTHBF-6) were used
in this study (Wise et al., 2004b).
WTHBF-6 cells have normal growth parameters, a normal stable karyotype
and cytotoxic and clastogenic responses to metals similar to primary cells (Wise
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et al., 2004b). Cells were cultured as adherent monolayers in DMEM/F12 50:50,
supplemented with 15% cosmic calf serum, 1% L-alanyl-L-glutamine, 1%
penicillin/streptomycin, and 0.1 mM sodium pyruvate. Cells were maintained in a
5% CO2-humidified environment at 37°C. They were fed every 48 h and subcultured at least once a week using 0.25% trypsin/1mM EDTA. All experiments
were performed with logarithmically growing cells.
Rat lung fibroblasts (RLFs) were cultured as adherent monolayers in rat
fibroblast growth medium. Cells were maintained in a 5% CO2-humidified
environment at 37°C. They were fed every 48 h and sub-cultured at least once a
week. All experiments were performed on logarithmically growing cells.
BHW200Lu cells were utilized to study Cr(VI) genotoxicity in a species with
a long life span and a low incidence of cancer. This cell line has a stable karyotype
of 42 chromosomes. Cells were cultured as adherent monolayers in DMEM/F12
50:50, supplemented with 15% cosmic calf serum, 1% L-alanyl-L-glutamine, 1%
penicillin/streptomycin, and 0.1 mM sodium pyruvate. Cells were maintained in a
5% CO2-humidified environment at 33°C. They were fed every 72 h and subcultured at least once a week. All experiments were performed on logarithmically
growing cells.

Treatment with particulate Cr(VI) compound
Insoluble Cr(VI) compounds are more carcinogenic than soluble Cr(VI)
compounds, so particulate Cr(VI) compounds are considered to be the most toxic
and carcinogenic (Levy et al., 1986; Levy and Venitt, 1986). In this dissertation, we
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used zinc chromate as our representative Cr(VI) compound because it is the most
potent form of particulate Cr(VI) (Wise et al., 2004a; Wise et al., 2010). Zinc
chromate, a partially soluble particulate chromate compound that was shown alone
by epidemiological studies to induce lung cancer (Kano et al., 1993). It has a wide
range of industrial uses, especially as a rust inhibitor and pigment.
Zinc chromate was prepared according to our published methods (Xie et
al., 2009) by washing twice with distilled water followed by two washes with
acetone to remove all water soluble and organic components and allowing the
particles to air dry. For treatment, zinc chromate was stirred in cold, sterile water
on a stir plate at 4°C overnight and administered as a suspension of particles using
a vortex. The particle size range of zinc chromate prepared using this method is
between 0.2 and 2.3 um, with an average size of 1.7 um (Wise et al 2002). To
account for treatment with a particulate compound, concentrations are expressed
as ug/cm2.
WTHBF-6 cells were treated at concentrations of 0.1-0.3 ug/cm2 zinc
chromate, rat lung cells were treated with 0.2 or 0.4 ug/cm2 zinc chromate, and
bowhead whale cells were treated with 0.1-0.4 ug/cm2 zinc chromate. These
concentrations are within the range of documented exposure levels (Danadevi et
al., 2004; Ishikawa et al., 1994b). The cytotoxicity of these doses at various
exposure times has been previously described (Holmes et al., 2010). While zinc
chromate induces a time and concentration-dependent increase in cytotoxicity,
plenty of cells survive the 120 h exposures (Holmes et al., 2010).
For animal treatment, zinc chromate was stirred in cold, sterile 0.9% sodium
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chloride solution on a stir plate at 4°C overnight and administered as a suspension
of particles using a vortex. The route of administration to animals was by
oropharyngeal aspiration with zinc chromate suspension. The doses administered
are as shown in Figure 1.1. This technique has been reported to avoid the loss of
the dosing suspension in the gastrointestinal tract from swallowing by animals,
thereby ensuring the most efficient delivery of the drug to the lungs (Rao et al.,
2003). Vortex the zinc chromate solution for 10 s to suspend the particles before
processing. Animals were removed from the chamber after brief anesthesia with
3% isoflurane. The nostrils were pinched, the tongue was squeezed out, and zinc
chromate suspension or saline was instilled into the back of the animal's throat.
After the animals took 6-7 deep breaths to ensure inhalation of the dosing
suspension, the animals were returned to their cages.

Immunofluorescent staining
DNA damage response proteins, including γ-H2AX and RAD51,
accumulate and/or modify near chromosomal DNA double strand breaks to form
nuclear foci visible under a fluorescence microscope, which is helpful for the study
of DNA damage and repair. Immunofluorescence was conducted as previously
described with minor alterations (Xie et al., 2005).

Immunofluorescent staining of formalin-fixed paraffin embedded tissue samples
For γ-H2AX and RAD51 immunofluorescent staining, lung sections (5
microns thick) were rehydrated with xylene followed by incubation with an ethanol
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gradient. 1 mM EDTA (pH 7.9) was used for antigen retrieval, which was performed
in a vegetable steamer for 30 minutes, and slides were cooled at room temperature
(RT) for 45 minutes. Slides were then rinsed 3 times for 5 minutes each with TBST.
Slides were then blocked with TrueBlack blocking buffer for 15 minutes at room
temperature and incubated with the primary antibody diluted with TrueBlack
background suppressor overnight at 4°C. Anti-γ-H2AX antibody was used at 1:750,
anti-RAD51 at 1:10000, anti-cytokeratin at 1:100, and anti-PMCA ATPase at 1:500.
Next, slides were rinsed 3 times for 5 minutes each with TBST. Goat anti-rabbit
Alexa Fluor 488 (1:500) and Goat anti-mouse Alexa Fluor 555 (1:500) were added
to slides and incubated for 60 minutes at RT. Slides were then rinsed 3 times for
5 minutes with TBS. Next, slides were immersed in 3% Sudan black B with 70%
ethanol for 20 minutes, followed by three washes with TBS for 5 minutes. The
coverslips were mounted with DAPI. Nuclear foci were scored in 100 cells per
concentration/time point by confocal microscopy.

Immunofluorescent staining of cells
For cells, immunofluorescence was conducted as previously described with
minor alterations (Xie et al., 2005). Briefly, cells were seeded on glass chamber
slides coated with FNC, allowed to re-enter logarithmic growth and treated with
zinc chromate for either 24 or 120 h. At harvest, cells were fixed with 4%
paraformaldehyde for 10 min, permeabilized with 0.2% Triton X-100 for 10 min and
blocked with 10% goat serum in PBS for 1 h. For RAD51 foci, cells were fixed with
4% paraformaldehyde for 10 min, and permeabilized with 0.5% Triton X-100 for 30
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mins. Cells were then incubated with anti-γ-H2AX (Cell Signaling 2577L; 1:100) or
anti-RAD51 (Santa Cruz sc-8349; 1:200) antibodies at 4°C overnight, washed with
PBS and incubated with Alexa Fluor 488 (1:2000) for 1 h. Cells were washed with
PBS, and coverslips were mounted with DAPI. Nuclear foci were scored in 100
cells per concentration/timepoint by fluorescence microscopy. Results were
expressed as the percentage of cells with >5 or >20 foci based on background
levels such that negative controls had 5% or less of cells with this level. Images of
100 cells per concentration/timepoint were obtained under an Olympus
microscope.

Confocal microscopy and image analysis
Confocal images were captured under an A1 confocal inverted Nikon
Eclipse Ti microscope equipped with 20x and 100x Plan Fluor objectives. The
acquired images were then denoised using the NIS-Elements software version AR
5.20.02. High magnification images (100x) were analyzed for foci counting. Region
of interest (ROI) analysis was then conducted on images using the NIS-Elements
software to measure signal intensity.

Neutral comet assay
The comet assay, also known as single-cell gel electrophoresis, is a method
for measuring DNA strand breaks in eukaryotic cells. Under neutral and nondenaturing pH conditions, the intact DNA double helix remains supercoiled. In
contrast, fragmented DNA resulting from double strand breaks can relax its
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supercoiled structure and create differences in migration in an electrophoretic field.
Therefore, the neutral comet assay allows the direct detection of DNA double
strand breaks in individual cells.
The comet assay was performed as previously described (Xie et al., 2005)
with some modifications. Briefly, logarithmically growing BHW200Lu cells were
seeded into 6-well plates and treated with zinc chromate for 24 and 120 h after
resting. After treatment, cells were washed, collected and resuspended in cold
PBS. The cell suspension was then mixed with pre-warmed low-melting agarose
at a 1:10 ratio and evenly spread onto comet slides, which were then placed on
ice allowing cells to solidify. After complete solidification, cells were lysed by
immersing the slides in freshly prepared lysis solution (2.5 M NaCl, 100 mM EDTA,
10 mM Tris, 1% SDS, pH 10) containing 1% Triton X-100 at 4°C for 30 minutes.
Slides were then immersed in pre-warmed enzyme digestion solution (2.5 M NaCl,
100 mM EDTA, 10 mM Tris, pH 10) with 1 mg/ml proteinase k for 2 hours at 37°C.
Electrophoresis was carried out at 21 V (1 V/cm) for 20 min in freshly prepared
electrophoresis buffer (300 mM sodium acetate, 100 mM Tris, pH 9.0). Finally,
slides were immersed in DNA precipitation buffer (0.15 M NH4Ac, ethanol) for 20
minutes followed by fixation with 70% ethanol and staining with SYBR green. All
the steps described above were conducted under reduced light to prevent spurious
DNA damage. Comet images were captured under an Olympus fluorescence
microscope equipped with a SensiCam camera. Image analysis was carried out
with the Comet Assay IV software (Perceptive Inc., UK). Tail intensity was adopted
as a measurement to quantify DNA damage. One hundred randomly selected cells
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were analyzed for each treatment. Each experiment was repeated three times.

Flow cytometry for cell cycle arrest and gamma-H2A.X staining
In order to examine cell cycle distribution and determine DNA double strand
breaks during the cell cycle, flow cytometry for cell cycle analysis and gammaH2A.X staining were used according to methods described by Huang and
Darzynkiewicz (Huang and Darzynkiewicz, 2006). Briefly, cells were harvested
after zinc chromate treatment and fixed with 4% paraformaldehyde for 15 minutes
on ice. Cells were washed with 1x PBS and centrifuged at 300 x g for 4 minutes at
room temperature and transferred to a new tube containing cold 70% ethanol.
Samples were stored at -20°C for at least a week before analysis. After fixation
and permeabilization, cells were washed with FACS Buffer (1x PBS, 10 mM
sodium azide, 5% FBS). Cells were then blocked with 2% rat serum (StemCell
Technologies) for 15 minutes followed by incubation with primary anti-γ-H2AXAF647 (pS140) antibodies at the manufacturer’s recommended amount of 0.5 µg
per sample for 1 hour at room temperature. An isotype control sample was
incubated with Mouse IgG1 kappa-AF647 Isotype antibody at the manufacturer’s
recommended concentration of 0.5 µg per sample for 1 hour at room temperature.
Samples were washed with FACS buffer before incubation for 30 minutes in the
dark with 1 mL PI staining solution. The PI staining solution was as follows per
sample: 1 mL PBS, 1 mg RNase A and 5 µL PI [1 mg/mL in water] (Invitrogen,
P3566). Samples were analyzed by flow cytometry (Attune NxT V6, ThermoFisher
Scientific). Data were stratified by phase of the cell cycle based on PI fluorescence
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into G1, S, and G2M phases. Within each phase of the cell cycle, DNA damage
was quantified by calculating the percentage of cells staining positive for γ-H2AX
normalized to control fluorescence. Data were expressed as the percentage of
cells in each phase of the cell cycle and the percent γ-H2AX positive cells in each
phase of the cell cycle normalized to control for each phase.

Sister chromatid exchange assessment
Sister chromatid exchanges (SCEs) were quantified as an indirect measure
of HR repair activity. SCEs are the product of the exchange of homologous
sequences between sister chromatids during the repair of a double strand break
(Sonoda et al., 1999). SCEs form as a result of cross-over between the newly
generated DNA strand and the template strand during the resolution of a Holiday
Junction (Sonoda et al., 1999). While SCEs do not represent all HR resolution
products, they serve as a useful indicator of HR repair.
BHW200Lu cells were seeded into 100-mm dishes, allowed to enter
logarithmic growth and treated with 0-0.4 ug/cm2 zinc chromate for 24 and 120 h.
Cells were incubated concurrently with 0.6 ug/ml BrdU for two cell cycles prior to
harvesting (72 h in the case of BHW200Lu cells). Following exposure, cells were
harvested, prepared and dropped onto clean, wet slides according to the
chromosome aberration protocol previously described. Slides were aged overnight
or baked at 60°C for 1 h, soaked in 1x PBS for 5 min and stained with 0.5 ug/ml
Hoechst 33258 pentahydrate solution for 10 min at room temperature. Excess
solution was removed from the slides, followed by the addition of 25 ug/ml Hoechst
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33258 pentahydrate solution and a glass coverslip. Coverslipped slides were
incubated under 27 W fluorescent lights for 11 h in a humid chamber. At the end
of this incubation, coverslips were washed off with distilled water and slides were
incubated in pre-warmed 2x sodium chloride/sodium citrate solution for 15 min at
60°C. Finally, slides were washed with distilled water, stained with 4% Giemsa
stain in Gurr’s buffer and mounted. The total number of SCEs was obtained in fifty
harlequin stained metaphases per concentration/timepoint.

Mitotic index
To determine whether cells accumulate during mitosis, the mitotic index was
measured as previously described (Xie et al., 2008). Cells were seeded and
treated with various concentrations of zinc chromate for 24 h or 120 h. After
treatment, cells were harvested and incubated in 0.075 M KCl hypotonic solution
for 10 min. Then, cells were fixed, and dropped on slides, which were uniformly
stained with 5% Giemsa stain in Gurr’s buffer. The mitotic index was determined
as the number of mitotic cells per 5000 total relative to control cells by light
microscopy. Three independent experiments were conducted.

Chromosomal aberration assay
Chromosomal aberrations were measured to determine clastogenicity
according to our published methods (Wise et al., 2002). Briefly, cells were seeded
and treated with various concentrations of zinc chromate for 24 or 120 h. Five
hours prior to treatment end, 0.1 ug/ml demecolcine was added to arrest cells in
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metaphase. Cells were then harvested, fixed, and dropped on slides as described
in the sister chromatid exchange assay method. Finally, slides were stained with
5% Giemsa stain and scored for chromosome aberrations using previously defined
criteria (Wise et al., 2002). One hundred metaphases were analyzed for each
treatment, and three independent experiments were conducted.

Clonogenic survival assay
Cytotoxicity was determined by a clonogenic survival assay as previously
reported (Wise et al., 2002). Cells were seeded and then treated for 24 h or 120 h
with suspensions of zinc chromate. After treatment, cells were harvested, counted
and reseeded at colony forming density (1000 cells in 100-mm plates). Cells were
then allowed to grow to form colonies. The resulting colonies were fixed with 100%
methanol, stained with crystal violet and counted. Each experiment was repeated
at least three times.

Statistics
All data were expressed as mean ± standard error of the mean (SEM) from
3 experiments. In the animal study, simple linear regression was used to compare
dose responses. In the animal study, two-way ANOVA was used when comparing
different treatments, time points, lung regions, lung lobes, sexes, and cell types. In
the cell culture study, two-way ANOVA was used when comparing different
species, time points, and treatments. When comparing the means of two variables,
two-way ANOVA with Dunnett multiple comparisons test was performed. Exposed
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and unexposed groups were compared using one-way ANOVA. Statistical
significance was determined at p<0.05.
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CHAPTER III
RESULTS

Overview
Cr(VI) has been classified as a human lung carcinogen for decades, but the
mechanism of Cr(VI)-induced cancer has not been fully elucidated. Chromosomal
instability is a hallmark of lung cancer and is a driving event in Cr(VI)-induced lung
cancer (Masuda and Takahashi 2002; Wise et al., 2018). Cr(VI)-induced structural
chromosomal instability has been reported in epidemiologic studies focused on
chromate workers and in numerous cell culture studies (Halasova et al., 2008;
Halasova et al., 2012; Maeng et al., 2004; Qin et al., 2014; Xie et al., 2005; Xie et
al., 2009; Wise et al., 2002; Wise et al., 2003; Wise et al., 2006). Unrepaired or
misrepaired DNA double strand breaks are the primary mechanism for the
formation of structural chromosomal instability. Numerous cell culture studies have
shown that Cr(VI) induces the formation of DNA double strand breaks. The HR
repair pathway without error repairing DNA double strand breaks prevents Cr(VI)induced structural chromosomal instability and neoplastic transformation (Bryant
et al., 2006; Stackpole et al., 2007; Xie et al., 2007). Recent studies have shown
that acute Cr(VI) exposure increases HR repair activity in human lung cells
whereas prolonged Cr(VI) exposure inhibits HR function (Xie et al. 2009, Qin et al.
2014, Browning et al. 2016). However, these outcomes were discovered in cell
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culture experiments, and the effects of Cr(VI) in laboratory animals and in other
wildlife species are currently unknown. Cr(VI)-induced double strand break and
HR repair in vivo have not been investigated so far. Therefore, it is urgent and
important to study Cr(VI)-induced double strand breaks and HR repair in vivo in
experimental animal models. This project translates Cr(VI)-induced HR deficiency
and chromosomal instability outcomes from human lung cells into experimental
animals, human lung tumors, and whale cells.
Studies have found Cr(VI) induces DNA double strand breaks in many cell
culture studies. Recent studies have shown acute Cr(VI) activates HR repair
activity to repair increased DNA double strand breaks in human lung cells (Xie et
al. 2009; Qin et al. 2014; Browning et al. 2016). Therefore, in Aim 1, we
investigated DNA double strand breaks and HR repair activity in acute (24-hour)
Cr(VI)-exposed rat lung tissue to test our hypothesis that acute exposure to
particulate Cr(VI) induces DNA double strand breaks and induces HR repair in vivo.
Prolonged exposure in human lung cells was found to inhibit HR repair
activity (Qin et al. 2014; Browning et al. 2016). Inhibition of HR repair results in
structural chromosomal instability due to the failure of DNA double strand breaks
to be repaired without errors. Therefore in Aim 2, we investigated DNA double
strand breaks and HR repair activity in subchronic Cr(VI)-exposed rat lung tissue
to test our hypothesis that subchronic exposure to particulate Cr(VI) induces DNA
double strand breaks, but inhibits HR repair in vivo. Then we translated the
outcomes into chromate workers’ lung tumors to investigate the hypothesis that
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Cr(VI)-induced DNA double strand break and HR repair inhibition continue to tumor
formation.
Whales live in extreme environments and are exposed to high levels of
Cr(VI) (Wise et al. 2019a; Wise et al., 2019b). They are long-lived species and
exhibit a higher level of protection against cancer (de Magalhães, 2015; Keane et
al., 2015). However, how whales evade carcinogenesis is unclear. Studies have
shown that whale cells are more resistant to Cr(VI)-induced chromosome instability
than human cells (Li Chen et al., 2009a; Li Chen et al., 2009b; Li Chen et al., 2012;
Wise et al., 2015). However, no studies have investigated this mechanism of
resistance to Cr(VI)-induced chromosomal damage. Therefore, Aim 3 in this
project tests the hypothesis that whale cells exhibit a protective mechanism against
Cr(VI)-induced chromosomal instability. We measured the effects of acute and
prolonged Cr(VI) exposure on DNA double strand breaks, HR repair and structural
chromosomal instability in bowhead whale lung cells. We then compared the
effects of Cr(VI) exposure on whale and human cells.
The results for these three aims are presented in 3 parts, Aim 1, Aim 2 and
Aim 3, as depicted in Figure 3.1. In Aim 1, we measured metal levels, lung
histological changes, DNA double strand breaks and HR repair in 24-hour Cr(VI)
exposure rat lungs. In Aim 2, we measured metal levels, lung histological changes,
DNA double strand breaks and HR repair after 90-day Cr(VI) exposure. In Aim 2
we examined HR repair in chromate workers’ lung tumor tissue slices. In Aim 3,
we investigated Cr(VI)-induced DNA double strand breaks, and the effect of
particulate Cr(VI) on HR repair in whale lung cells. Then we investigated cell cycle
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profiles and determined in which cell cycle phase Cr(VI) caused DNA double
strand breaks. After investigating chromosomal instability induced by Cr(VI) and
its effect on HR repair in whale cells, we further contrasted the effects of Cr(VI) on
chromosomal instability and HR repair in whale and human cells. All aims and
objectives are detailed below.
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Figure 3.1. Organizational schematic of the research project.
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Aim 1: Demonstrate particulate Cr(VI) induces DNA double strand breaks and
HR repair in rat lung after 24-hour exposure.

BACKGROUND
Chromosomal instability is a major driver of Cr(VI) carcinogenesis (Chen et
al., 2019; Rager et al., 2019; Wise et al., 2018). However, the mechanism of Cr(VI)induced structural chromosomal instability remains largely unknown. Among the
various forms of DNA damage induced by Cr(VI) compounds, DNA double strand
breaks pose the greatest threat to genome integrity. If unrepaired or incorrectly
repaired, DNA double strand breaks can lead to genomic instability and promote
Cr(VI)-induced carcinogenesis. HR repair is a high-fidelity DNA double strand
break repair pathway that repairs dangerous DNA double strand breaks in a
manner that maintains genome stability. HR repair prevents Cr(VI)-induced
chromosomal instability (Bryant et al., 2006; Gastaldo et al., 2007). Studies have
shown that acute Cr(VI) exposure induces double strand breaks and increases HR
repair activity in human lung cells (Xie et al., 2009; Qin et al., 2014; Browning et
al., 2016). However, these data were all obtained in cell culture experiments, and
it is not known whether the same outcomes can be seen in animals. Therefore, we
investigated DNA double strand breaks and HR repair in rat lungs after acute Cr(VI)
exposure.

RESULTS
Chromium accumulation in the Lung
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The main organ impacted by Cr(VI) is the lungs. Inhalation exposure of
Cr(VI) particulates is the predominant mode of exposure in chromium workers.
Therefore, we exposed rats to zinc chromate particles in saline solution by
oropharyngeal aspiration in this study. Since we aim to study the effects of
chromium on rat lungs, we first needed to determine whether chromium reaches
and accumulates in the lungs. We measured Cr levels in rat lung tissue by ICPMS.
After 24-hour Cr(VI) exposure, we found Cr accumulation in rat lung tissue
(Figure 3.2). Cr levels in the rat lungs increased in a dose-dependent manner
(linear regression analysis: p<0.0001) (Figure 3.3). After 24-hour exposure to 0
(saline), 0.2, 0.4, and 0.8 mg/kg zinc chromate, the average Cr levels in whole lung
tissues were 0.120, 3.295, 6.147, and 16.145 mg Cr/kg lung tissue, respectively.
The 0.8 mg/kg zinc chromate treatment group was significantly increased in Cr
level compared with the saline group (p<0.0001) (Figure 3.2).
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Figure 3.2. Cr levels in whole rat lungs after 24-hour exposure. Cr levels (relative
to saline) increased with dose after 24-hour zinc chromate exposure. The 0.8
mg/kg zinc chromate group had significantly higher levels than the saline group.
Error bar = standard error of the mean. Statistically different from the control (saline)
group: ****p<0.0001.
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Figure 3.3. Cr levels in whole rat lungs after 24-hour exposure shown with a linear
regression line. This figure shows a linear correlation between these 4 variables:
saline, 0.2 mg/kg, 0.4 mg/kg and 0.8 mg/kg zinc chromate. The p value is <0.0001.
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When airborne particles are inhaled into the airways, most particles are
removed by mucociliary clearance by macrophage phagocytosis (Lippmann et
al.,1980). A small fraction is redistributed and remains within the lung tissue
(Oberholster, 1988). The deposition and removal of particles in the respiratory tract
occur in a non-uniform manner. Therefore, we investigated the specific distribution
of zinc chromate particles in both the left and right lungs of rats. We found Cr levels
increased in a dose-dependent manner in both the left and right lungs, after 24hour zinc chromate exposure (Figure 3.4). After 24-hour exposure to 0 (saline),
0.2, 0.4, and 0.8 mg/kg zinc chromate, the average Cr levels in left rat lungs were
0.011, 0.359, 1.091, and 1.163 mg Cr/kg lung tissue, respectively. In right rat lungs,
after 24-hour exposure to 0 (saline), 0.2, 0.4, and 0.8 mg/kg zinc chromate, the
average Cr levels were 0.072, 3.423, 5.773, and 14.556 mg Cr/kg lung tissue,
respectively. The elevation of Cr levels in the right lung was statistically significant,
after 24-hour 0.4 and 0.8 mg/kg zinc chromate exposures (*p<0.05 and
****p<0.0001, respectively). Compared with Cr levels in the left lung, there was a
statistically significant increase in chromium deposition in the right lung (p<0.0001).
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Figure 3.4. Cr levels in left rat lungs vs. right rat lungs after 24-hour exposure. This
figure shows Cr levels increased in a dose-dependent manner in the left and right
lungs. Cr-induced level increases were statistically significant in the right lung. Cr
levels in right rat lungs were significantly increased compared with left rat lungs.
Error bar = standard error of the mean. Statistically different from the control (saline)
group: *p<0.05, ****p<0.0001.
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The left lung of the rat has only one lobe, and the right lung has four lobes,
including the superior, middle, inferior, and accessory lobes. We further
determined the distribution of Cr in each lung lobe. Cr levels increased in a dosedependent manner in each individual rat lung lobe after 24-hour zinc chromate
exposure (Figure 3.5). For example, after 24-hour exposure to 0 (saline), 0.2, 0.4,
and 0.8 mg/kg zinc chromate, the average Cr levels in the right inferior lobe were
0.027, 1.273, 3.630, and 4.578 mg Cr/kg lung tissue, respectively. The elevation
of Cr levels in the right inferior lobe was statistically significant, after 24-hour 0.4
and 0.8 mg/kg zinc chromate exposures (***p<0.001 and ****p<0.0001,
respectively). We also found Cr levels significantly increased in the right accessary
lobe after 24-hour 0.8 mg/kg zinc chromate exposure (****p<0.0001). However,
the increase in Cr concentration in the bronchial tree was significantly less
pronounced than in other lobes after acute exposure (*p<0.05) (Figure 3.6). This
outcome suggests that chromium was inhaled and deposited into the distal airways
in the rat lungs.
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Figure 3.5. Cr distribution in individual rat lung lobes after 24-hour zinc chromate
exposure. Cr levels increased in a dose-dependent manner in each individual rat
lung lobe. In the right inferior lobe and right accessary lobes, Cr levels were
significantly higher than in the saline group. Error bar = standard error of the mean.
Statistically different from the control (saline) group: ***p<0.001, ****p<0.0001.
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Figure 3.6. Cr distribution in the bronchial tree vs. other lung lobes after 24-hour
zinc chromate exposure. Cr level elevation was statistically significantly less
pronounced in the bronchial tree than in the other lung lobes. A. Elevation of Cr
levels in bronchial tree vs. left lung (*p<0.05). B. Elevation of Cr levels in bronchial
tree vs. right superior lobe (*p<0.05). C. Elevation of Cr levels in bronchial tree vs.
right middle lobe. D. Elevation of Cr levels in bronchial tree vs. right inferior lobe
(**p<0.01). E. Elevation of Cr levels in bronchial tree vs. right accessory lobe
(****p<0.0001). Error bar = standard error of the mean.
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Lung Histological Change
Repeated exposure to Cr(VI) induces lung damage and inflammation.
Beaver et al. found that a single nasal aspiration exposure to zinc chromate
particles caused lung tissue damage and inflammation that persisted for up to 21
days in mice (Beaver et al., 2009). We therefore investigated Cr(VI)-induced lung
histological changes by H&E staining before investigating Cr(VI)-induced DNA
damage. We found infiltration of inflammatory cells in the alveolar area after 24hour Cr(VI) exposure. Inflammatory cells accumulated around the alveoli and
terminal airways (Figure 3.7). In the group exposed to saline for 24 h, the main cell
types aggregated in the alveolar region were macrophages. While exposed to zinc
chromate for 24 hours, various inflammatory cells were gathered around the
alveolar area

and

terminal

airways,

mainly

neutrophils.

Cr(VI)-induced

inflammatory cells aggregated around the alveolar area and terminal airways
showed a slightly increasing trend after 24-hour exposure (Figure 3.8).
Since the cell types of inflammatory cell aggregation after acute exposure
differed between saline and Cr(VI) exposures, we investigated macrophage
aggregation and non-macrophage aggregation separately. We found macrophage
aggregation did not differ between groups after acute exposure, whereas nonmacrophage inflammatory cells increased significantly with increasing zinc
chromate doses after acute Cr(VI) exposure (Figure 3.9). These data suggest the
inflammatory response to acute chromium exposure is dominated by the
aggregation of non-macrophages, including neutrophils and lymphocytes.
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Figure 3.7. Cr(VI) induces inflammation in rat lung after 24-hour exposure. a.
Macrophages accumulate in the alveolar region after 24-hour exposure to saline.
b. Neutrophils and lymphocytes accumulate in the alveolar region after 24-hour
exposure to 0.2 mg/kg zinc chromate. c. Many neutrophils and lymphocytes
accumulate in the alveolar region after 24-hour exposure to 0.4 mg/kg zinc
chromate. d. Many neutrophils and lymphocytes accumulate in the alveolar region
after 24-hour exposure to 0.8 mg/kg zinc chromate. Magnifications for a - d are
x400.
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Figure 3.8. Cr(VI) induces inflammatory cell aggregation in the rat lung after 24hour exposure. Inflammatory cell aggregation increased after 24-hour exposure to
zinc chromate compared with saline exposure. Inflammatory cells were scored
according to Table 1.3. Error bar = standard error of the mean.
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Figure 3.9. Cr induced non-macrophage inflammatory cell aggregation in rat lung
after 24-hour exposure. This graph shows macrophage aggregation and nonmacrophage inflammatory cell aggregation are different after acute exposure
(****p<0.0001). Macrophage aggregation did not differ between groups after 24hour exposure, whereas non-macrophage inflammatory cells were significantly
increased after 24-hour zinc chromate exposure. Cr(VI)-induced non-macrophage
inflammatory cell aggregations were significantly increased in a dose-dependent
manner after exposure to 0.2, 0.4 and 0.8 mg/kg zinc chromate (*p<0.05, **p<0.01,
***p<0.001).
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DNA Double Strand Breaks
Histone H2AX is phosphorylated at Ser 139 in response to DNA double
strand breaks (Fernandez-Capetillo et al., 2004). The number of phosphorylated
H2AX foci forming at double strand break sites can represent the number of DNA
double strand breaks (Rogakou et al., 1999; Sedelnikova et al., 2002). Therefore,
the formation of γ-H2AX foci is considered a quantitative marker of DNA double
strand breaks. Although numerous cell culture studies have shown that Cr(VI)
induces the formation of double strand breaks, Cr(VI)-induced double strand
breaks in vivo have not been investigated so far. In the present study, we detected
the formation of γ-H2AX foci in Cr(VI)-exposed rat lungs by immunofluorescence.
We found Cr(VI) induced γ-H2AX foci formation in rat lungs after 24-hour zinc
chromate exposure (Figure 3.10). We investigated γ-H2AX foci formation in
different lung sites. Cr(VI)-induced γ-H2AX foci formation increased in a dosedependent manner in bronchioles. Specifically, after 24-hour exposure to 0 (saline),
0.2, 0.4, and 0.8 mg/kg zinc chromate in bronchioles, the percent of cells with γH2AX foci were 8.1, 20.2, 25.9, and 30.4%, respectively. There were statistically
significant γ-H2AX foci formation increases in bronchioles after exposure to 0.4
and 0.8 mg/kg zinc chromate (**p<0.01 and ***p<0.001, respectively) (Figure 3.11).
However, after 24-hour exposure to zinc chromate, there was a slight increase in
γ-H2AX foci formation in the alveoli. In bronchioles, the formation of γ-H2AX foci
caused by Cr(VI) was more pronounced than in alveoli (****p<0.0001) (Figure
3.11).

82

Figure 3.10. Particulate Cr(VI) induces DNA double strand breaks in the rat lung.
Representative images of γ-H2AX foci are shown. First column, merged image;
second column, DAPI staining; third column, γ-H2AX foci staining; fourth column,
staining for cytokeratin, a marker of epithelial cells.
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Figure 3.11. Comparison of γ-H2AX foci formation after 24-hour zinc chromate
exposure within and between groups of different lung regions. Cr(VI)-induced γH2AX foci formed in both the bronchiolar and alveolar regions. γ-H2AX foci
formation in bronchioles increased with zinc chromate dose. After exposure to 0.4
and 0.8 mg/kg zinc chromate, γ-H2AX foci formation in bronchioles was
significantly increased (**p<0.01, ***p<0.001). The formation of γ-H2AX foci in the
alveoli was slightly increased after 24-hour exposure to zinc chromate. Cr(VI)induced γ-H2AX foci formation showed statistically significant differences between
bronchioles and alveoli (****p<0.0001). Error bar = standard error of the mean.
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Epidemiological studies of chromate workers found that chromate-induced
tumors are epithelial carcinomas, mainly squamous cell carcinomas (Hirose et al.,
2002; Ishikawa et al., 1994a). Since squamous cell carcinomas originate from
epithelial cells, we further investigated Cr(VI)-induced DNA double strand breaks
in rat lung epithelial and non-epithelial cells. We also investigated the bronchiolar
and alveolar regions of the lung. As a result, we found few γ-H2AX foci formed in
bronchiolar non-epithelial cells after 24-hour zinc chromate exposure, whereas γH2AX foci formation in bronchiolar epithelial cells increased with Cr dose.
Specifically, after 24-hour exposure to 0 (saline), 0.2, 0.4, and 0.8 mg/kg zinc
chromate in bronchiolar epithelial cells, the rats of cells with γ-H2AX foci were
5.1%, 7.8%, 12.1%, and 12.9%, respectively. γ-H2AX foci formation in bronchiolar
epithelial cells was significantly increased after exposure to 0.4 and 0.8 mg/kg zinc
chromate (*p<0.05) (Figure 3.12). In bronchioles, Cr(VI)-induced γ-H2AX foci
formation was almost exclusively in epithelial cells (****p<0.0001) (Figure 3.12).
We found that γ-H2AX foci formation in alveolar non-epithelial cells was
almost unchanged after 24-hour Cr(VI) exposure compared with saline exposure,
whereas γ-H2AX foci formation in alveolar epithelial cells increased with Cr(VI)
dose (Fig. 3.13). When comparing alveolar non-epithelial and epithelial cells, we
found that Cr(VI)-induced γ-H2AX foci formation was predominantly in epithelial
cells (****p<0.0001) (Figure 3.13).
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Figure 3.12. Comparison of γ-H2AX foci formation in bronchioles after 24-hour
exposure to zinc chromate within and between groups of non-epithelial and
epithelial cells. Few γ-H2AX foci formed in bronchiolar non-epithelial cells after 24
hours of zinc chromate exposure, whereas γ-H2AX foci formation in bronchiolar
epithelial cells increased with Cr(VI) doses. γ-H2AX foci formation in bronchiolar
epithelial cells was significantly increased after exposure to 0.4 and 0.8 mg/kg zinc
chromate (*p<0.05). In bronchioles, Cr(VI)-induced γ-H2AX foci formation was
significantly different between non-epithelial and epithelial cells (****p<0.0001).

86

Saline
0.2 mg/kg Zinc Chromate
0.4 mg/kg Zinc Chromate
0.8 mg/kg Zinc Chromate

Percent of Cells with >3
γ-H2AX Foci

****
25
20
15
10
5
0

Non-epithelial Cells

Epithelial Cells

Cell Types
Figure 3.13. Comparison of γ-H2AX foci formation in alveoli after 24-hour exposure
to zinc chromate within and between groups of non-epithelial and epithelial cells.
γ-H2AX foci formation in alveolar non-epithelial cells was almost unchanged
compared to saline exposure, whereas γ-H2AX foci formation in alveolar epithelial
cells increased with Cr(VI) dose. Cr(VI)-induced γ-H2AX foci formation was
significantly different between alveolar non-epithelial and epithelial cells
(****p<0.0001).
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HR Repair
HR repair is the accurate repair of DNA double strand breaks using
undamaged sister chromatids as a template to maintain the integrity of the genome
(Van et al. 2001). Recombinase RAD51, a key repair protein in HR repair, binds
single-stranded DNA and forms nuclear filaments that play a key role in HR by
guiding strand exchange and homology searching (Filippo et al., 2008; Li et al.,
2008). Our previous study found that acute particulate Cr(VI) activates HR repair
to prevent Cr(VI)-induced DNA double strand breaks, whereas prolonged
particulate Cr(VI) inhibits HR repair by targeting RAD51 (Qin et al., 2014; Browning
et al., 2016). We therefore investigated RAD51 expression to assess HR repair in
rat lungs after 24-hour zinc chromate exposure by immunofluorescence. We found
that Cr(VI) induced RAD51 foci formation in rat lungs following 24-hour zinc
chromate exposure (Figure 3.14). We next investigated RAD51 foci formation in
different lung sites. Cr(VI)-induced RAD51 foci formation increased in a dosedependent manner in bronchioles. Specifically, after 24-hour exposure to 0
(saline), 0.2, 0.4, and 0.8 mg/kg zinc chromate in the bronchioles, the rates of cells
with RAD51 foci were 9.1, 11.1, 17.75, and 24.63, respectively. RAD51 foci
formation in bronchioles was significantly increased after exposure to 0.8 mg/kg
zinc chromate (***p<0.001) (Figure 3.15). However, after 24-hour exposure to zinc
chromate, there was no increase in RAD51 foci formation in the alveoli compared
to the saline-exposed group. Cr(VI)-induced RAD51 foci formation after 24-hour
zinc chromate exposure was significantly different in the bronchioles and alveoli
(****p<0.0001) (Figure 3.15).
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Figure 3.14. Particulate Cr(VI) induces RAD51 foci formation in the rat lung.
Representative images of RAD51 foci are shown. First column, merged image;
second column, DAPI staining; third column, RAD51 foci staining; fourth column,
staining for PMCA ATPase, a marker of the cell membrane.
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Figure 3.15. Comparison of RAD51 foci formation after 24-hour zinc chromate
exposure within and between groups of different lung regions. RAD51 foci
formation was increased in bronchioles in a dose-dependent manner after 24-hour
exposure, and was significantly increased after exposure to 0.8 mg/kg zinc
chromate (***p<0.001). After 24-hour exposure to zinc chromate, there was no
increase in RAD51 foci formation in alveoli compared with the saline-exposed
group. Cr(VI)-induced RAD51 foci formation was significantly different in
bronchioles and alveoli after 24-h zinc chromate exposure (****p<0.0001). Error
bar = standard error of the mean.
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Sex differences
There are gender differences in the incidence of lung cancer among nonsmoking patients. Women who do not smoke have higher rates of lung cancer than
men. Therefore, we investigated whether there are differences in lung Cr levels,
lung histological changes, DNA double strand breaks, and HR repair between
female and male rats.

Chromium Uptake
We investigated potential differences in Cr levels in the lungs of female and
male rats after 24-hour zinc chromate exposure. We found Cr levels increased in
a dose-dependent manner in either left or right lung lobe, female or male rat (Figure
3.16). We compared left and right lung Cr levels within sex groups. We found Cr
levels were higher in the right lung than in the left within the same sex group (Figure
3.16). For example, within the female group, after 24-hour exposure to 0 (saline),
0.2, 0.4, and 0.8 mg/kg zinc chromate, the mean levels of Cr in the left lung were
0.010, 0.417, 0.678, and 1.456 mg Cr/kg lung tissue, respectively; these values in
the right lung were 0.087, 3.997, 7.244, and 19.685 mg Cr/kg lung tissue,
respectively. In the right lung of female rats, there were statistically significant
increases following exposure to 0.4 and 0.8 mg/kg zinc chromate (*p<0.05 and
****p<0.0001, respectively). In the female rat group, dose-dependent increases in
Cr levels were statistically significant in the right lung when compared to the left
lung (****p<0.0001). In the male rat group, after 24-hour zinc chromate exposure
at 0 (saline), 0.2, 0.4 and 0.8 mg/kg, the mean levels of Cr in the left lung were
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0.0127, 0.301, 1.505 and 1.163 mg Cr/kg lung tissue, respectively, versus 0.072,
3.423, 5.773 and 14.556 mg Cr/kg lung tissue in the right lung, respectively. There
was a statistically significant increase after exposure to 0.8 mg/kg zinc chromate
(**p<0.01). Likewise, there was a statistically significant increase in Cr levels in the
right lung compared with the left lung in the male rat group (**p<0.01). The
difference between the left and right lungs in female rats was statistically more
significant (Figure 3.16). Changes in Cr level deposition were also statistically
different between sexes (*p<0.05) (Figure 3.16).
We then investigated the distribution of Cr in each lung lobe by sex. We
found dose-dependent increases in Cr levels in all lobes, in both females and
males, with the exception of the left lung, right superior lobe, and the right inferior
lobe of male rats (Figure 3.17). The Cr levels in the lung lobes were not similar to
those in the corresponding lung lobes in different sex groups. For example, in the
right superior lung of female rats, Cr concentrations increased with Cr(VI) dose,
but in the right superior lung of male rats, Cr concentrations instead decreased
compared with 0.2 mg/kg after 24-hour exposure to 0.4 and 0.8 mg/kg zinc
chromate. In the right inferior lung of female rats, there was a statistically significant
increase in Cr concentration after 24-hour exposure to 0.4 and 0.8 mg/kg zinc
chromate (*p<0.05, ****p<0.0001), whereas in the right inferior lung of male rats,
the concentration was only statistically significant after 24-hour exposure to 0.4
mg/kg zinc chromate (*p<0.05). However, the Cr level decreased after 24-hour
exposure to 0.8 mg/kg zinc chromate compared with 0.4 mg/kg exposure. Although
there was a dose-dependent increase in Cr concentration with statistical

92

significance after 24-hour exposure to 0.8 mg/kg zinc chromate, in the right
accessory lobe of both female and male rats (****p<0.0001). There was
considerable variability in Cr levels after exposure to 0.8 mg/kg zinc chromate in
male rats. In the right middle lobe, the trend of increasing Cr concentration with
increasing dose was similar in both sex groups. Therefore, we selected the middle
lobe of the rat lung for subsequent immunofluorescence studies. In addition, we
found that in the female rat group, the distribution of Cr in different lung lobes was
significantly different (****p<0.0001). Moreover, there were statistically significant
differences in the distribution of Cr in each lobe between the different sex groups
(*p<0.05).
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Figure 3.16. Comparison of Cr levels in the left and right lungs of rats after
exposure for 24 hours within and between groups of different sexes. Cr levels
increased dose-dependently in either left or right lung, female or male rat. In the
same sex group, the right lung had higher Cr content than the left lung. In the right
lung of the female group, there were statistically significant increases following 24hour exposure to 0.4 and 0.8 mg/kg zinc chromate (*p<0.05, ****p<0.0001). In the
female rat group, there was a statistically significant dose-dependent increase in
Cr levels in the right lung compared with the left lung (****p<0.0001). There was
also a statistically significant increase in Cr levels in the right lung of the male rat
group compared with the left lung (**p<0.01). Among groups, there was a
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statistically significant increase (**p<0.01) in the right lungs of male rats exposed
to 0.8 mg/kg zinc chromate for 24 hours. Changes in Cr deposition were also
statistically different between sexes (*p<0.05). Error bar = standard error of the
mean.
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Figure 3.17. Comparison of Cr distribution in lung lobes after exposure for 24 hours
within and between groups of different sexes. The graph shows a dose-dependent
increase in Cr content in all lung lobes, including in females and males, except the
left, right upper, and right lower lobes of male rats. The distribution of Cr in lung
lobes of different sex groups was different from those of the corresponding lung
lobes. In the right lower lung of female rats, Cr concentrations were significantly
increased after 24-hour exposure to 0.4 and 0.8 mg/kg zinc chromate (*p<0.05 and
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****p<0.0001, respectively), while in male rats of the right lower lung, they were
significantly different after 24-hour 0.4 mg/kg zinc chromate exposure (*p<0.05).
In the right accessory lobe of female and male rats, there were statistically
significant increases in Cr concentrations after 24-hour exposure to 0.8 mg/kg zinc
chromate (****p<0.0001). In the female rat group, the distribution of Cr in different
lung lobes was significantly different (****p<0.0001). There were statistically
significant differences in Cr distribution in each lobe between the different sex
groups (*p<0.05). Error bar = standard error of the mean.
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Lung Histological Change
We next investigated potential differences in inflammatory cell aggregation
in the lungs of female and male rats. We found aggregation of inflammatory cells
in the lungs of female rats was significantly more pronounced after 24-hour
exposure to zinc chromate than to saline exposure (Figure 3.18). Inflammatory cell
scores significantly increased after 24-hour exposure to 0.2 and 0.8 mg/kg zinc
chromate (*p<0.05 and **p<0.01, respectively). However, 24-hour exposure to zinc
chromate in male rats resulted in a slightly greater degree of inflammatory cell
aggregation in the lungs than in the saline-exposed group (Figure 3.18). There
were statistically significant differences in inflammatory cell aggregation between
the different sex groups (****p<0.0001).
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Figure 3.18. Comparison of inflammatory cell aggregation after exposure for 24
hours within and between groups of different sexes. Inflammatory cell aggregation
in the lungs of female rats was more pronounced after 24-hour exposure to zinc
chromate compared with the saline group. Inflammatory cell scores were
significantly increased after exposure to 0.2 and 0.8 mg/kg zinc chromate for 24
hours (*p<0.05, **p<0.01). 24-hour exposure to zinc chromate in male rats resulted
in slightly higher levels of inflammatory cell aggregation in the lungs than in the
saline-exposed group. Inflammatory cell aggregation was statistically different
between the female and male groups (****p<0.0001). Error bar = standard error of
the mean.
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DNA Double Strand Breaks
We then investigated γ-H2AX foci formation in bronchioles and alveoli by
sex. We found that in bronchioles, γ-H2AX foci formation increased with zinc
chromate dose in both female and male rats (Figure 3.19). Cr(VI)-induced foci
formation was not statistically different between sex groups in bronchioles. In
alveoli, γ-H2AX foci formation in male rats all increased with zinc chromate dose
but not in female rats (Fig. 3.20). γ-H2AX foci formation was significantly increased
in male rats after 24h zinc chromate exposure (*p<0.05). Comparing γ-H2AX foci
formation in alveoli between sex groups, there were some differences in Cr(VI)induced γ-H2AX foci formation, although the difference was not statistically
significant.
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Figure 3.19. Comparison of γ-H2AX foci formation in bronchioles after 24-hour
exposure to zinc chromate within and between groups of different sexes. There
were dose-dependent increases in foci formation in female and male rats following
24-hour exposure to zinc chromate. When comparing bronchioles between sex
groups, no statistical differences in Cr(VI)-induced foci formation were found. Error
bar = standard error of the mean.
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Figure 3.20. Comparison of γ-H2AX foci formation in alveoli after 24-hour exposure
to zinc chromate within and between groups of different sexes. γ-H2AX foci
formation in alveoli increased with zinc chromate doses in male rats, but not in
female rats. γ-H2AX foci formation was significantly increased in male rats after
24-hour exposure to zinc chromate (*p<0.05). Cr(VI)-induced γ-H2AX foci
formation was not statistically different between the sex groups in alveoli. Error bar
= standard error of the mean.
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HR Repair
We also studied RAD51 foci formation in bronchioles and alveoli by sex. We
found that in bronchioles, RAD51 foci formation increased with zinc chromate
doses in female and male rats (Figure 3.21). When comparing the sex groups for
Cr(VI)-induced RAD51 foci formation in bronchioles, no statistical differences were
found. In alveoli, RAD51 foci formation increased with zinc chromate doses in male
rats, but not in female rats (Figure 3.22). When comparing different sex groups in
alveoli, there were some differences in Cr(VI)-induced RAD51 foci formation,
although they were not statistically significant.
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Figure 3.21 Comparison of RAD51 foci formation in bronchioles after 24-hour
exposure to zinc chromate within and between groups of different sexes. RAD51
foci formation increased with zinc chromate dose in female and male rats in
bronchioles after 24-hour exposure. When comparing the sex groups in
bronchioles, no significant differences in Cr(VI)-induced RAD51 foci formation
were found. Error bar = standard error of the mean.
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Figure 3.22. Comparison of RAD51 foci formation in alveoli after 24-hour exposure
to zinc chromate within and between groups of different sexes. RAD51 foci
formation in alveoli in female rats was not increased after Cr(VI) exposure
compared with the saline-exposed group. RAD51 foci formation in male rats
increased with zinc chromate dose in alveoli. Cr(VI)-induced RAD51 foci formation
was not significantly different between sex groups in the alveoli. Error bar =
standard error of the mean.
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Accumulation of Other Metals
Zinc Levels
Because we treated the rats with zinc chromate, we also measured zinc
levels in the rat lungs. Zinc is an essential trace element for the human body. It
can pass through the cell membrane both inside and outside the cell according to
the needs of the cell. We found that zinc levels in rat lung tissue did not increase
with dose after 24-hour zinc chromate exposure (Figure 3.23). For example, after
24-hour exposure to 0 (saline), 0.2, 0.4, and 0.8 mg/kg zinc chromate, the mean
levels of zinc in the whole lung were 98.792, 86.435, 91.2, and 121.655,
respectively. Mean whole lung zinc levels were even lower in the 0.2 and 0.4
treatment groups than in the saline group. Combined with Cr data in the whole rat
lung, a dose-dependent accumulation of Cr was confirmed in the rat lung. After
entering the cell, hexavalent chromium is reduced to trivalent chromium, which
easily binds to intracellular macromolecules and then is too large to pass through
the membrane and return to the outside of the cell. However, the transport of zinc
inside and outside the cell membrane is bidirectional due to cellular requirements.
We then investigated the distribution of zinc levels in the left and right lungs
of rats, respectively. After 24-hour exposure, zinc levels in the left rat lung exposed
to zinc chromate were not higher than those of rats exposed to saline (Figure 3.24).
However, after exposure to 0.4 mg/kg and 0.8 mg/kg zinc chromate for 24 hours,
respectively, the levels of zinc in the right rat lung were higher than those of the
saline group (Figure 3.24). There was a statistically significant increase after
exposure to 0.8 mg/kg zinc chromate (*p<0.05). Zinc levels were significantly
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higher in the right lung than in the left lung (****p<0.0001). Combined with Cr data,
more zinc chromate particles accumulated in the right lung of rats.
We further assessed zinc distribution in each lung lobe. After 24-hour
exposure to zinc chromate, zinc levels did not change consistently in each rat lung
lobe (Figure 3.25). Zinc levels were increased in the right inferior and accessary
lung lobes, whereas zinc levels were decreased in the left lung lobe, right superior
lung lobe and bronchial tree after 24-hour exposure to zinc chromate. Zinc levels
in the right middle lung lobe slightly increased after 0.8 mg/kg zinc chromate
exposure and decreased after 0.2 and 0.4 mg/kg zinc chromate exposures. After
24-hour 0.8 mg/kg zinc chromate exposure, zinc levels in the right accessory lobe
were significantly increased (****p<0.0001). Significantly lower metal levels in the
bronchial tree found in the Cr data than in other lobes were not found in the zinc
data.
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Figure 3.23. Zinc levels in whole rat lungs after 24-hour exposure. Zinc levels in
the whole lung tissue of rats did not increase in a dose-dependent manner
compared to the saline group after 24-hour exposure to zinc chromate.
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Figure 3.24. Zinc levels in the left and right rat lungs after 24-hour exposure. Zinc
levels in the left lung of rats did not increase after 24-hour exposure to zinc
chromate. However, after exposure to 0.4 mg/kg and 0.8 mg/kg zinc chromate for
24 hours, respectively, zinc levels in the right lung of rats increased. There was a
statistically significant increase after exposure to 0.8 mg/kg zinc chromate
(*p<0.05). Zinc levels were significantly higher in the right lung compared with the
left lung (****p<0.0001). Error bar = standard error of the mean.
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Figure 3.25. Zinc distribution in each individual rat lung lobe after 24-hour zinc
chromate exposure. This figure shows changes in zinc levels in each rat lung lobe
were not consistent after 24-hour exposure to zinc chromate. Zinc levels were
increased in the right middle lung and right accessory lung, whereas zinc levels
were decreased in the left lung, right upper lung, and bronchial tree. Zinc levels in
the right middle lung slightly increased after 0.8 mg/kg zinc chromate exposure
and decreased after 0.2 and 0.4 mg/kg zinc chromate exposures. Zinc levels in the
right appendage were significantly increased after 24-hour 0.8 mg/kg zinc
chromate exposure (****p<0.0001). Error bar = standard error of the mean.
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Iron Uptake
We investigated iron levels in rat lungs. We found iron levels did not
increase but instead slightly decreased in rat lung tissue after 24-hour exposure to
zinc chromate (Figure 3.26). For example, after 24-hour zinc chromate exposure
at 0 (saline), 0.2, 0.4, and 0.8 mg/kg, mean whole lung iron levels were 177.497,
150.513, 119.59, and 175.933, respectively. Mean whole lung zinc levels were
even lower in the 0.2 and 0.4 treatment groups than in the saline group. Combined
with Cr and zinc level data in the whole rat lung, a dose-dependent accumulation
of chromium in the rat lungs was further confirmed.
We further investigated iron distribution in each lung lobe. After 24-hour
exposure to zinc chromate, iron levels in each rat lung lobe tended to decrease
except for a slight increase in the bronchial tree (Figure 3.28). Iron levels in the left
and right lower lungs were significantly reduced after 24-hour exposure to 0.4
mg/kg zinc chromate (*p<0.05). Iron levels in the bronchial tree were higher than
in other lobes.
There is a certain relationship between the metabolism of different metals
such as iron, zinc, copper and chromium in the body, and their interactions are
either antagonistic or synergistic (Staniek and Wójciak, 2018). Staniek and Wójciak
found that CR(III) supplementation reduces iron levels in the kidneys of rats in the
recommended iron diet group (Staniek and Wójciak, 2018). We therefore
investigated whether chromium exposure affects functional iron levels in rat lungs.
We used the ratio of iron content to Cr content to assess functional iron levels in
rat lungs. We found functional iron levels were significantly reduced after 24-hour
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zinc chromate exposure (Figure 3.29). Specifically, after 24-hour exposure to 0
(saline), 0.2 mg/kg, 0.4 mg/kg and 0.8 mg/kg zinc chromate, iron to Cr ratios in rat
lungs were 11701, 3254, 1326 and 1428, respectively. These data suggest that Cr
exposure affects iron metabolism in rats.
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Figure 3.26. Iron levels in the whole rat lungs after 24-hour exposure. Iron levels
in the rat lung tissue decreased after 24-hour exposure to zinc chromate. Mean
whole-lung iron levels were lower than those of the saline group after 24-hour zinc
chromate exposure at 0.2 and 0.4 mg/kg. Error bar = standard error of the mean.
We then investigated the distribution of iron levels in the left and right lungs of rats,
respectively. After 24-hour exposure, iron levels in both the left and right lungs of
rats exposed to zinc chromate were not higher than those of rats exposed to saline
(Figure 3.27). Iron levels were significantly higher in the right lung than in the left
lung (****p<0.0001).
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Figure 3.27. Iron levels in the left and right rat lungs after 24-hour exposure. This
figure shows iron levels in both the left and right lungs of rats were no higher than
in saline-exposed rats after 24-hour zinc chromate exposure. Iron levels were
statistically significantly higher in the right lung when compared to the left lung
(****p<0.0001). Error bar = standard error of the mean.
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Figure 3.28. Iron distribution in individual rat lung lobes after 24-hour zinc chromate
exposure. Iron levels in each rat lobe decreased except for a slight increase in the
bronchial tree after 24-hour exposure to zinc chromate. Iron levels in the left lung
and right inferior lung lobe were significantly decreased after 24-hour exposure to
0.4 mg/kg zinc chromate (*p<0.05). The iron levels were higher in the bronchial
tree than in other lobes. Error bar = standard error of the mean.
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Figure 3.29. Functional iron levels in the rat lung after 24-hour zinc chromate
exposure. Functional iron levels decreased after 24-hour zinc chromate exposure.
After 24-hour exposure to 0.2 mg/kg, 0.4 mg/kg and 0.8 mg/kg zinc chromate,
respectively, the ratios of iron to Cr in the lungs of rats were significantly lower than
those of the saline group (***p=0.001, ****p=0.001).
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SUMMARY
Cr has been listed as a lung carcinogen for decades, but the carcinogenic
mechanism of chromium remains unclear. We found in a previous cell culture study
that acute Cr(VI) causes DNA double strand breaks and activates HR repair to
protect Cr(VI)-induced chromosomal instability. However, these effects have not
been verified in animal experiments. We therefore performed corresponding
studies in the lungs of rats after acute Cr(VI) exposure.
In this aim, we found a dose-dependent increase in rat lung Cr levels after
24-hour zinc chromate exposure. Chromium accumulation was more pronounced
in the right lung than in the left lung. Furthermore, when Cr concentrations in each
lung lobe were examined separately, we found that Cr concentration increase in
the bronchial tree after acute exposure was significantly less pronounced than in
other lobes. These results indicate that Cr(VI) was inhaled and deposited into the
distal airways of the rat lung.
Cr(VI)-induced lung histological changes were investigated by H&E staining,
and we found inflammatory cell infiltration in the alveolar region after 24-hour Cr(VI)
exposure. Inflammatory cells accumulated around the alveoli and terminal airways.
In the group exposed to saline for 24 hours, the predominant cell type that
aggregated in the alveolar region was macrophages. After 24-hour exposure to
zinc chromate, various inflammatory cells, mainly neutrophils, aggregated in the
alveolar region and around the terminal airways. After 24-hour exposure, Cr(VI)induced inflammatory cells clustered around the alveolar areas and terminal
airways with a slight increasing trend.
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We detected γ-H2AX foci formation in Cr(VI)-exposed rat lungs by
immunofluorescence. We found that Cr(VI) induced γ-H2AX foci formation in rat
lungs 24- hours after zinc chromate exposure. Cr(VI)-induced γ-H2AX foci
formation was increased in bronchioles in a dose-dependent manner. γ-H2AX foci
formation caused by Cr(VI) was more pronounced in bronchioles than in alveoli.
Moreover, Cr(VI)-induced γ-H2AX foci were formed almost exclusively in epithelial
cells, both in bronchiolar and alveolar regions.
We also investigated RAD51 to assess HR repair in rat lungs following 24hour zinc chromate exposure by immunofluorescence. The results showed Cr(VI)
induced RAD51 foci formation in rat lungs after 24-hour exposure to zinc chromate.
Cr(VI)-induced RAD51 foci formation increased in a dose-dependent manner in
bronchioles. However, there was no increase in RAD51 foci formation in alveoli
compared with the saline group. After 24-hour zinc chromate exposure, Cr(VI)induced RAD51 foci formation was more pronounced in bronchioles than in alveoli.
Comparing different sex groups, we found higher lung levels of Cr in female
rats than in male rats. However, acute inflammatory response to Cr(VI) exposure
was stronger in male rats than in female rats in terms of lung histology. There were
no significant gender differences in the formation of γ-H2AX foci and RAD51 foci.
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Aim 2: Demonstrate particulate Cr(VI) induces DNA double strand breaks, inhibits
HR repair in the rat lung after 90-day exposure.

BACKGROUND
The HR repair pathway can repair dangerous DNA double strand breaks to
prevent Cr(VI)-induced chromosomal instability (Bryant et al., 2006; Gastaldo et
al., 2007). However, these data were found in cell culture experiments, and it is
not known whether the same results can be seen in animals. In Aim 1, we found
acute Cr(VI) induced DNA double strand breaks and HR repair active in rat lung.
Cell cultured studies have shown prolonged Cr(VI) exposure induces HR
dysfunction by inhibiting RAD51 (Qin et al., 2014; Browning et al., 2016). We
therefore investigated DNA double strand breaks and HR repair in rat lungs
following subchronic Cr(VI) exposure. We exposed rats to zinc chromate single
dose weekly for 90-day and then investigated metal levels, lung histological
changes, DNA double strand breaks, and HR repair in rat lungs.

RESULTS
Chromium Accumulation in Lung
After 90 days of oropharyngeal inhalation exposure of rats to zinc chromate,
we evaluated whether chromium reached and accumulated in the lungs. We
measured Cr levels in rat lung tissue by ICP-MS. Cr accumulation was detected in
rat lung tissue (Figure 3.30). We observed dose-dependent increases in Cr levels
following 90-day exposure with 0, 0.4, and 0.8 mg/kg zinc chromate (linear
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regression analysis: p<0.0001) (Figure 3.31). After 90-day exposure to 0 (saline),
0.4, and 0.8 mg/kg zinc chromate, average Cr levels in whole lung tissues were
0.1560, 12.50, and 12.42 mg Cr/kg lung tissue, respectively. Cr levels were
significantly higher than the saline group after exposure to 0.4 and 0.8 mg/kg zinc
chromate. (***p<0.001) (Figure 3.30).
The deposition and removal of inhaled particles in the respiratory tract occur
in an uneven manner. We next investigated the specific distribution of zinc
chromate particles in both the left and right lungs of rats. We found after 90-day
exposure to zinc chromate, Cr levels in the left and right lungs increased in a dosedependent manner (Figure 3.32). After 90-day exposure to 0 (saline), 0.4 and 0.8
mg/kg zinc chromate, mean Cr levels in the left lungs of rats were 0.008, 1.607,
and 1.838 mg Cr/kg lung tissue, respectively, and in the right lung of rats, they are
0.104, 10.67 and 10.22 mg Cr/kg lung tissue. After 90-day 0.4 and 0.8 mg/kg zinc
chromate exposures, there were statistically significant increases in Cr levels in
the right lung (****p<0.0001). In the 0.8 mg/kg treatment group, Cr accumulation
in the right lung was not higher than that of the 0.4 mg/kg treatment group. Cr
levels were significantly increased in the right lung compared with the left lung
(p<0.0001).
As for the 24-hour exposure study, we further investigated the distribution
of Cr in the lung lobes of each rat after 90-day zinc chromate exposure. After 90day exposure to zinc chromate, Cr levels in each rat lung lobe increased in a dosedependent manner (Figure 3.33). For example, after 90-day exposure to saline,
0.4 and 0.8 mg/kg zinc chromate exposure, mean Cr levels in the right superior
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lobe were 0.017, 7.003 and 2.864 mg Cr/kg lung tissue, respectively. After 90-day
0.4 and 0.8 mg/kg zinc chromate exposures, there were statistically significant
increases in right superior lobe Cr levels (****p<0.0001, *p<0.05). We also found
Cr levels in the right accessory lobe were significantly increased after 90-day 0.8
mg/kg zinc chromate exposure (**p<0.01). However, the increase in Cr
concentration in the bronchial tree after 90-day exposure was significantly lower
than in other lobes (*p<0.05) (Fig. 3.34). This result indicates particulate Cr(VI)
was inhaled and deposited into the distal airways of the rat lungs after 90-day
exposure.
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Figure 3.30. Cr levels in whole rat lungs after 90-day exposure. Cr levels increased
after 90-day zinc chromate exposure. There were dose-dependent increases in Cr
levels following 90-day exposure with 0 (saline), 0.4, and 0.8 mg/kg zinc chromate
(linear regression analysis: p<0.0001). Compared with the saline-exposed group,
Cr levels were significantly increased after exposure to 0.4 and 0.8 mg/kg zinc
chromate (***p<0.001). Error bar = standard error of the mean.
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Figure 3.31. Cr levels in whole rat lungs after 90-day exposure shown with
regression line. There was a linear correlation between these 3 groups, including
0 (saline), 0.4 mg/kg and 0.8 mg/kg zinc chromate (p=0.0009).
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Figure 3.32. Cr levels in the left rat lung vs. right rat lung after 90-day exposure. Cr
levels increased in a dose-dependent manner in the left and right lungs (linear
regression analysis: left lung p<0.05 and right lung p<0.01). Cr level increases
were statistically significant in the right lung (****p<0.0001). Cr levels were
significantly increased in the right rat lung compared with the left rat lung
(****p<0.0001). Error bar = standard error of the mean.

124

Saline
0.4 mg/kg Zinc Chromate
0.8 mg/kg Zinc Chromate

Cr Level
(mg/kg lung tissue)

20

****

15

**

*

10
5

R

Le
ft
lu
ng

ig
ht
su
pe
ri o
rl
R
ob
ig
e
ht
m
id
dl
e
lo
R
be
ig
ht
in
fe
rio
R
ig
rl
ht
ob
ac
e
ce
ss
ar
y
lo
be
Br
on
ch
ia
lt
re
e

0

Lung lobes
Figure 3.33. Cr distribution in each individual rat lung lobe after 90-day zinc
chromate exposure. Cr levels in each rat lung lobe increased in a dose-dependent
manner after 90-day exposure to zinc chromate. Right upper lobe Cr levels were
significantly increased after 90-day zinc chromate exposure at 0.4 and 0.8 mg/kg
(****p<0.0001 and *p<0.05, respectively). Cr levels in the right accessory lobe were
significantly increased after 90-day 0.8 mg/kg zinc chromate exposure (**p<0.01).
Error bar = standard error of the mean.
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Figure 3.34. Cr distribution in the bronchial tree and other lung lobes after 90-day
zinc chromate exposure. Cr level elevation was significantly less pronounced in
the bronchial tree than in the other lung lobes. A. Cr level elevation in the bronchial
tree vs. left lung (**p<0.01). B. Cr level elevation in the bronchial tree vs. right
superior lobe (**p<0.01). C. Cr level elevation in the bronchial tree vs. right middle
lobe (**p<0.01). D. Cr level elevation in the bronchial tree vs. right inferior lobe
(*p<0.05). E. Cr level elevation in the bronchial tree vs. right accessory lobe
(****p<0.0001). Error bar = standard error of the mean.
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Lung Histological Change
We investigated Cr(VI)-induced lung histological changes following 90-day
zinc chromate exposure by H&E staining. We found macrophage aggregation and
lymphocyte aggregation in the alveolar region after 90-day Cr exposure.
Macrophages accumulated mainly around the alveoli and terminal airways (Figure
3.35). Lymphocytes were mainly in the alveolar interstitium, and the alveolar wall
was thickened. A large number of necrotic cells were seen in the alveoli.
Thickening of the blood vessel wall was seen in the lungs of Cr(VI)-exposed rats
(Figure 3.35). Cr(VI)-induced macrophage aggregation around the alveolar areas
and terminal airways, and increased with Cr dose after 90-day exposure to zinc
chromate (Fig. 3.36).
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Figure 3.35. Cr(VI) induces inflammation and vascular wall changes in the rat lung
after 90-day exposure. a. Few macrophages accumulated in the alveolar region
after 90-day exposure to saline. b. Some macrophages accumulated in the
alveolar region after 90-day exposure to 0.4 mg/kg zinc chromate. c. A great
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number of macrophages accumulated in the alveolar region after 90-day exposure
to 0.8 mg/kg zinc chromate. d. Many necrotic cells and macrophages in the alveoli,
with alveolar wall thickening. e. Normal blood vessels in the rat lung after 90-day
exposure to saline. f. Blood vessel wall thickening in the rat lung after 90-day 0.8
mg/kg zinc chromate exposure. Magnification in a-f: x400.
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Figure 3.36. Cr induces macrophage aggregation in the rat lung after 90-day
exposure. Macrophage aggregation increased after 90-day exposure to zinc
chromate compared with saline exposure. After 90-day exposure to 0.4 and 0.8
mg/kg zinc chromate, there were statistically significant increases in macrophage
scores (*****p<0.0001). Macrophages were scored according to Table 1.3.
Macrophages and inflammatory cells scoring system. Error bar = standard error of
the mean.
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DNA Double Strand Break
Having established that particulate Cr(VI) was inhaled and deposited and
caused histological changes in rat lungs, we next examined the formation of γH2AX foci in Cr-exposed rat lungs by immunofluorescence. We found Cr(VI)
induced γ-H2AX foci formation in rat lungs after 90-day zinc chromate exposure
(Figure 3.37). We also studied γ-H2AX foci formation in different lung sites. Cr(VI)induced γ-H2AX foci formation was increased in a dose-dependent manner in
bronchioles and alveoli. Specifically, after exposure to 0 (saline), 0.4, and 0.8
mg/kg zinc chromate for 90 days in bronchioles, the rates of cells with γ-H2AX foci
were 4.63%, 21.88%, and 22.50%, respectively. After exposure to 0.4 and 0.8
mg/kg zinc chromate, γ-H2AX foci formation in bronchioles were significantly
increased (**p<0.01) (Fig. 3.38). Meanwhile, after 90-day exposure to zinc
chromate, γ-H2AX foci formation was slightly increased in alveoli. Cr(VI)-induced
γ-H2AX foci formation was more significant in bronchioles than in alveoli after 90day zinc chromate exposure (*p<0.05) (Fig. 3.38).
In acute Cr(VI)-exposure rats, we found Cr(VI)-induced DNA double strand
breaks mostly in epithelial cells. We further investigated Cr(VI)-induced DNA
double strand breaks in both epithelial and non-epithelial cells, by measuring γH2AX foci formation, after exposure to 90-day zinc chromate. We also measured
γ-H2AX foci formation in different regions of the lung, i.e., bronchiolar and alveolar
regions. We found few γ-H2AX foci formed in bronchiolar non-epithelial cells after
90-day zinc chromate exposure, whereas γ-H2AX foci formation in bronchiolar
epithelial cells increased with Cr(VI) dose. Specifically, after exposure to 0 (saline),
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0.4 and 0.8 mg/kg zinc chromate for 90 days, the rates of cells with γ-H2AX foci in
bronchiolar epithelial cells were 2.25%, 10.38%, and 12.50%, respectively. γH2AX foci formation in bronchiolar epithelial cells was significantly increased after
exposure to 0.4 and 0.8 mg/kg zinc chromate (**p<0.01 and ****p<0.0001,
respectively) (Figure 3.39). In bronchioles, there was a statistically significant
difference in Cr(VI)-induced γ-H2AX foci between epithelial and non-epithelial
cells. This data demonstrates Cr(VI)-induced γ-H2AX foci in bronchioles formed
almost exclusively in epithelial cells (****p<0.0001) (Fig. 3.39).
We also observed little changes in γ-H2AX foci formation in alveolar nonepithelial cells after 90-day Cr exposure compared with saline exposure, whereas
γ-H2AX foci formation in alveolar epithelial cells increased with Cr(VI) dose (Fig.
3.40). Specifically, the rates of cells with γ-H2AX foci in alveolar epithelial cells
were 4.50%, 8.38% and 12.00% after 90-day 0 (saline), 0.4 and 0.8 mg/kg zinc
chromate exposures, respectively. γ-H2AX foci formation in alveolar epithelial cells
was significantly increased after exposure to 0.8 mg/kg zinc chromate (**p<0.01)
(Figure 3.40). When comparing alveolar non-epithelial cells and epithelial cells,
Cr(VI)-induced γ-H2AX foci formation was significantly different (****p<0.0001)
(Figure 3.40). These data suggest Cr(VI)-induced γ-H2AX foci formation in the
alveoli are almost exclusively formed in epithelial cells.
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Figure 3.37. Particulate Cr(VI) induces DNA double strand breaks in the rat lung
after 90-day exposure. Representative images of γ-H2AX foci are shown. First
column, merged image; second column, DAPI staining; third column, γ-H2AX foci
staining; fourth column, staining of cytokeratin, a marker of epithelial cells.
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Figure 3.38. Comparison of γ-H2AX foci formation after 90-day zinc chromate
exposure within and between groups of different lung regions. Cr(VI)-induced γH2AX foci formation in both bronchioles and alveoli. γ-H2AX foci formation in
bronchioles increased with zinc chromate dose. γ-H2AX foci formation in
bronchioles was significantly increased after exposure to 0.4 and 0.8 mg/kg zinc
chromate (**p<0.01). γ-H2AX foci formation in alveoli was slightly increased after
90-day exposure to zinc chromate. Cr(VI)-induced γ-H2AX foci formation showed
statistically significant differences between bronchioles and alveoli (*p<0.05). Error
bar = standard error of the mean.
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Figure 3.39. Comparison of γ-H2AX foci formation in bronchioles after 90-day
exposure to zinc chromate within and between groups of non-epithelial and
epithelial cells. After 90-day zinc chromate exposure, few γ-H2AX foci formed in
bronchiolar non-epithelial cells, whereas γ-H2AX foci formed in bronchiolar
epithelial cells increased with Cr(VI) dose. γ-H2AX foci formation in bronchiolar
epithelial cells was significantly increased after exposure to 0.4 and 0.8 mg/kg zinc
chromate (**p<0.01 and ****p<0.0001, receptively). Cr(VI)-induced γ-H2AX foci
formation in bronchioles was significantly different between non-epithelial and
epithelial cells after 90-day zinc chromate exposure (****p<0.0001).
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Figure 3.40. Comparison of γ-H2AX foci formation in alveoli after 90-day exposure
to zinc chromate within and between groups of non-epithelial and epithelial cells.
γ-H2AX foci formation in alveolar non-epithelial cells was almost unchanged
compared with saline exposure, whereas γ-H2AX foci formation in alveolar
epithelial cells increased with Cr(VI) dose. γ-H2AX foci formation in alveolar
epithelial cells was significantly increased after exposure to 0.8 mg/kg zinc
chromate (**p<0.01). Cr(VI)-induced γ-H2AX foci formation was significantly
different when comparing alveolar non-epithelial and epithelial cells after 90-day
exposure to zinc chromate (****p<0.0001).
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HR Repair
Broken DNA duplexes are repaired without error by HR repair. Our previous
study found acute particulate Cr(VI) activates HR repair to prevent Cr(VI)-induced
DNA double strand breaks, whereas prolonged particulate Cr(VI) inhibits HR repair
by targeting RAD51, the key enzyme in HR repair (Qin et al., 2014; Browning et
al.; 2016). We found HR repair activation in the lungs of rats acutely exposed to
zinc chromate. Therefore, it is imperative to investigate HR after subchronic Cr(VI)
exposure. We investigated RAD51 to assess HR repair in rat lungs after 90-day
zinc chromate exposure by immunofluorescent staining. We found Cr(VI) inhibited
RAD51 foci formation in rat lungs after 90-day exposure to zinc chromate (Figure
3.41). Next, we investigated RAD51 foci formation in different lung sites. Cr(VI)induced RAD51 foci formation was reduced in a dose-dependent manner in
bronchioles. Specifically, after 90-day exposure to 0 (saline), 0.4 and 0.8 mg/kg
zinc chromate in bronchioles, the rates of cells with RAD51 foci were 20.00%,
11.94% and 9.313%, respectively. RAD51 foci formation in bronchioles were
significantly reduced after exposure to 0.4 and 0.8 mg/kg zinc chromate (*p<0.05,
**p<0.01) (Figure 3.42). However, after 90-day exposure to zinc chromate, RAD51
foci formation in alveoli was slightly reduced compared with the saline-exposed
group. After 90-day zinc chromate exposure, Cr(VI)-induced RAD51 foci formation
was statistically different between bronchioles and alveoli (****p<0.0001) (Figure
3.42). These data indicate Cr(VI)-induced RAD51 inhibition is more obvious in the
bronchiolar region than in the alveolar region.
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Figure 3.41. Particulate Cr(VI) reduces RAD51 foci formation in the rat lung after
90-day exposure. Representative images of RAD51 foci are shown. First column,
merged image; second column, DAPI staining; third column, RAD51 foci staining;
fourth column, staining of PMCA ATPase, a marker of the cell membrane.
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Figure 3.42. Comparison of RAD51 foci formation after 90-day zinc chromate
exposure within and between groups of different lung regions. RAD51 foci
formation was decreased in bronchioles in a dose-dependent manner after 90-day
Cr(VI) exposure. RAD51 foci formation in bronchioles was significantly decreased
after exposure to 0.4 and 0.8 mg/kg zinc chromate (*p<0.05 and **p<0.01,
respectively). After 90-day exposure to 0.4 mg/kg zinc chromate, there was no
decrease in the formation of RAD51 foci in alveoli compared to the saline-exposed
group. However, there was a slight decrease in RAD51 foci formation in alveoli
after 90-day exposure to 0.8 mg/kg zinc chromate. Cr(VI)-induced RAD51 foci
formation was significantly different between bronchioles and alveoli after 90-day
zinc chromate exposure (****p<0.0001). Error bar = standard error of the mean.
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Sex differences
We investigated whether there were differences in lung Cr levels, lung
histological changes, DNA double strand breaks, and HR repair in female and male
rats after 90-day zinc chromate exposure.

Chromium Levels
We investigated whether there were differences in Cr levels in the lungs of
female and male rats after 90-day exposure to zinc chromate. First, we
investigated left and right lung Cr levels by sex. We found Cr levels increased in
the left or right lung after 90-day exposure to zinc chromate in both females and
males (Figure 3.41). We compared left and right lung Cr levels within the sex
groups. We found in the same-sex group, Cr content in the right lung was higher
than that of the left lung (Figure 3.43). For example, in the female group, after 90day exposure to 0 (saline), 0.4 and 0.8 mg/kg zinc chromate, mean Cr levels in the
left lung were 0.007, 2.062 and 1.332 mg Cr/kg lung tissue, respectively. After 90day exposure to 0 (saline), 0.4 and 0.8 mg/kg zinc chromate, the mean levels of
Cr in the right lung were 0.049, 7.111 and 9.881 mg Cr/kg lung tissue, respectively.
In the right lung of female rats, there were statistically significant increases
following exposure to 0.4 and 0.8 mg/kg zinc chromate (*p<0.05 and **p<0.01,
respectively). In the female rat group, there was a statistically significant dosedependent increase in Cr levels in the right lung compared with the left lung
(**p<0.01). In the male rat group, mean Cr levels in the left lung after 90-day
exposure to zinc chromate at 0 (saline), 0.4 and 0.8 mg/kg were 0.008, 1.152 and
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2.344 mg Cr/kg lung tissue, respectively. After 90-day exposure to 0 (saline), 0.4
and 0.8 mg/kg zinc chromate, the mean levels of Cr in the right lung were 0.160,
14.22 and 10.56 mg Cr/kg lung tissue, respectively. There were statistically
significant increases after exposure to 0.4 and 0.8 mg/kg zinc chromate
(***p<0.001 and **p<0.01, respectively). Likewise, there was a statistically
significant increase in Cr levels in the right lung compared with the left lung in the
male rat group (***p<0.001). Comparing the sex groups, changes in Cr levels were
not significantly different between the sexes (Figure 3.44).
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Figure 3.43. Comparison of Cr levels in the left and right lungs of rats after
exposure for 90-day within and between groups of different sexes. Cr levels
increased in both the left and right lungs, in female and male rats. In the same sex
group, the right lung had higher Cr content than the left lung. In the right lung of
the female group, there were statistically significant increases following 90-day
exposure to 0.4 and 0.8 mg/kg zinc chromate (*p<0.05 and **p<0.01, respectively).
In the female rat group, there was a statistically significant dose-dependent
increase in Cr levels in the right lung compared with the left lung (**p<0.01). There
was also a statistically significant increase in Cr levels in the right lung of the male
rat group compared with the left lung (***p<0.001). In addition, there were
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statistically significant increases (***p<0.001 and **p<0.01, respectively) in the
right lung of male rats exposed to 0.4 and 0.8 mg/kg zinc chromate for 90 days.
Changes in Cr levels were not statistically different between the different sex
groups. Error bar = standard error of the mean.
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We then investigated Cr distribution in each lung lobe by sex. We found
dose-dependent increases in Cr levels in all lobes in females and males, except
for the right upper lobe in male rats and the left and right upper lungs in female
rats (Figure 3.42). Cr distribution in lung lobes of different sex groups was different
from that of corresponding lung lobes. For example, in the right inferior lung of
female rats, Cr levels increased with Cr(VI) dose, but in the right inferior lung of
male rats, Cr levels did not change after 90-day exposure to 0.4 and 0.8 mg/kg
zinc chromate compared with saline exposure. In the right superior and accessary
lung lobes, changes in Cr levels after 90-day exposure to 0.4 and 0.8 mg/kg zinc
chromate were more pronounced in males than in females, although no statistically
significant differences were found. In the right middle lobe, the trends of increasing
Cr concentration with Cr(VI) dose were similar in different sex groups. Therefore,
we selected the middle lobe of the rat lung for subsequent immunofluorescence
studies. Furthermore, we found Cr distribution in different lung lobes was
statistically different in the male rat group (**p<0.01). However, there was no
statistically significant difference in Cr distribution in each lobe between the
different sex groups.
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Figure 3.44. Comparison of the distribution in each lung lobe after exposure for 90
days within and between groups of different sexes. Dose-dependent increases in
Cr levels in all lobes in females and males were found, except the right upper lobe
in male rats, and the left and right upper lungs in female rats. Cr distribution in lung
lobes in different sex groups was different from those of corresponding lung lobes.
In the right lower lung of female rats, Cr levels increased with zinc chromate doses,
but in the right lower lung of male rats, Cr levels did not change with increasing
doses. In the right upper and accessary lung lobes, changes in Cr levels after 90day exposure to 0.4 and 0.8 mg/kg zinc chromate were more obvious in male rats
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than in female rats, although no statistically significant differences were found. In
the right middle lobe, the trends of increasing Cr concentration with Cr(VI) dose
were similar in the different sex groups. In addition, Cr distribution in different lung
lobes in the male rat group were statistically different (**p<0.01). There were no
statistically significant differences in Cr distribution in each lobe between the
different sex groups. Error bar = standard error of the mean.
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Lung Histological Change
We next investigated whether there were differences in macrophage
aggregation in the lungs of female and male rats. We found the aggregations of
macrophages in the lungs of female and male rats were increased after 90-day
exposure to zinc chromate compared to exposure to saline (Figure 3.45). For
example, after 90-day exposure to saline, 0.4 and 0.8 mg/kg zinc chromate, the
lung macrophage scores of female rats were 1.071, 2.607 and 2.464, respectively.
After 90-day exposure to saline, 0.4 and 0.8 mg/kg zinc chromate, male rat lung
macrophage scores were 1.071, 2.821 and 2.643, respectively. After 90-day
exposure to 0.4 and 0.8 mg/kg zinc chromate, there were significant increases in
lung macrophage scores in both male and female rats (****p<0.0001). There were
no statistically significant differences in macrophage aggregation between the sex
groups.
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Figure 3.45. Comparison of macrophage aggregation after exposure for 90 days
within and between groups of different sexes. Macrophage aggregation scores in
female and male rat lungs were increased after 90-day exposure to zinc chromate.
Macrophage scores were significantly increased after exposure to 0.4 and 0.8
mg/kg zinc chromate for 90 days (***p<0.001 and ****p<0.0001, respectively).
Comparing the sex groups, there were no statistically significant differences in
macrophage aggregation scores between female and male rats. Error bar =
standard error of the mean.
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DNA Double Strand Breaks
We then investigated γ-H2AX foci formation in bronchioles and alveoli by
sex after 90-day zinc chromate exposure. We found in bronchioles, γ-H2AX foci
formation was increased in female and male rats following zinc chromate exposure
(Fig. 3.46). Specifically, the formation of γ-H2AX foci in female rats increased with
zinc chromate dose, although not significantly. After 90-day 0.8 mg/kg zinc chrome
exposure, γ-H2AX foci formation was increased in male rats compared with saline
exposure but was not higher than in the 0.4 mg/kg group. Comparing the sex
groups for bronchioles, no statistically significant differences in Cr(VI)-induced foci
formation were found. In alveoli, γ-H2AX foci formation increased with zinc
chromate dose in both female and male rats (Figure 3.47). γ-H2AX foci formation
was significantly increased in female rats after exposure to 0.8 mg/kg zinc
chromate for 90 days (*p<0.05). Comparing the sex groups for alveoli, there were
some differences in Cr(VI)-induced γ-H2AX foci formation, although they were not
statistically significant.
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Figure 3.46. Comparison of γ-H2AX foci formation in bronchioles after 90-day
exposure to zinc chromate within and between groups of different sexes. γ-H2AX
foci formation was increased in the bronchioles of female and male rats following
90-day exposure to zinc chromate. Comparing the sex groups for bronchioles, no
statistically significant differences in Cr(VI)-induced foci formation were found.
Error bar = standard error of the mean.
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Figure 3.47. Comparison of γ-H2AX foci formation in alveoli after 90-day exposure
to zinc chromate within and between groups of different sexes. γ-H2AX foci
formation in alveoli increased with zinc chromate dose in both female and male
rats. γ-H2AX foci formation was significantly increased in female rats after 90-day
exposure to zinc chromate (*p<0.05). Cr(VI)-induced γ-H2AX foci formation was
not statistically different between the sex groups in alveoli. Error bar = standard
error of the mean.
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HR Repair
We investigated RAD51 foci formation in bronchioles and alveoli by sex. We
found in bronchioles, RAD51 foci formation decreased with increasing zinc
chromate dose in female and male rats (Figure 3.48). Cr(VI)-induced reduction in
RAD51 foci formation in bronchioles was somewhat different, although not
statistically different, between the sex groups. In the alveoli of male rats, RAD51
foci formation decreased with increasing zinc chromate dose, which was not found
in female rats (Figure 3.49). Comparing the different sex groups for alveoli, there
were some differences in Cr(VI)-induced RAD51 foci formation, although they were
not statistically significant.
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Figure 3.48 Comparison of RAD51 foci formation in bronchioles after 90-day
exposure to zinc chromate within and between groups of different sexes. RAD51
foci formation decreased with zinc chromate dose in female and male rats in
bronchioles after 24 h exposure. Comparing the sex groups for bronchioles, no
statistically significant differences in Cr(VI)-induced RAD51 foci formation were
found. Error bar = standard error of the mean.
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Figure 3.49. Comparison of RAD51 foci formation in alveoli after 90-day exposure
to zinc chromate within and between groups of different sexes. RAD51 foci
formation in the alveoli of female rats was not decreased after Cr(VI) exposure
compared to the saline group. RAD51 foci formation in male rats decreased with
increasing zinc chromate dose in the alveoli. Cr(VI)-induced RAD51 foci formation
was not statistically different between the sex groups for alveoli. Error bar =
standard error of the mean.
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Accumulation of Other Metals
Zinc Levels
We measured zinc levels in rat lungs after 90-day exposure to zinc
chromate. We found zinc levels in rat lung tissue increased with increasing dose
after 90-day exposure to zinc chromate (Figure 3.50). For example, after 90-day 0
(saline), 0.4 and 0.8 mg/kg zinc chromate exposure, mean whole lung zinc levels
were 66.90, 72.51 and 82.51, respectively. Combined with the data on Cr levels in
the whole rat lung, a dose-dependent accumulation of zinc chromate in the rat lung
was demonstrated.
We next investigated the distribution of zinc levels in both the left and right
lungs of rats. After 90-day exposure, zinc levels in the left lung of rats exposed to
zinc chromate were not higher than those of rats exposed to saline (Fig. 3.51).
However, after 90-day exposure to 0.4 mg/kg and 0.8 mg/kg of zinc chromate,
respectively, the levels of zinc in the right lung of rats were higher than those of
the saline group (Fig. 3.51). There was a statistically significant increase after
exposure to 0.8 mg/kg zinc chromate (**p<0.01). Zinc levels were significantly
higher in the right lung than in the left lung (****p<0.0001). Combined with the Cr
data, more zinc chromate particles accumulated in the right lung of the treated rats.
We further investigated the distribution of zinc in each lung lobe. After 90day exposure to zinc chromate, zinc levels in each rat lung lobe did not change
with zinc chromate dose except for increases in the right upper lung, right lower
lung, and bronchial tree (Figure 3.52). After 90-day 0.8 mg/kg zinc chromate
exposure, zinc levels in the right upper and lower lung lobes were significantly
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increased (*p<0.05). Significantly lower levels of Cr in the bronchial tree found in
the 90-day Cr(VI) exposure data compared with other lobes were not found in the
zinc data.

157

**

Zinc Level
(mg/kg lung tissue)

100
90
80
70
60
50

Saline

0.4

0.8

Zinc Chromate Concentration (mg/kg)

Figure 3.50. Zinc levels in whole rat lungs after 90-day exposure. Zinc levels in the
whole lung tissue of rats increased in a dose-dependent manner compared to the
saline group after 90-day exposure to zinc chromate. Zinc levels were significantly
higher after 90-day exposure to 0.8 mg/kg of zinc chromate compared with the
saline-exposed group (**p<0.01). Error bar = standard error of the mean.
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Figure 3.51. Zinc levels in rat left lung vs. right lung after 90-day exposure. Zinc
levels in the left lung of rats did not increase after 90-day exposure to zinc
chromate, whereas zinc levels in the right lung increased with zinc chromate dose.
There was a statistically significant increase after exposure to 0.8 mg/kg zinc
chromate in the right lung (*p<0.05). Zinc levels were significantly higher in the
right lung than in the left lung (****p<0.0001). Error bar = standard error of the
mean.
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Figure 3.52. Zinc distribution in each individual rat lung lobe after 90-day zinc
chromate exposure. Zinc levels in each rat lung lobe did not change after 90-day
exposure to zinc chromate except for increases in the right upper lung lobe, right
lower lung lobe and bronchial tree. Zinc levels in the right upper and lower lung
lobes were significantly increased after 90-day 0.8 mg/kg zinc chromate exposure
(*p<0.05). Error bar = standard error of the mean.
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Iron Levels
We investigated iron levels in rat lungs. We found a slight increase in iron
levels in rat lung tissue after 90-day exposure to zinc chromate (Figure 3.53). For
example, after 90-day 0 (saline), 0.4 and 0.8 mg/kg zinc chromate exposure, mean
whole lung iron levels were 101.2, 115.3 and 131.4 mg Iron/kg lung tissue,
respectively. Combined with the data on Cr and zinc levels in the whole rat lung, it
is further confirmed there is a dose-dependent accumulation of Cr in the rat lung.
We then investigated the distribution of iron levels in the left and right lungs
of rats, respectively. After 90-day exposure to zinc chromate, iron levels in the left
lung did not change compared to saline exposure. Iron levels in the right lung of
rats exposed to zinc chromate were higher than those of the saline-exposed group
(Figure 3.54). Iron levels were significantly higher in the right lung than in the left
lung (****p<0.0001).
We next investigated the distribution of iron in each lung lobe. After 90-day
exposure to zinc chromate, iron levels in each rat lung lobe did not change with
zinc chromate dose, except for increases in the right lower lung lobe and bronchial
tree (Figure 3.55). Iron levels in the bronchial tree were significantly increased after
90-day zinc chromate exposure at 0.4 and 0.8 mg/kg (***p<0.001 and **p<0.01,
respectively). Iron levels were higher in the bronchial tree than in other lobes.
We further investigated whether subchronic Cr(VI) exposure affects
functional iron levels in rat lungs. We found a significant decrease in functional iron
levels after 90-day zinc chromate exposure (Figure 3.56). Specifically, after 90-day
exposure to 0 (saline), 0.4 mg/kg, and 0.8 mg/kg zinc chromate, iron-to-Cr ratios
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in rat lungs were 7318, 413.7, and 497.2, respectively. These data suggest
subchronic Cr(VI) exposure affects iron metabolism in rats.
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Figure 3.53. Iron levels in whole rat lungs after 90-day exposure. Iron levels in rat
lung tissue slightly increased after 90-day exposure to zinc chromate. Whole lung
iron levels were not significantly different between the Cr(VI)- and saline-exposed
groups. Error bar = standard error of the mean.
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Figure 3.54. Iron levels in rat left lung vs. right lung after 90-day exposure. Iron
levels were unchanged in the left lung but elevated in the right lung after 90-day
exposure to zinc chromate. Iron levels were significantly higher in the right lung of
rats exposed to 0.8 mg/kg zinc chromate compared with the saline group (*p<0.05).
There was a statistically significant difference in iron levels between the left and
right lungs (****p<0.0001). Error bar = standard error of the mean.
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Figure 3.55. Iron distribution in individual rat lung lobes after 90-day zinc chromate
exposure. Iron levels in each rat lung lobe did not change with zinc chromate dose
after 90-day exposure to zinc chromate, except for increases in the right lower lung
lobe and bronchial tree. Iron levels in the bronchial tree were significantly
increased after 90-day zinc chromate exposure at 0.4 and 0.8 mg/kg (***p<0.001
and **p<0.01, respectively). Comparing lung lobes, iron levels were higher in the
bronchial tree compared with other lobes. Error bar = standard error of the mean.
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Figure 3.56. Functional iron levels in rat lungs after 90-day zinc chromate exposure.
Functional iron levels were significantly reduced after 90-day zinc chromate
exposure. After 90-day exposure to 0.4 mg/kg and 0.8 mg/kg zinc chromate, the
ratios of iron to Cr in the lungs of rats were significantly lower versus the saline
group (****p<0.001).
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Comparison of acute and subchronic exposures
After we completed our investigations in rats with different exposure times,
we compared the levels of Cr, the extent of DNA damage, and the effect of Cr(VI)
on HR repair after acute and subchronic exposures.

Chromium Levels
Comparing Cr levels in rat lungs between acute and subchronic exposures,
we found at 0.4 mg/kg zinc chromate, Cr levels in the lungs of rats were higher
with subchronic exposure than with acute exposure. However, at 0.8 mg/kg zinc
chromate, Cr levels in the lungs were lower after subchronic exposure than in the
acute exposure group, and even did not exceed the levels of subchronic exposure
at 0.4 mg/kg zinc chromate (Figure 3.57). A possible reason is that there is a Cr
uptake saturation capacity at high dose after subchronic exposure. We therefore
investigated the relative concentrations of Cr in tissues, expressed as a relative
concentration P value (Weber, 1983). We found in the acute exposure group, the
change in P value did not vary significantly between doses, whereas in the
subchronic exposure group, the P value for exposure to 0.8 mg/kg zinc chromate
was lower than that for exposure to 0.4 mg/kg zinc chromate (Figure 3.58). These
data suggest after subchronic exposure to zinc chromate, Cr levels in the lung
tissue could reach saturation. When Cr levels were investigated separately in the
left and right lungs, Cr levels in the left lung did not differ significantly after different
exposure times. In the right lung, the differences in Cr levels after different
exposure times were similar to total Cr levels (Figure 3.59).
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Figure 3.57. Comparison of total Cr levels after different zinc chromate exposure
times. Cr levels in the lungs of rats after subchronic exposure were higher than
those of the acute exposure group at 0.4 mg/kg zinc chromate. When exposed to
0.8 mg/kg zinc chromate, Cr levels were lower in the subchronic exposure group
than in the acute exposure group, and even lower than in the 0.4 mg/kg zinc
chromate group of the same time point.
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Figure 3.58. Comparison of the relative concentration of Cr in the lung tissue at
different zinc chromate exposure times. The relative concentration of Cr in the
tissue was expressed as a relative concentration P value: P = (Cr levels in
tissue/wet organ weight) / (administered Cr dose/animal weight at sacrifice). P
values were different within groups with different zinc chromate exposure times.
Changes in P values were not significantly different between dosed concentrations
in the 24-hour exposure group. In the subchronic exposure group, the P value was
lower for 0.8 mg/kg zinc chromate exposure than for 0.4 exposure (p=0.0999).
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Figure 3.59. Comparison of Cr levels in left and right lungs after different zinc Cr
exposure times. Cr levels in the left lung did not differ significantly after different
exposure times. In the right lung, when exposed to 0.4 mg/kg zinc chromate, the
subchronic exposure group had higher lung Cr levels than the acute exposure
group. At 0.8 mg/kg zinc chromate, Cr levels were lower in the subchronic
exposure group than in the acute exposure group.
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DNA double strand breaks
We compared Cr(VI)-induced DNA double strand breaks between acute
and subchronic exposures. We found Cr(VI)-induced γ-H2AX foci formation was
slightly higher in bronchioles after acute exposure compared with subchronic
exposure (Figure 3.60). However, in alveoli, Cr(VI)-induced γ-H2AX foci formation
in the subchronic group increased with zinc chromate dose, while in the acute
group, high doses of zinc chromate did not increase γ-H2AX foci formation
compared with low doses (Figure 3.60).
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Figure 3.60. Comparison of Cr(VI)-induced DNA double strand breaks in
bronchioles and alveoli after different zinc chromate exposure times. In bronchioles,
Cr(VI)-induced γ-H2AX foci formation was slightly higher in the 24-hour exposure
group than in the 90-day group. In the alveolar region, Cr(VI)-induced γ-H2AX foci
formation increased with zinc chromate dose in the 90-day exposure group, while
24-hour exposure to 0.8 mg/kg zinc chromate did not increase γ-H2AX foci
formation compared with 0.4 mg/kg zinc chromate exposure for the same time.
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HR repair
We next compared changes in HR repair following zinc chromate exposure
between the acute and subchronic groups. We found in bronchioles, different
exposure times elicited completely different responses to HR repair. Specifically,
RAD51 foci formation increased with dose after acute zinc chromate exposure,
while decreasing with increasing dose with subchronic zinc chromate exposure
(Figure 3.59). This result indicated Cr(VI) activated HR repair after acute exposure,
whereas subchronic exposure to Cr(VI) inhibited HR repair. In addition, in alveoli,
RAD51 foci formation did not change after zinc chromate exposure and did not
differ between groups at different exposure times (Figure 3.61).
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Figure 3.61. Comparison of changes in HR repair in bronchioles and alveoli after
different zinc chromate exposure times. In bronchioles, RAD51 foci formation
increased with dose after 24-hour zinc chromate exposure but decreased with
increasing dose with 90-day zinc chromate exposure. In alveoli, RAD51 foci
formation did not change after zinc chromate exposure and showed no difference
between groups with different exposure times. *p<0.05.
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Chromate-associated Lung Cancers’ study
Epidemiological studies have found high rates of lung cancer among
chromate workers. Kondo et al. reported the pathological type of chromium-related
lung tumors is mainly squamous cell carcinoma. They found accumulation of Cr(VI)
particles at lung bifurcations during bronchoscopy of chromate workers and
pathological examination of lung tumors. We investigated DNA double strand
breaks and HR repair in lung tumor tissue sections from these chromate workers
to further clarify whether chromium-induced DNA double strand breaks and HR
repair inhibition persist to tumor formation. The three lung tumors investigated in
this project were all squamous cell carcinomas. The lung tissue used as a control
group was the corresponding normal adjacent lung tissue samples from the same
patients. Normal lung tissue structure, including normal bronchial and normal
alveolar areas, can be seen in the lung tissue of the control group (Figure 3.62).
The tissue of the lung tumor lost the normal lung structure, which was replaced
with a tumor-shaped cell mass. Keratin pearls and intercellular bridges were visible
within the cell mass (Figure 3.62).
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Figure 3.62. Morphological characteristics of chromium-related lung cancer in
H&E-stained tissue sections. a. and b. Normal lung tissue adjacent to the tumor in
the same lung cancer patient. Normal lung tissue structure including bronchioles
and alveoli can be seen. Magnifications for a and b are ×100 and x400,
respectively. c. and d. Lung cancer tissue without normal lung tissue structure.
Keratin pearls and intercellular bridges are visible within the cell mass.
Magnifications for c and d are ×100 and x400, respectively.
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DNA Double Strand Breaks
By immunofluorescence, we investigated γ-H2AX foci formation in
chromate workers’ lung tumor tissue sections to determine whether Cr(VI)-induced
DNA double strand breaks persist into tumor formation. We detected γ-H2AX foci
in tumor tissue cells (Fig. 3.63), and γ-H2AX foci formation was significantly
increased in tumor tissue cells compared with normal adjacent lung tissue (Fig.
3.64). This data suggests Cr(VI) causes DNA double strand breaks that persist
through tumor formation rather than being transient.
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Figure 3.63. Cr(VI)-induced γ-H2AX foci in chromate worker lung tumor tissue.
Green dot signals in the nucleus are γ-H2AX foci.
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Figure 3.64. Cr(VI)-induced DNA double strand breaks in chromate worker lung
tumor tissue. γ-H2AX foci formation was significantly increased in tumor tissue
cells compared with normal adjacent lung tissue (p<0.05). Error bar = standard
error of the mean.
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HR repair
We next investigated RAD51 foci formation in chromate worker lung tumor
tissue sections to determine whether Cr(VI)-induced HR deficiency persists into
tumor formation. We found more RAD51 foci in the nucleus of normal adjacent
lung tissue, whereas RAD51 foci were almost invisible in the nucleus of tumor
tissue (Fig. 3.65). We then performed ROI analysis of nuclei on the images
acquired by confocal microscopy. We found the signal intensity of RAD51 was
lower in tumor tissue than in normal adjacent lung tissue (Fig. 3.66). These data
suggest Cr(VI) causes HR defects that persist into tumor formation rather than
being transient.
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Figure 3.65. RAD51 foci in normal adjacent lung and tumor tissues from a
chromate worker’s lung. Green dot signals in the nucleus are RAD51 foci. Red
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signals reflect PMCA ATPase expression. Magnifications for A and B are ×200 and
x1000 with x3 digital zoom, respectively.
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Figure 3.66. Cr(VI)-induced HR deficiency in chromate worker lung tumor tissue.
The mean signal intensity of RAD51 was lower in the tumor tissue than in normal
adjacent lung tissue (p=0.2059). Image analysis was performed with the nucleus
as the region of interest, on 100 intact, non-overlapping and random nuclei.
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SUMMARY
In this aim, we found Cr accumulated in rat lung tissue in a dose-dependent
manner after 90-day zinc chromate exposure. Cr levels in the left and right lungs
both increased in a dose-dependent manner. Cr levels were significantly elevated
in the right lung compared with the left lung. We also found Cr dose elevation was
significantly lower in the bronchial tree after 90-day exposure than in other lobes.
This result indicates particulate Cr(VI) was inhaled and deposited into the distal
airways of the rat lung after 90-day exposure.
Cr(VI)-induced lung histological changes were investigated by H&E staining.
We found macrophage aggregation and lymphocyte aggregation in the alveolar
region after 90-day Cr exposure. A large number of necrotic cells could be seen in
alveoli. Vascular wall thickening was observed in the lungs of Cr(VI)-exposed rats.
Cr(VI)-induced macrophage aggregation was found around the alveolar region and
terminal airways, and increased with Cr dose after 90-day zinc chromate exposure.
We also found after 90-day zinc chromate exposure, Cr(VI) induced γ-H2AX
foci formation in rat lungs, which increased in a dose-dependent manner in
bronchioles and alveoli. γ-H2AX foci formation caused by Cr was more
pronounced in bronchioles than in alveoli. Cr(VI)-induced γ-H2AX foci formed
almost exclusively in bronchioles and alveolar epithelial cells after 90-day zinc
chromate exposure.
We next investigated RAD51 foci to assess HR repair in rat lungs after 90day zinc chromate exposure by immunofluorescence. We found Cr(VI) inhibited
RAD51 foci formation in rat lungs after 90-day zinc chromate exposure. Cr(VI)-
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induced RAD51 foci formation was reduced in a dose-dependent manner in
bronchioles and slightly in alveoli. These data suggest Cr(VI)-induced RAD51
inhibition is more pronounced in the bronchiolar region than in the alveolar region.
When comparing the sex groups, we found changes in Cr deposition did not
differ significantly between the sexes. There was also no statistically significant
difference in macrophage accumulation in the lungs of female and male rats. In
bronchioles and alveoli, there were some differences in Cr(VI)-induced γ-H2AX
foci formation in different sex groups, although they were not statistically significant.
Cr(VI)-induced γ-H2AX foci formation was higher in the female rat group than in
the male rat group. Comparing sex groups for bronchioles and alveoli, subchronic
Cr(VI)-induced RAD51 foci formation somewhat differed, although the differences
were not statistically significant.
We found significantly increased γ-H2AX foci formation and decreased
RAD51 foci formation in chromium-associated lung tumor tissue. This result
confirms Cr(VI)-induced DNA double strand breaks and HR deficiency persist
into tumor formation rather than being transient effects.
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Aim 3: Demonstrate particulate Cr(VI) induces DNA double strand break, but does
not induce HR repair failure resulting in chromosomal instability in whale lung cells.

BACKGROUND
Cr(VI) is a global pollutant and environmental toxicant. To understand how
Cr(VI) affects health, it is important to consider multiple perspectives by using the
One Environmental Health approach. One Environmental Health, a specific subset
of One Health, is a research strategy focused on the study of toxicants, aiming to
incorporate human health, wildlife health, and ecosystem health in order to
establish a more comprehensive understanding of global health (Pérez and Wise
2018). The whale model was included as a part of the One Environmental Health
Approach to investigate Cr(VI) carcinogenesis across species, because whales
live in an extreme environment and are exposed to a high level of Cr(VI) (Wise et
al., 2019a; Wise et al., 2019b). This type of analysis is performed to determine how
two species with different environmental adaptations respond differently to toxicant
exposure. Whales represent humans in the ocean, which means they are our
closest marine relatives. Whales are long-lived species and exhibit a higher level
of protection from cancer (de Magalhães, 2015; Keane et al., 2015). For example,
bowhead whales (Balaena mysticetus) live for over 200 years. The longevity of this
species while living in an extreme environment strongly suggests the existence of
effective mechanisms conferring resistance to cancer caused by environmental
carcinogens (Seim et al., 2014; Keane et al., 2015; Ma and Gladyshev, 2017).
However, how whales evade carcinogenesis is unknown. Studies show whale cells
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are more resistant to Cr(VI)-induced chromosome instability than human cells (Li
Chen et al., 2009a; Li Chen et al., 2009b; Li Chen et al., 2012; Wise et al., 2015).
A recent study showed prolonged Cr(VI) exposure does not inhibit HR repair in
North Atlantic Right Whale lung cells (Browning et al., 2017). Thus, HR repair may
play an important role in the increased Cr(VI) resistance observed in whale cells.
However, no more data are available investigating HR repair activity after Cr(VI)
exposure in whale cells. Therefore, investigating the effect of Cr(VI) in whale cells
may shed light on how to prevent Cr(VI)-induced chromosome instability.
Our previous studies found Cr(VI) exposure caused DNA double strand
breaks while inhibiting HR repair, resulting in chromosomal instability in human
lung cells (Browning et al., 2016; Qin et al., 2014; Wise et al., 2003; Wise et al.,
2002; Xie et al., 2009). In Aim 1 and Aim 2, we found Cr(VI) exposure caused DNA
double strand breaks in rat lung tissue, and we also observed the inhibition of HR
repair by subchronic Cr(VI) exposure. Cr(VI)-induced HR repair inhibition was
demonstrated in Cr(VI)-related lung tumors, that is, Cr(VI)-induced HR repair
inhibition persisted into tumor formation. Therefore in Aim 3, we translated these
outcomes in whale lung cells to further complement our understanding of the
mechanism of Cr(VI)-induced chromosomal instability.

RESULTS
DNA Double Strand Breaks
Cr(VI)-induced DNA damage has been shown to result in DNA double
strand breaks (DSBs) in human cells (Xie et al.,2008; Xie et al.,2009; Kost et al.;
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2012, Qin et al.,2014; Wise et al., 2016). We measured the ability of Cr(VI) to
induce DNA double strand breaks in bowhead whale lung cells by the neutral
comet assay and immunofluorescent analysis of γ-H2AX foci formation. We found
particulate Cr(VI) induced a concentration-dependent increase in comet tail
formation measured as tail intensity (Figure.3.67 A). Specifically, exposure to 0.1,
0.2, 0.3 and 0.4 ug/cm² zinc chromate resulted in 149.1, 182.9, 205.9 and 216.8%
tail intensity increases, respectively, relative to control bowhead whale cells after
acute exposure and 136.4, 162.1, 177.1 and 192.0% after prolonged exposure,
respectively.
Induction of double strand breaks triggers phosphorylation of histone H2A.X
on Ser 139, forming foci at the sites of DNA double strand break. The formation of
γ-H2AX foci is considered a quantitative marker of DNA double strand breaks
(Rogakou et al., 1999; Sedelnikova et al., 2002). We found particulate Cr(VI)
induced γ-H2AX foci formation in bowhead whale lung cells (Figure.3.67 B), and
γ-H2AX foci formation increased in a concentration-dependent manner
(Figure.3.67 C). Specifically, the percent of cells with γ-H2AX foci increased from
a control value of 11% to 26, 33, 42 and 51 % after 24-hour exposure to 0.1, 0.2,
0.3 and 0.4 ug/cm² zinc chromate, respectively, and from a control value of 6% to
20, 27, 45 and 41% after 120-hour exposure, respectively.
In human cells, Cr(VI)-induced DNA double strand breaks occur indirectly
and only manifest in the late S phase or G2 phase after 24-hour exposure
(Wakeman et al., 2004; Ha, et al., 2004; Zhang et al., 2001; O'Brien et al., 2002;
Reynolds et al., 2007; Xie et al., 2009; Holmes et al., 2010). In order to understand
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in which cell cycle phase Cr(VI)-induced DNA double strand breaks occur, we
detected γ-H2AX in various cell cycle phases by flow cytometry. Based on the
difference in cellular DNA content, we divided the cells into G1, S, and G2/M
phases. Through gating analysis of γ-H2AX and DNA content distribution, the
percentages of γ-H2AX expressed cells in each phase of the cell cycle were
estimated. We found DNA double strand breaks occurred in the S and G2/M phase
in bowhead whale lung cells (Figure.3.67 D and E). Specifically, after 24-hour
exposure to zinc chromate, the proportions of γ-H2AX-positive bowhead whale
lung cells in the S and G2/M phases were higher than that of the G1 phase in the
high-concentration Cr(VI) exposure group (Figure.3.67 D). This phenomenon was
more pronounced after 120-hour exposure. We found Cr(VI)-induced DNA double
strand breaks occurred in the S and G2/M phases with increasing zinc chromate
concentrations in bowhead whale lung cells (Figure.3.67 E).
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Figure.3.67. Cr(VI) induces DNA double strand breaks in bowhead whale lung cells.
Cr(VI) induced DNA double strand breaks in bowhead whale lung cells as
measured by the neutral comet assay, immunofluorescent signal count for γ-H2AX
foci and flow cytometry. A) Cr(VI) induced DNA double strand breaks as measured
by the neutral comet assay. Comet tail intensity, reflecting double-strand DNA
breaks, was significantly increased compared with the control group after exposure
to 0.3 and 0.4 ug/cm² zinc chromate for 24 hours and 0.4 ug/cm² zinc chromate for
120 hours (*p<0.05 and **p<0.01, respectively). Comparing groups with different
exposure times, no statistically significant difference was found. B) Representative
images of γ-H2AX foci in bowhead whale lung cells. The first column is DAPI
stained nuclear image, the second one is the respective γ-H2AX foci image, and
the third one is the merged image. C) Cr(VI)-DNA double strand breaks in
bowhead whale lung cells measured by γ-H2AX foci count obtained by
immunofluorescence. γ-H2AX foci formation increased in a concentrationdependent manner after both 24-hour and 120-hour zinc chromate exposures. γH2AX foci formation significantly increased after 24 and 120 hours of treatment
with 0.2, 0.3 and 0.4 ug/cm² zinc chromate (*p<0.05, ***p<0.001, ****p<0.0001).
Comparing groups with different exposure times, no statistically significant
difference was found. D) Cr(VI)-induced DNA double strand breaks occurred in S
and G2/M phases in bowhead whale lung cells after 24-hour Cr(VI) exposure. 24hour high Cr(VI) concentration induced the proportions of γ-H2AX-positive whale
lung cells in the S phase and G2/M phases. E) Cr(VI)-induced DNA double strand
breaks occurred in the S and G2/M phases in bowhead whale lung cells after 120-
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hour Cr(VI) exposure. The proportions of γ-H2AX-positive whale lung cells in the
S phase and G2/M phase were higher than that of the G1 phase after 120-hour
Cr(VI) exposure. After exposure to 0.3 ug/cm² zinc chromate, the proportions of γH2AX-positive whale lung cells in the S phase and G2/M phase were significantly
higher than control values (*p<0.05).

195

Cell Cycle Profile
When DNA damage occurs within the cell, the cell undergoes a DNA
damage response. The DNA damage response is a network of cellular pathways
that sense, signal, and repair DNA damage, including cell cycle arrest, activation
of DNA repair networks, and apoptosis (Zhou and Elledge, 2000). If DNA damage
is detected at cell cycle checkpoints, cell cycle arrest occurs activating repair
mechanisms to repair DNA damage. Since Cr(VI)-induced G2 arrest was observed
in our laboratory and others s (O'Brien et al., 2002; Reynolds et al., 2007; Xie et
al., 2009; Holmes et al., 2010), we tested whether Cr(VI) induces G2 arrest after
prolonged exposure in bowhead whale lung cells. We measured cell cycle profiles
by flow cytometry. There were not obviously increased bowhead whale lung cells
in G2/M after 24-hour or 120-hour zinc chromate exposure (Figure.3.68 A, B, and
C). Since the data obtained by flow cytometry is the sum of the percentages of
cells in the G2 and M phases, we do not know the actual proportions of cells in the
G2 and M phases, separately. We therefore measured the mitotic index in whale
lung cells to determine whether cells accumulate during mitosis. We found there
were decreases of bowhead whale lung cells in mitosis in a concentrationdependent manner after 24-hour and 120-hour zinc chromate exposure
(Figure.3.68 D and E). Taken together, no obvious increase of cells in G2/M
combined with a reduction in mitotic cells indicated Cr(VI) induced G2 phase arrest
in whale cells, which was not detectable by flow cytometry.
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Figure.3.68. Cr(VI)-induced G2 phase arrest in whale lung cells. Cr(VI) induced
G2 arrest in bowhead whale lung cells. A) Cell cycle profiles after 24-hour zinc
chromate exposure in the whale lung cells. B) Cell cycle profiles after 120-hour
zinc chromate exposure in the whale lung cells. C) The percentage of cells in the
G2/M phase did not increase after 24-hour zinc chromate exposure. D) The
percentage of cells in the G2/M phase did not increase after 120-hour zinc
chromate exposure. E) Cr(VI) induced mitotic index decreases of bowhead whale
lung. There were decreases of bowhead whale lung cells in mitosis in a
concentration-dependent manner after 24-hour and 120-hour zinc chromate
exposure. After 24-hour exposure, 0.3 and 0.4 ug/cm² zinc chromate significantly
decreased the numbers of bowhead whale lung cells in mitosis (*p<0.05).

199

HR Repair

HR repair is the accurate repair of DNA double strand breaks using
undamaged sister chromatids as a template to maintain genome integrity (Van et
al. 2001). Our previous studies found prolonged particulate Cr(VI) inhibits HR
repair by targeting RAD51 (Qin et al., 2014; Browning et al., 2016). HR repair
protects against Cr(VI)-induced DNA double strand breaks, and we have shown
prolonged particulate Cr(VI) induced almost equal amounts of DNA double strand
breaks in human lung cells and bowhead whale lung cells. Therefore, we evaluated
HR repair in particulate Cr(VI) treated bowhead whale lung cells by sister
chromatid exchange assay. Sister chromatid exchange is the result of the
crossover between sister chromatids in the resolution step of HR and is quantified
as a measure of HR repair activity. We found particulate Cr(VI) induced a
significant concentration-dependent increase in sister chromatid exchange
formation after both 24-hour and 120-hour exposure (Figure.3.69 A). Specifically,
24-hour exposure to 0, 0.1, 0.2, 0.3 and 0.4 ug/cm² zinc chromate induced an
average of 0.05, 0.12, 0.16, 0.21 and 0.23 sister chromatid exchanges per
chromosome, respectively; and 120-hour exposure induced an average of 0.07,
0.12, 0.18,0.21 and 0.22 sister chromatid exchanges per chromosome,
respectively (Figure.3.69 A).
RAD51, the recombination enzyme, is a key protein of the HR repair
pathway. Upon induction of DNA double strand breaks, RAD51 is recruited and
localizes to the nucleus (Essers et al., 2002). Then we measured RAD51 foci
formation to confirm HR repair is functional in whale cells following particulate
Cr(VI) exposure (Figure.3.69 B). We found Cr(VI) induced a significant increase in
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RAD51 nuclear foci formation (Figure.3.69 C). Specifically, the percent of cells with
RAD51 foci increased from a control value of 12 to 20, 25, 27 and 29% after 24hour exposure to 0.1, 0.2, 0.3 and 0.4 ug/cm² zinc chromate and from a control
value of 8 to 13, 21, 24 and 27% after 120-hour exposure, respectively. All these
data suggest HR repair is functional in bowhead whale cells after zinc chromate
exposure.
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Figure.3.69. Cr(VI)-induced HR repair active in bowhead whale cells. HR repair
remained functional in bowhead whale cells after zinc chromate exposure as
measured by the sister chromatid exchange assay and immunofluorescent
analysis of RAD51 foci formation. A) HR repair measured by the sister chromatid
exchange assay. SCE significantly increased in a concentration-dependent
manner after 24-hour and 120-hour zinc chromate exposures. 24-hour exposure
to 0.2, 0.3 and 0.4 ug/cm² zinc chromate induced a significant increase in SCE
compared with the control group (**p<0.01 or ****p<0.0001). 120-hour exposure to
0.2 and 0.3 ug/cm² zinc chromate induced a significant increase in SCE compared
with the control group (**p<0.01 and ****p<0.0001, respectively). # show 1
experiment data, there were no metaphases in the other two experiments. B)
Representative images of RAD51 foci in bowhead whale lung cells. First column,
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DAPI staining; second column, RAD51 foci staining; third column, merged image.
C) RAD51 foci formation was significantly increased in a concentration-dependent
manner after 24-hour and 120-hour zinc chromate exposures. 24-hour exposure
to 0.2, 0.3 and 0.4 ug/cm² zinc chromate induced significant increases in RAD51
foci formation compared with controls (**p<0.01 or ***p<0.001). Exposure to 0.2,
0.3 and 0.4 ug/cm² zinc chromate for 120 hours significantly increased RAD51
nuclear foci formation compared with controls (*p<0.05, **p<0.01, ***p<0.001).
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Chromosome instability
If DNA double strand breaks are not repaired or are improperly repaired,
they can lead to structural chromosome instability. We measured chromosome
damage in bowhead whale lung cells. For the chromosomal damage study, we
used two chromosomal damage measures. One measure is the percentage of
metaphases with damage, which determines the frequency of damaged cells.
Another measure was the total aberration per 100 metaphases to measure the
extent of damage within the cell. The difference between the two genotoxicity
measures indicates that the number of cells with multiple aberrations is increasing.
We found chromosome damage increased in a concentration-dependent manner
in bowhead whale lung cells after both 24-hour and 120-hour exposure to zinc
chromate (Figure 3.70). Cr(VI) did not increase the number of cells with multiple
aberrations in bowhead whale lung cells. However, Cr(VI)-induced chromosome
damage did not increase further after 120-hour exposure than after 24-hour
exposure. This result indicates Cr(VI) exposure did not induce chromosomal
instability in whale lung cells.
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Figure.3.70. Cr(VI) does not induce chromosome instability in whale lung cells.
Chromosome damage was increased in a concentration-dependent manner after
24-hour and 120-hour zinc chromate exposures. A) The percentages of
metaphases with damage were increased in a concentration-dependent manner
after 24-hour and 120-hour zinc chromate exposures. 24-hour exposure to 0.3 and
0.4 ug/cm² zinc chromate induced significant increases in chromosome damage
compared with controls (**p<0.01). After 120-hour exposure to zinc chromate,
chromosome damage did not surpass that of 24-hour exposure. B) Total
chromosome damage was increased in a concentration-dependent manner after
24-hour and 120-hour zinc chromate exposures. 24-hour exposure to 0.3 and 0.4
ug/cm² zinc chromate induced significant increases in chromosome damage
compared with controls (*p<0.05 and **p<0.01, respectively). At 120-hour
exposure to zinc chromate, total chromosome damage did not surpass that of 24hour exposure.
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Cytotoxicity
Because prolonged Cr(VI) does not induce chromosome instability in
bowhead whale lung cells, we hypothesized bowhead whale lung cells may avoid
Cr(VI)-induced cytotoxicity. Thus, we measured Cr(VI)-induced cytotoxicity in
bowhead whale lung cells. We found zinc chromate induced concentrationdependent cytotoxicity in bowhead whale lung cells (Figure 71).
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Figure.3.71. Cr(VI)-induced cytotoxicity in bowhead whale lung cells. Cr(VI)
induced cytotoxicity in bowhead whale lung cells in a concentration manner after
24-hour and 120-hour exposures. After 24-hour exposure to 0.4 ug/cm², cell
survival was significantly decreased compared with the control group (*p<0.05).
After 120-hour exposure to 0.3 and 0.4 ug/cm², cell survival was significantly
decreased compared with the control group (*p<0.05 and **p<0.01, respectively).
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Comparisons with human lung cells and rat lung cells
Next, we compared Cr(VI)-induced DNA double strand breaks, HR repair
inhibition, chromosomal instability, and cytotoxicity in lung cells of different species.
We used lung fibroblasts for all three species as whale epithelial cells have not
been successfully cultured and human lung epithelial cell lines are all aneuploid.
The reason why we added some rat lung cell comparisons is to clarify whether
differences found between human lung cells and whale lung cells reflect whale
specific outcomes.

Cr(VI)-DNA double strand break
We compared the ability of Cr(VI) to induce DNA double strand breaks in
bowhead whale lung cells, human lung cells and rat lung cells, using neutral comet
assay. We found Cr(VI)-induced similar DNA double strand breaks levels in all
three species' cell lines (Figure 3. 72 A). Because in human cells the breaks all
occur in the late S/G2 phase and not in the G1 phase, we compared the profiles
of DNA double strand breaks in the cell cycle between bowhead whale lung cells
and human lung cells using flow cytometry. We found with increasing zinc
chromate concentrations in human lung cells, more DNA double strand breaks
occurred in S and G2/M phases (Figure 3. 72 B and C). The proportion of γ-H2AXpositive human lung cells in the S phase was higher after 24-hour Cr(VI) exposure
and 120-hour Cr(VI) exposure (Figure 3. 72 B). However, in bowhead whale lung
cells, Cr(VI)-induced DNA double strand breaks were found in the S phase and
G2/M phase in the high-concentration exposure group (Figure 3.72 C). Overall, the
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data show for both whale and human lung cells, Cr(VI)-induced DNA double
strands occurred in S or G2.
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Figure.3.72. Comparison of Cr(VI)-induced DNA double strand breaks in human
lung cells, rat lung cells and bowhead whale lung cells. A) The intensity of comet
tails produced in human lung cells, rat lung cells and bowhead whale lung cells
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were similar after 0.2 ug/cm² zinc chromate exposure. After 24-hour exposure,
Cr(VI)-induced comet tail intensity was slightly higher in human lung cells, but after
120-hour exposure, Cr(VI)-induced comet tail intensities in the three species’ cell
lines were pretty close. B) and C) show Cr(VI)-induced DNA double strand breaks
occur in the S and G2/M phases in human lung cells. B) The proportions of H2AXpositive human lung cells in the S and G2/M phases were higher than those of the
G1 phase after 24-hour Cr(VI) exposure. After exposure to 0.3 ug/cm² zinc
chromate, the proportion of H2AX-positive human lung cells in the S phase was
significantly higher than the control value (*p<0.05). C) The proportions of H2AXpositive human lung cells were higher in the S and G2/M phases compared with
the G1 phase after 120-hour Cr(VI) exposure. After exposure to 0.1 and 0.2 ug/cm²
zinc chromate, the proportions of H2AX-positive human lung cells in the S phase
were significantly higher than the control value (*p<0.05).
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Cr(VI)-induced cell cycle arrest
When DNA damage is detected by cell cycle checkpoints, cell cycle arrest
occurs, and repair mechanisms are activated to repair DNA damage. It is well
established that Cr(VI) induces a G2 arrest in human lung cells after acute
exposure, but chronic exposures have not been considered. Above, we reported,
for bowhead whale lung cells, after prolonged exposure Cr(VI)-induced a G2 arrest
that is not obvious from flow cytometry. Here we show prolonged zinc chromate
exposure induced a G2/M arrest in a concentration-dependent manner in human
lung cells (Figure.3.73). Our previous study has examined chromium-induced
changes in the mitotic index of human lung cells and found that zinc chromate
induces a concentration-dependent decrease in the number of mitotic cells (Xie et
al., 2009). Thus considered altogether, particulate Cr(VI) induced a G2 arrest in
human and whale lung cells after both acute and prolonged exposures.
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Figure.3.73. Cr(VI) induces G2/M phase arrest in human lung cells. Cr(VI) induces
G2/M arrest in a concentration-dependent manner in human lung cells. A) and B)
are cell cycle profiles in human lung cells. A) Cell cycle profiles after 24-hour zinc
chromate exposure in the human lung cells. B) Cell cycle profiles after 120-hour
zinc chromate exposure in the human lung cells. C) and D) show the changes of
the percentage of human lung cells in cell cycle phases after Cr(VI) exposure. C)
The percentage of cells in the G1 phase decreased while those of cells in the G2/M
phase increased with increasing Cr(VI) concentration after 24-hour zinc chromate
exposure. Exposure to 0.1, 0.2 and 0.3 ug/cm² zinc chromate resulted in
significantly higher percentages of cells in G2/M than the control value (*p<0.05).
D) The percentage of cells in the G1 phase decreased while those of cells in the
G2/M phase increased with increasing Cr(VI) concentration after 120-hour zinc
chromate exposure. Exposure to 0.1, 0.2 and 0.3 ug/cm² zinc chromate induced
significant increases in the percentages of cells in the G2/M phase compared with
control cells (*p<0.05).
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Cr(VI)-induced HR repair inhibition
HR repair prevents Cr(VI)-induced DNA double strand breaks. We have
shown that Cr(VI) induces similar numbers of DNA double strand breaks in human
lung cells, rat lung cells, and bowhead whale lung cells. We compared changes in
Cr(VI)-induced HR repair in lung cells of these different species. Comparing HR
repair function in human lung cells, rat lung cells, and bowhead whale lung cells
by measuring RAD51 foci formation, we found Cr(VI) induced HR repair after acute
exposure, but inhibited HR after prolonged exposure in rat and human lung cells.
Notably, and in contrast, Cr(VI)

did not inhibit HR repair, after prolonged

exposures in whale lung cells (Figure 3.74 B).
To clarify this finding, we considered HR repair in whale and human lung
cells using the sister chromatid exchange assay. Consistent with the RAD51 foci
data, after acute exposure to 0.2 ug/cm² zinc chromate, sister chromatid
exchanges increased in both human and whale lung cells, but after 120-hour
exposure, they were significantly reduced in human lung cells, but were not
affected in bowhead whale lung cells (Figure 3.74 A). Taken altogether, these data
show whale lung cells escape Cr(VI)-induced repair inhibition.
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Figure.3.74. Comparison of Cr(VI)-induced HR repair changes in human lung cells,
rat lung cells and bowhead whale lung cells. Cr(VI)-induced HR repair changes
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were different in these three species' cell lines. A) Comparison of Cr(VI)-induced
sister chromatid exchanges between human lung cells and bowhead whale lung
cells. This figure shows the difference of 0.2 ug/cm² zinc chromate induced sister
chromatid exchanges between human lung cells and bowhead whale lung cells. In
human lung cells, Cr(VI)-induced sister chromatid exchanges were much less
abundant in the 120-hour exposure group compared with the 24-hour exposure
group. In bowhead whale lung cells, Cr(VI)-induced sister chromatid exchanges in
the 120-hour exposure group were similar to the 24-hour exposure group. B)
RAD51 foci information produced in those three species’ cell lines were different
after 0.2 ug/cm² zinc chromate exposure. After 24-hour exposure, Cr(VI)-induced
RAD51 foci information was less pronounced in rat and whale lung cells compared
with human lung cells. However, after 120-hour exposure, Cr(VI)-induced RAD51
foci information decreased in human and rat lung cells but still increased in
bowhead whale lung cells.
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Cr(VI)-induced chromosome instability
If HR repair is inhibited, cells will sort to other DNA repair pathways, which
are low fidelity repair pathways. Improperly repaired DNA double strand breaks
can lead to structural chromosomal damage and cause chromosome instability.
We compared Cr(VI) -induced chromosomal instability in whale lung cells and
human lung cells. We found higher percentages of metaphases with damage in
human lung cells than in bowhead whale lung cells after 24-hour and 120-hour
Cr(VI) exposure (Figure 3.75 A). The total amount of chromosome damage in
human lung cells was significantly higher after 120-hour Cr(VI) exposure than that
after 24-hour Cr(VI) exposure (Figure 3.75 B). However, in bowhead whale lung
cells, the total chromosome damage after 120-hour Cr(VI) exposure was lower
than that after 24-hour Cr(VI) exposure. These data indicate Cr(VI) induces
chromosomal instability in human lung cells, but not in bowhead whale lung cells.
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Figure.3.75. Comparison of Cr(VI)-chromosome instability in human lung cells and
bowhead whale lung cells. Cr(VI)-induced chromosomal instability differed in these
two types of lung cells. A) The comparison of the percentage of mid-term damage
in human lung cells and bowhead whale lung cells after Cr(VI) exposure. The
percentage of metaphase with damage was higher in human lung cells than in
bowhead whale lung cells after both 24-hour and 120-hour Cr(VI) exposure. B)
The comparison of total chromosomal damage in human lung cells and bowhead
whale lung cells after Cr(VI) exposure. In human lung cells, total chromosomal
damage was significantly higher after 120-hour Cr(VI) exposure than after 24-hour
Cr(VI) exposure; however, in bowhead whale lung cells, total chromosomal
damage was lower after 120-hour Cr(VI) exposure compared with 24-hour Cr(VI)
exposure.
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Cr(VI)-Induced Cytotoxicity
Given whale cells have better HR and avoid chromosome instability, we
hypothesized these differences would manifest as less Cr(VI)-induced cell death.
Indeed, when we compared Cr(VI)-induced cytotoxicity in human lung cells and
bowhead whale lung cells, we found more bowhead whale lung cells survive than
human lung cells at the same zinc chromate concentration and exposure time
(Figure 3.76).
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Figure.3.76. Comparison of Cr(VI)-induced cytotoxicity between human lung cells
and bowhead whale lung cells. Whale lung cells were more resistant to Cr(VI)induced cytotoxicity than human lung cells. The viability of cells in both cell lines
decreased with concentration after 24-hour and 120-hour zinc chromate
exposures. Bowhead whale lung cells had much higher survival rates than human
lung cells at the same zinc chromate concentration and exposure time.
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Summary
In Aim 3, in order to further complement our understanding of the
mechanism of Cr(VI)-induced chromosomal instability, we translated to whale lung
cells the outcomes of Cr(VI)-induced DNA double strand breaks, affecting HR
repair, and causing chromosomal instability that we found in human lung cells. We
found Cr(VI) induces DNA double strand breaks, G2 arrest, HR repair,
chromosome damage and cell death in whale cells after both acute and prolonged
exposures. Thus, Cr(VI) exposure is a potential health concern for whales.
We also compared outcomes in whale and human lung cells. We found
Cr(VI) induced equal amounts of DNA double strand breaks in bowhead and
human whale lung cells after prolonged exposure. This outcome indicates Cr(VI)
has the same clastogenic potency in both species at these doses. We also found
Cr(VI) induced HR after acute exposure in both species indicating HR is a key
response pathway. However, prolonged Cr(VI) exposures inhibited HR repair in
human cells, but whale cells escaped this repair inhibition. Subsequently and
consequently, there was no chromosome instability in the whale cell and less cell
death, while the human lung cells incurred Cr(VI)-induced chromosome instability
and increased cell death. We also found by comparing key select outcomes in rat
cells, that the whale outcomes were likely specific to whale cells, as outcomes in
rat cells were similar to those in human cells.
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CHAPTER IV
DISCUSSION

Overview
Cr(VI)-induced chromosome instability plays a key role in the mechanism
of Cr(VI) carcinogenesis (Masuda and Takahashi 2002; Wise et al., 2018). Studies
have found chromosome instability in chromium-associated lung tumors.
Numerous studies have reported Cr(VI) causes various forms of DNA damage (Qin
et al., 2014; Xie et al., 2005; Xie et al., 2009; Wise et al., 2002; Wise et al., 2003;
Wise et al., 2006). Double-strand breaks in these lesions are particularly lethal.
The presence of unrepaired or misrepaired DNA double-strand breaks is the
primary mechanism responsible for the structural instability of chromosomes. HR
repair is a high-fidelity DNA double-strand break repair mechanism that is critical
for preventing structural chromosome instability (Bryant et al., 2006; Stackpole et
al., 2007). Cell culture experiments have shown metals, including Cr(VI), cadmium,
lead, arsenic, and nickel, induce DNA double-strand breaks, and HR repair has
been shown to be the pathway to repair these DNA breaks (Bryant et al., 2006;
Gastaldo et al., 2007; Helleday et al., 2000; Stackpole et al., 2007). When HRrepair
is inhibited, the odds of high-fidelity repair of cells are reduced, resulting in the
increased incidence of chromosome instability.
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Our studies have demonstrated Cr(VI) causes DNA double-strand breaks
and Cr(VI) has different effects on HR repair at different exposure times. Following
acute exposure, Cr(VI) induces HR repair to repair Cr(VI)-induced DNA doublestrand breaks. However, after prolonged exposure, Cr(VI) causes defects in HR
repair and DNA double-strand breaks cannot be effectively repaired, resulting in
chromosome instability (Browning et al., 2016; Qin et al., 2014; Wise et al., 2003;
Wise et al., 2002; Xie et al., 2009). However, these results were derived from
cultured cells, and no studies have investigated Cr(VI)-induced DNA damage and
HR repair in experimental animals; in addition, there is no corresponding study of
HR repair in chromium-associated lung tumors. Thus, this project translates Cr(VI)induced DNA double-strand breaks and HR repair inhibition found in human lung
cells into experimental rats and chromium-associated human lung tumors, and
goes a step further, studying environmental toxicants in different species. The
results will help better explore the carcinogenic mechanisms of metals, and these
results were further translated into whale lung cells.
In Aim 1, we tested whether acute Cr(VI) exposure causes DNA doublestrand breaks and activates HR repair. We found acute Cr(VI) exposure induced
the formation of γ-H2AX and RAD51 foci in the rat lung, which were evident in the
bronchi. Cr(VI)-induced γ-H2AX foci and RAD51 foci formation increased in a
concentration-dependent manner. Whether in bronchioles or alveoli, Cr(VI)induced γ-H2AX foci formation almost exclusively occurred in epithelial cells.
In Aim 2, we tested whether subchronic Cr(VI) exposure inhibits HR repair.
In addition, HR repair was investigated in chromium-associated lung tumor tissue.

230

We found subchronic Cr(VI) exposure also induced an increase in γ-H2AX foci
formation in rat lungs in a concentration-dependent manner. However, subchronic
Cr(VI) exposure reduced RAD51 foci formation. These data indicate HR repair is
inhibited after subchronic Cr(VI) exposure. We also showed chromium-associated
human lung tumor tissues had more Cr(VI)-induced DNA double-strand breaks,
and HR repair was inhibited in these tumor tissues.
In Aim 3, we translated our findings in human and rat lung cells into whale
cells. Cr(VI)-induced DNA double-strand breaks, HR repair, and Cr(VI)-induced
chromosome damage were investigated. We found Cr(VI) exposure induces DNA
double strand breaks in whale lung cells with a similar amount of breaks as in
human lung cells. Prolonged Cr(VI) exposure did not inhibit HR repair in whale
lung cells, and thus Cr(VI) did not cause chromosome instability in whale lung cells.
Below, we discuss the data supporting these conclusions in detail.

Cr(VI)-induced DNA double-strand break in normal rat lung tissue, normal
human lung tissue and human lung tumors
Our study found particulate Cr(VI) induced DNA double-strand breaks in rat
lungs after acute and subchronic exposures, and in both human lung tumors and
adjacent normal human lung tissue isolated from former chromate workers. This
study is the first to report Cr(VI) exposure induces DNA double-strand break in
animals and humans. The outcomes are consistent with numerous cell culture
studies have found Cr(VI) is toxic to DNA, causing DNA double-strand breaks (Ha
et al., 2004; Wakeman et al., 2004; Xie et al., 2005; Reynolds et al., 2007; Xie et
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al. 2009; Qin et al., 2014; DeLoughery et al., 2015). The particulate Cr(VI)-induced
DNA double-strand breaks increased in a concentration-dependent manner in rat
lung after acute and subchronic exposures. These observations are consistent with
findings from cell culture studies that showed similar results in human lung cells
after acute and prolonged particulate Cr(VI) exposure (Xie et al., 2005; Xie et al.,
2009; Qin et al., 2014). Thus, our study successfully translates Cr(VI)-induced
DNA double-strand break to experimental animals.
The findings that Cr(VI)-induced DNA double-strand breaks in human lung
tumors demonstrate particulate Cr(VI)-induced DNA double strand break persist
into tumor formation long after exposure has ceased, rather than being a transient
and early phenomenon. Such an outcome is consistent with cell culture studies
showing Cr(VI)-induced changes persist in cells long after exposure has ceased
and that these changes are heritable at a cellular level (Wise et al., 2018). No
other studies have considered DNA double-strand breaks in Cr(VI) -related lung
tumors. High γ-H2AX expression has been reported in other tumors. A study
reported high expression of γ-H2AX in non-small cell lung cancers with unknown
contributing factors (Mattaios et al., 2013). γ-H2AX has been also studied in
multiple other cancer types as an indicator for the detection of DNA double-strand
breaks, including breast, colon, ovarian, and cervical cancer (Mei et al., 2015;
Nagelkerke et al., 2011; Sedelnikova et al., 2011; Brustmann et al., 2011). γ-H2AX
is highly expressed in these tumor tissues. However, these studies detected γH2AX by immunohistochemistry, rather than observing γ-H2AX foci by tissue
immunofluorescent staining.
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Taken together, Cr(VI)-induced DNA double strand break is found in
cultured cells, experimental animals, normal human lung tissue and human lung
tumors, and establishes Cr(VI)-induced DNA double strand break as a crucial
lesion in Cr(VI) carcinogenesis.

Cr(VI)-induced DNA double-strand break differs in bronchioles and alveoli
We observed differences in particulate Cr(VI)-induced double-strand breaks
in different lung regions. In bronchioles, Cr(VI)-induced DNA double-strand breaks
were prominent, while they were much lower in the alveoli. This outcome is
consistent with key observations about Cr(VI)-induced tumors. For example, our
result is consistent with findings from pathological studies that show Cr(VI)associated lung tumors are mostly squamous cell carcinomas, which originate
from the bronchial epithelium with very little tumor formation in the alveolar region
(Ewis et al., 2001; Ewis et al., 2006; Ishikawa Y et al., 1994a; Ishikawa Y et al.,
1994b; Kondo et al., 1997). in addition, premalignant lesions of the bronchial
epithelium were found in studies of rats chronically exposed to particulate Cr(VI).
Levy et al. found premalignant lesions (dysplasia, and squamous metaplasia) and
squamous cell carcinoma in rat bronchial epithelium exposed to particulate Cr(VI)
for over 2 years (Levy et al., 1986). Takahashi et al. found premalignant lesions in
the bronchial epithelium of rats after exposure to strontium chromate particles
inserted in the bronchus for 9 months (Takahashi et al., 2004). A pathology report
of Kondo et al. on fiberoptic bronchoscopy biopsies of chromium workers indicated
premalignant lesions in the bronchial epithelium, and the detected accumulation of
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Cr increased significantly with the progression of bronchial epithelial malignancy
(Kondo et al., 2003).
Our findings that Cr(VI) causes DNA double-strand breaks primarily in
bronchioles are consistent with reports that Cr(VI) causes premalignant lesions in
the bronchial epithelium. A study reported differences in the amounts of radiationinduced DNA double strand breaks between bronchioles and alveoli. Indeed,
Ochola et al. found more γ-H2AX foci formed in bronchial cells than in alveoli in
radiation-irradiated mouse lung tissue (Ochola et al., 2019). However, unlike our
findings, radiation-induced γ-H2AX foci were more formed in basal cells than in
apical cells of the epithelium. Therefore, this finding further illustrates the
importance of Cr(VI)-induced DNA double strand break in the mechanism of Cr(VI)
carcinogenesis. Our findings provide supporting evidence for Cr(VI)-induced
carcinogenesis in the bronchial epithelium.

Cr(VI)-induced DNA double-strand break in epithelial cells
We found Cr(VI) induced DNA double strand breaks almost exclusively in
epithelial cells in the rat lung. No other report on Cr(VI)-induced DNA double strand
breaks in epithelial cells in the lung tissue has been published. These findings
contrast with cell culture studies which show Cr(VI)-induced DNA double-strand
break both occur in lung epithelial cells and lung fibroblasts (Xie et al., 2005; Xie
et al., 2009; Qin et al., 2014; Reynolds et al., 2007; DeLoughery et al., 2015). The
explanation for this contrast is that in these cell culture studies, each lung cell type
is studied independently and grown under specific culture conditions. They were
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not considered as multiple types of cells grown in co-culture. Our result is
consistent with the findings from pathological studies that show Cr(VI) -associated
lung tumors are mostly squamous cell carcinomas, which originate from the
bronchial epithelial cells (Ewis et al., 2001; Ewis et al., 2006; Ishikawa Y et al.,
1994a; Ishikawa Y et al., 1994b; Kondo et al., 1997). The finding of epithelial cells
as the main cell type of Cr(VI)-induced DNA double strand breaks in the rat lung
provides strong evidence that Cr(VI) targets the bronchial epithelium.

Cr(VI)-induced HR repair active in rat lung after acute exposure
We found particulate Cr(VI)-induced HR repair was active in the rat lung
after acute exposure. This report is the first to consider HR repair in Cr(VI) exposed
animals. Our finding is consistent with the findings from cell culture studies, which
report HR repair is induced active and RAD51 increased after acute Cr(VI)
exposure (Bryant et al., 2006; Qin et al., 2014; Browning et al., 2016). These
findings mean the translation of Cr(VI)-induced HR repair activation from cell
culture work to experimental animals is successful.

Cr(VI)-induced HR repair inhibition in rat lung and human lung tumor
We observed subchronic particulate Cr(VI) exposure suppressed HR repair,
manifested as loss of RAD51 foci, in the rat lung tissue and in both human lung
tumors and adjacent normal human lung tissue isolated from former chromate
workers. This finding is also the first report of Cr(VI)-induced HR repair inhibition
in animal lung tissue and human lung tissue. Our findings are consistent with cell
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culture studies showing loss of HR repair and RAD51 function after prolonged
Cr(VI) exposure (Qin et al., 2014; Browning et al., 2016). Thus, we successfully
translated Cr(VI)-induced inhibition of HR repair to experimental animals, normal
human lung tissue and human lung tumors.
We found Cr(VI)-induced HR repair inhibition in human lung tumors. There
are no other reports of Cr(VI)-induced HR repair inhibition in human lung tumors.
Some studies considered HR repair in other lung tumors. A recent study evaluating
Cancer Genome Atlas (TCGA) data showed 53% of lung adenocarcinomas and
51% of squamous cell lung cancers have somatic alterations in at least one gene
for HR repair or Fanconi anemia (Saiama et al., 2014). Takenaka et al performed
immunohistochemical detection of RAD51 in 41 NSCLC surgical specimens, and
found RAD51 expression could be significantly detected in squamous cell
carcinoma, and poorly differentiated carcinoma (Takenaka et al., 2007). These
data are inconsistent with our study, which suggests loss of RAD51 may be
specific to Cr(VI)-induced lung tumors or perhaps metal-induced lung tumors. Such
a hypothesis is consistent with observations from a prospective study of Cr(VI)
workers which reported increased methylation levels of RAD51 CpG sites in
peripheral venous blood samples from chromate workers compared to a control
group (Hu et al., 1987). Our findings also demonstrate Cr(VI)-induced HR repair
inhibition persists long after exposure and into the tumorigenic stage, which is
consistent with cell culture studies showing Cr(VI)-induced changes persist in cells
long after exposure has ceased and that these changes are heritable at a cellular
level (Wise et al., 2018).
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Taken together, our findings establish Cr(VI)-induced HR repair inhibition is
a key mechanism that drives the Cr(VI) carcinogenetic mechanism.

Cr(VI)-induced DNA double strand break and HR repair inhibition has sex
difference
We found female and male rats responded differently to Cr(VI)-induced
DNA double strand break and HR repair changes. After subchronic particulate
Cr(VI) exposure, Cr(VI)-induced DNA double strand breaks were more numerous
in female rats than in male rats, and Cr(VI)-induced HR repair inhibition was more
obvious in female rats than in male rats. These results indicate that Cr(VI) induces
more DNA double-strand breaks and enhanced HR inhibition in female rats than
in male rats. This study is the first study to discover sex differences in Cr(VI)induced DNA double strand breaks and HR repair inhibition and these findings are
consistent with observations that non-smoking women have a higher incidence of
lung cancer than non-smoking men.
In fact, sex differences in terms of incidence and survival are striking in
many cancer types not associated with the reproductive system (Sung et al., 2021).
The reasons for these differences are unclear, but in addition to the environment
and lifestyle, sex hormones may play a role. Differences in sex steroid hormone
levels may therefore contribute to differences in cancer susceptibility between men
and women. Sex hormones have been found to regulate DNA repair, with positive
or negative regulation of HR repair (Wengner et al., 2020; Bowen et al., 2015; Wilk
et al., 2012). So far, research on the role of sex on DNA repair has been
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inconclusive. A study found women have a reduced ability to repair tobaccoinduced DNA damage using nucleotide excision repair (NER) (Wei et al., 2000),
and reduced NER activity was associated with an increased risk of lung cancer
(Spitz et al., 2003). Our study found HR repair, which is used to repair DNA doublestrand breaks in female rats, was significantly reduced after Cr(VI) exposure
compared with male rats, suggesting that sex hormones may be involved in the
regulation of Cr(VI) inhibition of HR repair.

Oropharyngeal Aspiration Rat Model Established
In this study, we successfully established an oropharyngeal aspiration rat
model to study particulate Cr(VI) carcinogenesis. We found Cr was inhaled into rat
lungs and accumulated in each lung lobe after both acute and subchronic
exposures. We observed the outcomes of Cr(VI)-induced DNA double strand
break and HR repair changes in rat lung tissues. Ours is the first study to apply
oropharyngeal aspiration to a rat model for studying Cr(VI). This mode of
administration has been used in two recent studies of mice considering the effects
of chronic repeated calcium chromate exposure (Zeidler-Erdely et al., 2020; Wang
et al., 2022). One study exposed A/J mice to iron sesquioxide or calcium chromate
through oropharyngeal aspiration once per week for 26 weeks and found increased
incidence of tumors compared with the control group (Zeidler-Erdely et al., 2020).
The other study exposed A/J mice to calcium chromate once per week for 26
weeks via oropharyngeal aspiration and found total RNA m6A levels in chromateexposed mouse lungs were significantly higher than in the vehicle group and
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METTL3 protein levels were drastically increased in chromate-caused mouse lung
tumors (Wang et al., 2022). These two mouse studies combined with our rat study
indicate oropharyngeal aspiration is a useful tool for studying Cr(VI)
carcinogenesis. We successfully translated the outcomes found in cell culture
studies to experimental animals through this model.

Whales Are Resistant to Cr(VI)-Induced HR Repair Deficiency and
Chromosome Instability
Few studies have examined the response of whale lung cells to Cr(VI)
exposure. This study is the first to investigate Cr(VI)-induced DNA double-strand
breaks and HR repair in bowhead whale cells and the first one to compare the
effects of Cr(VI) exposure in human lung cells, rat lung cells, and bowhead whale
lung cells.
We found Cr(VI) causes DNA double-strand breaks in bowhead whale lung
cells with the similar amount as in human lung cells. Meaza et al. reported that Cr
induces DNA double-strand breaks in fin whales' skin cells by the neutral comet
assay (Meaza et al., 2021). Our finding is consistent with this report
We found the canonical DNA break response to acute and prolonged
exposure to Cr(VI) in whale cells. Similar amounts of breaks formed, the cells
arrested in G2 and HR repair was induced consistent with a G2 arrest. Whale lung
cell response to Cr(VI)-induced DNA double strand breaks was similar to the
human lung cell response after acute exposure, but was notably different after
prolonged exposure. Specifically, prolonged particulate Cr(V) exposure induced
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HR repair in bowhead whale lung cells, but our previous reports in human lung
cells showed prolonged exposure inhibited HR repair (Qin et al., 2014; Browning
et al., 2016). Our data in bowhead whale cells is consistent with data on North
Atlantic right whale lung cells that found similar SCE levels after acute and chronic
SCE exposure (Browning et al., 2017). These findings suggest whales are
resistant to Cr(VI)-induced HR suppression. Such a conclusion is consistent with
our observations that Cr(VI): 1) caused a weaker G2 arrest, 2) did not cause
chromosomal instability and 3) showed lower cytotoxicity in bowhead whale cells.
Li Chen et al. found sperm whale skin cells are also resistant to acute Cr(VI)induced cytotoxicity and clastogenicity and show less cytotoxicity and genotoxicity
than the human skin cells (Li Chen et al., 2012).
It is interesting to note that Cr(VI)-induced G2 arrest in bowhead whale
lungs was not as pronounced as in human lung cells, or even detectable by flow
cytometry. This study is the first to investigate cell cycle profiles in whale cells and
the first report to compare Cr(VI)-induced G2 arrest in different species. It is
possible that the differences in G2 arrest may reflect some technical artifact in the
measurements or that the assay lack precision. However, it is also possible that
this result confirms that the efficiency and capacity of HR repair in whale lung cells
are superior to that in human lung cells. Perhaps, G2 arrest is less pronounced in
the whale cells because the repair for the breaks or the underlying lesions is more
efficient.
Taking together, bowhead whale lung cells are resistant to Cr(VI)-induced
HR repair deficiency, resulting in no chromosome instability and more cells
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surviving after Cr(VI) exposure. These outcomes mean Cr(VI)-induced HR repair
deficiency resulting in chromosome instability is the core driver in Cr(VI)
carcinogenesis. These findings shed an important light to explore the mechanism
of how whales avoid cancer.

Conclusion of this study's findings
We successfully translated Cr(VI)-induced DNA double strand break and
HR repair inhibition from cells to experimental animals, normal human lung tissue,
and Cr(VI)-associated human lung tumors. Our findings established a mechanism
for Cr(VI)-induced DNA double strand break and HR repair inhibition in Cr(VI)
carcinogenesis. The translated data in whale lung cells strongly confirm Cr(VI)induced HR repair deficiency resulting in chromosome instability is the core driver
in Cr(VI) carcinogenesis.
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FUTURE DIRECTIONS
The data presented in this project study help to explore the mechanism of
Cr(VI)-induced carcinogenesis. It is the first study to investigate DNA doublestrand breaks and HR repair in experimental animal lung tissue, normal human
lung tissue, and human lung tumors. We translated Cr(VI)-induced DNA doublestrand breaks and HR repair inhibition to subchronically exposed rat lungs and
chromium-related lung tumors. These data generate many new ideas and
hypotheses for future research.
We found HR repair inhibition in Cr-associated human lung tumors. With
only three tumors analyzed, there is a need to investigate HR repair in more Cr(VI)associated lung tumors. In addition, it would be interesting to consider HR repair
in lung tumors unrelated to Cr(VI). This effort will be a valuable future direction.
Already based on a preliminary analysis of RNA-seq data from large cohorts of
patients from the TCGA project, RAD51 expression actually increases in most lung
squamous cell carcinomas in general. Thus, this analysis combined with our
findings suggests Cr(VI)-induced RAD51 decrease may indeed be specific to
Cr(VI)-induced lung cancer.
Translational data in whale lung cells strongly confirm that Cr(VI)-induced
HR repair deficiency leading to chromosomal instability is a core driver of Cr(VI)
carcinogenesis. This outcome makes it necessary to investigate chromosomal
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instability in experimental animal lung tissue, normal human lung tissue, and
human lung tumors. We will investigate chromosomal instability using
fluorescence immune in situ hybridization.

Wise et al. found structural

chromosomal instability in some specific chromosomes in chronically exposed
human lung cells (Wise et al., 2018). We will investigate chromosomal instability
in lung tissue after chromium exposure using fluorescent in situ hybridization. The
translation of chromium-induced chromosomal instability into experimental animal
lung tissue and human lung tumors will be carried out.
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APC: Adenomatous polyposis coli
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ATSDR: Agency for Toxic Substances and Disease Registry
BLM/Dna2: Bloom helicase/Dna2 helicase
BrdU: 5-bromodeoxyuridine
CIN: Chromosome instability
c-NHEJ: Classical non-homologous end joining
Cr(III): Trivalent chromium
Cr(VI): Hexavalent chromium
Cr: Chromium
CtIP: C-terminal binding protein 1
DAPI: 4′,6-diamidino-2-phenylindole
DNA: Deoxyribonucleic acid
EDTA: Ethylenediaminetetraacetic acid
Exo1: Exonuclease 1
FISH: Fluorescence in situ hybridization
hMLH1: Human MutL homolog 1
hMLH2: Human MutL homolog 2
HR: Homologous recombination
hTERT: Human telomerase
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ICP-MS: inductively coupled plasma mass spectrometry
IR: Ionizing radiation
MGMT: O6-methylguanine-DNA methyltransferase
MMR: Mismatch repair
MRN: MRE11, RAD50 and Nbs1 complex
MSI: Microsatellite instability
NIOSH: National Institute for Occupational Safety and Health
OSHA: Occupational Safety and Health Administration
RAD51: RAD51 recombinase
RAD51C: RAD51 paralog C
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WTHBF-6: hTERT-immortalized human bronchial fibroblasts
XRCC3: X-Ray Repair Cross Complementing 3
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7. Kouokam, J.C., Speer, R.M., Meaza, I., Toyoda, J.H., Lu, H., Kong, M., and
Wise, Sr., J.P. The involvement of the inflammatory response in particulate
hexavalent chromium-induced toxicity. Presented at Research!Louisville,
Kentucky, October 2021.
Seminars and Oral Presentations
1. Homologous Recombination Repair Protects Against Genomic Instability in
Bowhead Whale Lung Cells after Prolonged Particulate Chromate Exposure.
Presented at Department of Pharmacology &Toxicology Seminar, Louisville,
February 2019.
2. Whale Cells are Resistant to Cr(VI)-induced Loss of Homologous
Recombination Repair. Presented at the annual meeting of the Ohio Valley
Chapter of the Society of Toxicology (OVSOT), November 2020.
3. Can Whales Resist Chromium-Induced Cancer? Presented at the annual
meeting of the Ohio Valley Chapter of the Society of Toxicology (OVSOT),
November 2020.
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4. Whale Cells Resist Cr(VI) Carcinogenesis. Presented at 3MT University of
Louisville, March 2021
5. Can Whales Resist Chromium-Induced Cancer? Presented at the annual
meeting of the Society of Toxicology (SOT), March 2021.
6. Whale Cells Are Resistant to Cr(VI)-induced Chromosome Instability. Three
Minute Poster Talk with the Genetic Toxicology Association Annual Meeting, May
2021.
7. Translating Particulate Hexavalent Chromium-Induced Chromosome Instability
from Human Lung Cells to Experimental Animals, Human Lung Tumors and Whale
Cells. Presented at the Department of Pharmacology &Toxicology Seminar,
Louisville, May 2021.
8. Hexavalent Chromium Inhibits Homologous Recombination Repair in Rat Lung.
Presented at the annual meeting of the Ohio Valley Chapter of the Society of
Toxicology (OVSOT), November 2021.
Meetings Attended (current year and previous 5 years)
2017 Research!Louisville
2018 Annual Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
Research!Louisville
Graduate Student Regional Research Conference
2019 Annual Meeting of the Society of Toxicology (SOT)
Annual Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
Research!Louisville
Graduate Student Regional Research Conference
2020 Annual Meeting of the Society of Toxicology (SOT)
Annual Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
American Society for Cell Biology
Graduate Student Regional Research Conference
2021 Annual Meeting of the Society of Toxicology (SOT)
Annual Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
Summer Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
Annual Meeting of Genetic Toxicology Association (GTA)
Research!Louisville
Annual Meeting of the Environmental Mutagenesis and Genomics Society
(EMGS)
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2022

Annual Meeting of the Society of Toxicology (SOT)

Honors, Awards and Professional Activities
2022

Dharm V. Singh Carcinogenesis Graduate Student Endowment Award,
Carcinogenesis Specialty Section, Society of Toxicology

2022 Travel Award, University of Louisville
2021 Second place, short oral presentation award, Ohio Valley Chapter of the
Society of Toxicology
2021 Graduate Student Council Fall Research Grant, University of Louisville
2021 Abstract Award, Genetic Toxicology Association 2021 Annual Meeting
2021 First place, short oral presentation award, Society of Toxicology
2021 Graduate Student Council Spring Research Grant, University of Louisville
2020 Second place, short oral presentation award, Ohio Valley Chapter of the
Society of Toxicology
2019 Student Travel Award, Society of Toxicology
2017 Graduate Student Council Research Grant, University of Louisville
Professional and Academic Memberships
2016 – Present Graduate Student Member – Society of Toxicology
Ohio Valley Regional Chapter, Metals Specialty Section, Carcinogenesis
Specialty Section, Women in Toxicology Special Interest Group
Field Work
2018-2021 Whale biopsy collection in the Gulf of Maine
Techniques and Skills
Cell culture
Western blot analysis
Immunofluorescence
Confocal microscopy
Chromosome analysis
Single cell gel electrophoresis
Flow cytometry
PCR
RT-qPCR
DNA transformation
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Plasmid transfection
Rat chemical inhalation exposures
Rat and mouse lung inflation, anesthesia, euthanasia, handling
Tissue staining (hematoxylin and eosin, picrosirius red, immunofluorescence)
Fluorescence in situ hybridization (FISH)
Wildlife primary cell line establishment
Whale ID and biopsy processing
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